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Abstract 
Design and application of probes of novel bioactivities 
Marie Landrum 
Ph.D, October 2009 
Whilst methods for the isolation and optimisation of bacterial enzymes for preparative 
biotransformations are well established the use of plant biocatalysts is relatively 
unexplored. Since the plant kingdom contains a greater diversity of potential 
biocatalysts this represents an untapped resource. Two simple plant enzyme systems 
were investigated: AtSFGH and AtCXE12. A series of profluorescent esters based on 
4-methylumbelliferone and fluorescein were synthesised and used in screening 
experiments against these enzymes. To produce libraries of recombinant proteins 
molecular biology techniques such as site-directed mutagenesis and error-prone PCR 
were utilised and Agrobacterium tumefaciens infiltration methods developed to increase 
the levels of transformation within plant protoplasts.  
In order to isolate specific enzymes probe molecules were developed in which a desired 
bioactivity resulted in the ‘switching on’ of a fluorophore during enzymatic processes. 
Several reactivity probes were synthesised which contained a fluorophore, a fluorescent 
quencher moiety and a functional group which was able to react with a specific protein 
target. An ester probe was developed which reacted with porcine liver esterase, with 
the enzymatic response causing the molecule to fragment in such a way as to release the 
fluorescent quencher and result in a concomitant increase in fluorescence. The modular 
synthesis and structure of the probe allowed for a variety of reactive groups to be 
introduced. 
Several BODIPY analogues were synthesised that were able to exclusively target the 
peroxisome organelle, as demonstrated by co-localisation studies. Their proliferation in 
the presence of external signals, such as the drug clofibrate and biotic stress, were 
studied. Confocal microscopy enabled the dynamics of the peroxisome to be visualised 
in a variety of cell types and species, including both plant and mammalian cells. In 
addition to this computational studies were carried out to enable the rational design of 
probes based on their fluorescent properties. Systematic alteration of the probe 
molecule has highlighted areas of the compound which are amenable to adaptation. 
This includes the ability to extend the conjugation of the pyrrole functionality which 
enables the emission wavelength, and hence colour, to be changed. 
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1  GENERAL INTRODUCTION 
1.1 Introduction 
The current state of the art for the development of new bioactivities relies on the 
expression of recombinant enzymes in bacterial hosts. Such an approach has limitations 
if the cellular environment required to support catalysis is absent in the microbial host. 
Recent advances in plant transformation technology potentially allow the exploitation 
of plant cells as a generic host for biocatalyst transgene expression. The use of plant 
expression systems has been limited by the relative efficiency in their transformation 
and their relatively short lifetime. These problems can be resolved by exploiting and 
enhancing the power of flow cytometry to rapidly analyse and sort large populations of 
plant protoplasts which have been genetically transformed to express libraries of 
recombinant biocatalysts. In the search for novel biocatalysts, current research is aimed 
towards the technique of directed evolution. Through the use of mutagenesis methods, 
directed evolution involves the production and selection of a variant enzyme with the 
desired properties.  
This project is concerned with the development of methodology for the identification, 
isolation and optimisation of novel biocatalysts. In order to achieve this, reactivity 
probes are used to isolate biocatalysts and the technique of flow cytometry employed to 
sort arrays of mutant enzymes against profluorescent probes. New specific, more stable 
enzymes can be produced and these exciting techniques, along with directed evolution, 
are discussed further within this chapter. The importance of transgenic hosts and 
reactivity probes will also be considered. Further details of the enzymes AtSFGH and 
AtCXE12, which have been targeted as model proteins of interest, are described in 
Chapter 2. These enzyme systems have been of previous interest to the group. 
Discussion of the procedures undertaken in the design and use of fluorescent reactivity 
probes based on both phenylacetylene and BODIPY are given in Chapters 3 and 4. The 
application of studies towards the isolation of oxidative cytochrome p450 is also 
discussed in Chapter 4. Studies undertaken on peroxisomes are detailed in Chapter 5. 
All experimental procedures are documented in Chapter 6.  
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1.2 Directed Evolution 
1.2.1 Introduction 
In an effort to mimic natural selection, directed evolution aims to generate an enzyme 
with improved or new activity by screening and selecting for the desired function from 
a large pool of enzyme variants. Current research is aimed at the production of enzyme 
variants with improved stability,1 specificity2 and selectivity,3 including 
enantioselectivity4 and regioselectivity.5 Directed evolution is a process of iterative 
cycles, with the mutant gene of the optimal enzyme variant subjected to several rounds 
of mutagenesis/expression/screening. This creates an evolutionary pressure, leading to 
a much improved enzyme. Mutations can be introduced at specific points using site-
directed mutagenesis or throughout the gene by random mutagenesis, such as error-
prone PCR and DNA shuffling. An important tool for all mutagenesis techniques is the 
polymerase chain reaction (PCR), which amplifies DNA. 
1.2.2 Polymerase Chain Reaction (PCR) 
This technique allows scientists to amplify a specific DNA sequence millions of times in 
just a few hours. During PCR, high temperature is used to separate the DNA molecules 
into single strands; synthetic sequences of single-stranded DNA serve as primers. Two 
different primer sequences are used to bracket the target region to be amplified. One 
primer is complementary to one DNA strand at the beginning of the target region; a 
second primer is complementary to the other strand at the end of the target region (See 
Figure 1.1). 
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Figure 1.1 The polymerase chain reaction (PCR) 
To perform a PCR reaction, a small quantity of the target DNA is added to a test tube 
with a buffered solution containing DNA polymerase, short oligonucleotide primers, 
the four deoxynucleotide bases of DNA and the cofactor MgCl2. The PCR mixture is 
taken though replication cycles consisting of: 
 94 – 96 ºC: DNA is denatured into single strands 
 50 – 65 ºC: Primers anneal (hybridise) by way of hydrogen bonds to their 
complementary sequences on either side of the target sequence 
Separate strands and 
anneal primers 
 
Separate strands  
and anneal primers 
Separate strands 
and anneal primers 
Extend primers 
Extend primers 
Extend primers 
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 72 ºC: DNA polymerase binds and extends a complementary strand from 
each primer 
Automated PCR came about through the use of Taq DNA polymerase which was 
isolated from the bacterium Thermus aquaticus. This enzyme is able to remain active 
through the heating required during the many cycles of amplification. After just 30 
cycles over 1 billion copies of the target DNA sequence can be synthesised. 
1.2.3 Site-directed Mutagenesis 
Site-directed mutagenesis, a technique that relies on computational or molecular 
modelling to identify the amino acids involved in key interactions with the substrate, is 
commonly used in directed evolution studies. In general, site-directed mutagenesis 
requires that the wild-type gene sequence be known. An oligonucleotide with a 
sequence containing a desired mutation is chemically synthesised and annealed by base 
pair H-bonding to the complementary wild-type gene sequence. The synthetic 
oligonucleotide is used as a primer for the in vitro synthesis of a new DNA strand that is 
complementary to the original (template) strand. This newly synthesised strand of 
DNA has the primer and the desired mutation incorporated into it. By using a pair of 
primers and the polymerase chain reaction it is possible to amplify the newly created 
DNA molecule and produce enough copies to make further manipulation of the new 
DNA possible.  
Arnold and co-workers5 utilised site-directed mutagenesis in the directed evolution of 
the bacterial cytochrome P450 BM-3. This enzyme hydroxylates linear medium chain 
(C12 – C18) fatty acids at the ω-1, ω-2 and ω-3 positions in the presence of O2, using 
NADPH as a co-factor. Using the crystal structure of the enzyme active site, two key 
residues, alanine328 and alanine82, were targeted for mutagenesis. Alanine328 was 
converted to valine in order to reduce the volume of the active site. The variant enzyme 
A328V was able to hydroxylate shorter chain fatty acids (C7 – C9) with a shift in the 
regioselectively towards the ω-2 position, compared with the wild-type which resulted 
in roughly equal hydroxylation at the ω-2, ω-3 and ω-4 position. It was also shown that 
a second mutant A82L was able to hydroxylate propane at faster rates and with higher 
turnover numbers than the wild-type enzyme. 
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1.2.4 Error-prone Polymerase Chain Reaction (epPCR) 
Error-prone polymerase chain reaction (epPCR) is a random mutagenesis technique 
used to introduce amino acid changes into proteins. Mutations are deliberately 
introduced during PCR through the use of error-prone DNA polymerases and varying 
reaction conditions. Traditional epPCR methods commonly employ Taq DNA 
polymerase as it lacks a 3’ – 5’ proofreading activity and is inherently error-prone.6 
Various conditions are employed to alter the mutation rates, which include the use of 
reaction buffers containing Mn2+ (in place of the normal divalent ion Mg2+) and 
unbalanced, or unnatural,7 dNTP concentrations.  Commonly a low mutation rate is 
chosen so as to ensure an average of only one amino acid exchange per enzyme 
molecule. However, the use of Taq polymerase often gives rise to a mutational bias, 
favouring transversions over transitions and being 4 times more likely to mutate As 
and Ts than Gs and Cs.8  
Various other polymerases have been used in an attempt to overcome this mutational 
bias. One example includes the error prone polymerase Mutazyme® II, developed by 
Stratagene.9 This enzyme exhibits a much lower mutational bias compared to Taq, 
Figure 1.2. 
 
Figure 1.2 Mutazyme II DNA polymerase mutates Gs and Cs at nearly identical rates compared to As 
and Ts. 
Reetz employed this technique to enhance the enantioselectivity of a lipase-catalysed 
hydrolytic kinetic resolution involving a chiral ester.10 The wild-type lipase from 
Pseudomonas aeruginosa, which catalyses the hydrolysis of ester 1 with slight preference 
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for the S-acid, See Scheme 1.1, was mutated into a variant enzyme which shows high 
S-preference. 
CO2R
1R COOHR COOHR
+
lipase
  1 R = n-C8H17
     R1 = p-NO2-C6H4
S R
 
Scheme 1.1 Lipase-catalysed hydrolysis of p-nitrophenol ester 1 
In an extension to this work, epPCR was again employed with a change in the 
conditions resulting in an increased mutation rate (2 – 3 amino acid changes, compared 
with 1 in the previous experiment). A library of 15,000 clones was screened which 
indentified several S-selective mutants, but also two R-selective variants.11 One of these 
R-variants was selected for further mutagenesis and after another two rounds of epPCR 
the E-value was increased from 2.0 to 7.0. 
Upon inserting the mutant genes into a host such as E. coli, variant enzymes are 
expressed which are individually screened for activity in the reaction of interest. As this 
process can be repeated several times there is no necessity to know anything about the 
structure or mechanism of the enzyme, an advantage when compared with site-
directed mutagenesis. This technique is discussed in more detail in section 2.2.3.4. 
1.2.5 DNA Shuffling 
More radical mutations can be achieved through recombination techniques. Stemmer 
was the first to report this and coined the technique DNA-shuffling.12 This method 
takes a collection of homologous genes and fragments them into small pieces by limited 
digestion with DNase I. Following purification to remove undigested material the 
combined fragments are then reassembled in a primer-less PCR reaction in the presence 
of a thermostable polymerase (See Figure 1.3). Recombination arises as a result of 
fragments from different parent genes cross-priming to produce a hybrid DNA strand. 
Stemmer’s group demonstrated their technique on a -lactamase enzyme system and 
results showed a 32,000-fold increase in activity, compared with a 16-fold increase 
when utilising only cassette mutagenesis and error-prone PCR techniques.  
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Shao et al13 reported the similar technique of random priming recombination (RPR), in 
which the gene fragments are obtained through random priming synthesis, avoiding 
the use of DNase I. Following template removal the fragments are used to reassemble 
parent sized hybrid genes as in conventional DNA shuffling.  
 
Figure 1.3 Homologous in vitro recombination method (DNA shuffling) used to create hybrid gene 
libraries from multiple parental sequences. Nat. Prod. Rep., 2004, 21, 492 – Reproduced by permission of The 
Royal Society of Chemistry 
A high level of recombination is important to achieve all possible combinations of 
mutations. As these recombinations can be biased, several methods have been 
developed to overcome this.14 These methods can be divided into distinct groups, each 
having their advantages and disadvantages, which are outlined below. 
1.2.5.1 Full length parent shuffling 
The staggered extension process (StEP),15 whereby the use of gene fragments is 
eliminated, uses template-switching as a way of building chimeric sequences from 
multiple parents (See Figure 1.4). The recombination of small fragments from different 
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origins using one or more full length strands allows a higher recombination frequency 
over normal DNA shuffling. However, these recombinations tend to be more elaborate.  
 
Figure 1.4 Staggered Extension Process (StEP). Nat. Prod. Rep., 2004, 21, 493 – Reproduced by permission of 
The Royal Society of Chemistry 
A more recently developed technique, which combines features of both DNA shuffling 
and StEP, is termed random chimeragenesis on transient templates (RACHITT).16 
Initially parental genes are fragmented using DNase I with a uracil-containing template 
strand used in the direct assembly of chimeras from the fragment pool. Fragments 
annealed to the transient template are trimmed and joined by treatment with nuclease 
competent polymerases and DNA ligase. The template strand is then glycosylated by 
uracil-DNA-glycosylase, rendering it non-amplifiable in further PCR experiments (See 
Figure 1.5). This effectively eliminates the parent templates from the gene pool, a 
common problem encountered with other methods of homologous recombination. 
Although RACHITT appears to be a more demanding technique than those previously 
discussed, a much more diverse library is produced due to a greater number of 
crossovers per gene. 
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Figure 1.5 Random Chimeragenesis on Transient Templates. Nat. Prod. Rep., 2004, 21, 493 – Reproduced 
by permission of The Royal Society of Chemistry 
A common problem with each of the above techniques is the prerequisite of a high 
DNA sequence homology in order to generate hybrid crossovers. To overcome this 
several methods have been developed to create hybrid libraries independent of the 
DNA sequence homology of the parental genes. This has been achieved by eliminating 
the need for homologous fragment hybridisation and allows the possibility for more 
distantly related protein sequences to be recombined in a combinatorial technique. 
1.2.5.2 Single cross-over 
This group includes methods that involve the recombination of low or non-homologous 
genes by ligating the front and back of two different genes. One such technique, known 
as incremental truncation for the creation of hybrid enzymes (ITCHY),17 involves the 
production of two opposing incremental truncation libraries, in which every single 
DNA base pair deletion is generated (See Figure 1.6). Following blunting with 
single-stranded nuclease, the two fragment libraries are then randomly fused 
head-to-tail to produce a single crossover hybrid gene library. As the ligation step is 
completely random hybrids of all possible lengths and reading frames are produced. 
The selection of variants is possible by size. 
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Figure 1.6 Incremental Truncation for the Creation of Hybrid Enzymes. Nat. Prod. Rep., 2004, 21, 493 – 
Reproduced by permission of The Royal Society of Chemistry 
Another technique within this group is termed sequence homology-independent 
protein recombination (SHIPREC). This involves the fusion of two parent genes to form 
a dimer which is then digested with DNase I to produce random length fragments. 
Fragments that are the same length as either of the two parent genes are isolated and 
the remaining ends are fused by circularisation (See Figure 1.7).  
 
Figure 1.7 Sequence Homology-Independent Protein Recombination. Nat. Prod. Rep., 2004, 21, 493 – 
Reproduced by permission of The Royal Society of Chemistry 
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Sieber and co-workers successfully used this method to produce interspecies hybrids of 
a human cytochrome P450 (1A2) and a soluble bacterium P450 (BM3). They identified 
two functional P450 hybrids which were more soluble in the bacterial cytoplasm than 
the wild-type 1A2 enzyme. Problems with the single crossover technique include the 
fact that only one recombination point is possible. Increasing numbers of crossovers are 
desirable as they have been shown to improve the evolution of proteins with 
appropriate characteristics.18 
1.2.5.3 Domain swapping 
Techniques within this group include exon shuffling19 and degenerate oligonucleotide 
gene shuffling (DOGS)20 and incorporate the recombination of structural, functional or 
less homologous parts of different family members. Bequist and co-workers developed 
the DOGS procedure21 using degenerate primers that allowed control of the level of 
recombination between the genes that are shuffled and hence reduces the regeneration 
of unshuffled parent genes. Arnold et al19 have developed the sequence-independent 
site-directed chimeragenesis (SISDC) method, which allows crossovers at multiple sites 
and is independent of DNA sequence identity shared by the parent genes (See Figure 
1.8). They showed that the ligation of building blocks regenerated a full-length and 
highly recombined library of two distantly related -lactamases, TEM-1 and PSE-4. It 
often results in more active enzymes but with only a few recombination points, which 
are often difficult to locate.  
 
Figure 1.8 Sequence-Independent Site-Directed Chimeragenesis. Nat. Prod. Rep., 2004, 21, 493 – 
Reproduced by permission of The Royal Society of Chemistry 
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1.2.5.4 In vivo recombination 
These methods involve recombination using the gap repair system of yeast or the 
recE/recT system of E. coli. Abécassis et al22 used the combinatorial libraries enhanced 
by recombination in yeast (CLERY) procedure to successfully create hybridised 
cytochrome P450 CYP1A1 and CYP1A2 enzymes.  This process results in a high yield as 
there is no ligation necessary, however, specialised vectors and multiple steps are 
required.  
1.2.5.5 Synthetic shuffling 
Synthetic shuffling, which includes single step shuffling, involves the recombination of 
known or unknown mutations in synthetic oligonucleotides. It uses sequence length 
rather than sequence similarity to achieve crossovers at positions likely to be 
structurally related (See Figure 1.9). Developed by Ness et al23 this method was used in 
the study of the serine protease subtilisin, in which a variant enzyme was generated 
with both improved thermostability and high pH tolerance. Two synthetic variants 
were found to be two- to four-fold more active at pH 10 after heat treatment at 70 C, 
compared with Savinase®, the current commercial product. Synthetic shuffling allows 
the recombination of close mutations, but this technique is expensive and good 
selection is necessary. 
 
Figure 1.9 Synthetic Shuffling. Nat. Prod. Rep., 2004, 21, 493 – Reproduced by permission of The Royal Society 
of Chemistry 
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1.3 Screening and Selection Techniques 
1.3.1 Introduction 
The success of a directed evolution experiment is highly dependent on the screening 
method used to locate the optimum variant. Since most directed evolution experiments 
generate a huge mutant library, typically around 15,000 clones, a high throughput 
selection strategy needs to be developed to screen for different enzyme functions. These 
methods should be sufficiently sensitive and specific to identify positive variants.24 An 
important point to note here is the difference between the terms selection and 
screening. Screening involves the assaying of all library members individually and 
requires an active search of all the variants produced. In selection criteria, conditions 
are set that allow only variants of interest to appear. This is achieved by exploiting the 
conditions favourable for the exclusive survival of desired variants. Some of the most 
commonly utilised techniques, including pH indicators, digital imaging, in vivo 
compartmentalisation and fluorescence activated cell sorting are outlined in the 
following section. 
1.3.2 pH-Indicators 
pH indicators allow the screening of libraries based on the change in pH as a result of 
the enzyme reaction. This can be seen in the following example in which Bornscheuer et 
al produced a variant esterase enzyme library and screened for mutants on the basis of 
pH.25 These libraries were assayed by means of agar plates in the presence of pH 
indicators in combination with a growth assay. Identification of the desired variants, 
which were required to hydrolyse the sterically hindered esters 2 and 3, Scheme 1.2, 
was performed using a combination of neutral red and crystal violet indicators. The 
formation of a red colour, caused by a pH decrease due to the released acid, allowed the 
easy detection of active variants. 
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Scheme 1.2 
They also introduced a selection criterion by utilising the metabolite of the glycol ester 
3, as the release of the carbon source glycerol facilitates growth on the minimal media 
used. Using this strategy Bornscheuer identified a double mutant which hydrolysed 3 
in a stereoselective manner.  
Major advantages of the use of pH indicators are that a large number of clones can be 
examined within a short space of time, e.g. 300 – 500 colonies per plate, the wide variety 
of pH indicators allowing the adaption of the assay to the optimum pH range of the 
enzyme of interest and that there is no need for special substrates. 
1.3.3 Colorimetric Assay 
UV/Vis spectrophotometry methods permit high throughput screening due to the 
simple and fast measurements which can be taken. Zocher et al26 utilised UV/Vis 
spectrophotometry in the determination of epoxide hydrolytic activity by measuring 
the decrease of epoxide concentration. They used the 4-(p-nitrobenzyl)pyridine (NBP, 4) 
test, which can determine the epoxide concentration due to alkylation of 4, Scheme 1.3. 
N
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Scheme 1.3 Alkylation of epoxide by NBP, 4 
Purple/Blue 
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Various substituted epoxide substrates, such as styrene oxide, indene oxide, n-hexane 
oxide and n-decane oxide were used. A linear correlation between epoxide 
concentration and absorbance was found for all epoxides except n-decane oxide. A 
microtiter-plate assay with a robotic arm was used and showed a high sensitivity for 
the detection of low levels of epoxide concentration (0.1 – 1 mg/well). This method was 
found to be suitable for the screening of epoxide hydrolase in the presence of other 
enzymes such as esterases, lipases or proteases. Zocher postulates that with the use of 
enantiomerically pure epoxides the identification of enzyme variants with high 
enantioselectivity should be possible. 
1.3.4 Digital Imaging 
This technique relies on the metabolite product being coloured and/or fluorescent, 
allowing easy detection. A specific advantage of fluorescence-based imaging is the high 
degree of sensitivity, which allows the use of very dilute substrate concentrations and 
extremely small amounts of catalysts. Copeland et al have used a fluorescence-based 
method for assaying the activity of catalysts in acylation reactions.27 They were able to 
determine the activity of several acylation catalysts by the use of a molecular sensor 
which fluoresces upon formation of the product (See Figure 1.10). In their experiments, 
isopropanol (5; R1 = R2 = CH3) was treated with acetic acid anhydride in the presence of 
the nonfluorescent chemosensor 6. In the absence of catalysts no fluorescence was 
observed. Upon the addition of tetrapeptide catalysts, of which 7 is an example, 
fluorescence was detected using a fluorescent plate reader, monitored for 30 – 40 
minutes. 
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Figure 1.10 
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For coloured metabolites, UV/Vis spectrophotometry can be used for the screening of 
variant enzymes. Janes and co-workers have developed a colorimetric assay for testing 
the enantioselectivity of esterases in ester hydrolyses.28 This assay was able to simulate 
the competitive conditions of an enzymatic process. A mixture of the p-nitrophenol 
ester of one enantiomeric form of a chiral ester 8 and a reference compound, the 
resorufin ester 9, was subjected to enzyme-catalysed hydrolysis. Upon hydrolysis of S-8 
and the reference compound 9, yellow and pink chromophores were formed. If both 
substrates are hydrolysed the solution turns deep orange (See Scheme 1.4). 
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Scheme 1.4 
The two hydrolyses were monitored in the same solution by recording the UV/Vis 
absorption of the two products at 404 and 572 nm wavelengths. The ratio of hydrolysis 
of the two different compounds yielded the selectivity of the esterase for S-8 over the 
reference, 9. To determine the enantioselectivity of the enzyme the assay was repeated 
using R-8 and 9. This method is able to overcome previous limitations as in past 
experiments both the R and S enantiomers needed to be screened separately, therefore 
unable to test normal enzymatic conditions, such as competitive binding of the two 
enantiomers to the enzyme. 
This screening technique was successfully used to identify a lipase with a much 
improved enantioselectivity. The wild type enzyme, with a 2% ee, was optimised to 
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yield a lipase exhibiting an 81% ee in only four cycles of epPCR.29 One limitation that 
remains is that the optimisation is performed on the p-nitrophenol ester 8 and not on a 
more practical ester such as the analogous methyl ester. 
1.3.5 IR Thermography  
This screening technique uses an infrared camera to detect minute changes in 
temperature in the reaction vessel, with an increase relating to an increase in activity. IR 
radiation is actively emitted from all objects and no external light source is required for 
imaging. The IR image of an object is composed of emitted and reflected radiation with 
the relative ratio different for each surface. The different colours on these images 
visualise different photon intensities of detected IR radiation. From these photon 
intensities blackbody temperatures can be calculated by Planck’s law. These blackbody 
temperatures can be converted to the actual surface temperature of the object only if no 
reflection occurs or becomes insignificant and its emissivity is known.30 A PtSi-based 
camera was used in order to allow emissivity correction. To avoid reflections at the 
catalyst library, a slate plate of low reflectively was chosen. As these two factors were 
controlled the heat evolution due to the catalytic activity of the enzyme was reliably 
detected since only temperature changes are visible. Temperature differences of 0.1 K 
are clearly detected. 
Reetz used this technique to screen for enantioselective lipases in the acylation of 
1-phenylethanol, 10, with vinyl acetate (See Scheme 1.5).31 This reaction proceeds with 
99% enantioselectivity in favour of the R-ester in the presence of a catalytic amount of 
lipase. Using a microtiter plate, Reetz added vinyl acetate to separate solutions of R-10, 
S-10 and rac-10 and measured the temperature change at 5 second intervals, taking 250 
recordings. 
Ph
OH
Ph
OAc
Ph
OH
OAc
rac-10 S-10  
Scheme 1.5 
Changes in temperature could be clearly seen, indicated by the appearance of red spots 
(See Figure 1.11), showing that R-10 reacts preferentially over S-10. As spatial resolution 
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is not a problem this method lends itself towards the high-throughput screening of 
active enzymes. 
 
Figure 1.11 Time-resolved IR-thermographic imaging of the lipase-catalysed enantioselective 
acylation of 10 after 0.5 mins. The bar on the right is the temperature/colour key of the temperature 
window used (ºC). Reetz M.T., Becker M.H., Kühling K.M. and Holzwarth A., Detection of Catalytic Activity in 
Combinatorial Libraries of Heterogeneous Catalysts by IR Thermography, Angew. Chim. Int. Ed., 1998, 37, 2647-
2650. Copyright Wiley-VCH Verlag GmbH & Co. KGaA. Reproduced with permission. 
1.3.6 Yeast Two-hybrid System 
Directed evolution is generally limited to those reactions in which enzyme variants can 
be easily screened or selected, often restricting this to reactions in which the product is 
fluorescent or an essential metabolite. The yeast two-hybrid system overcomes this 
problem and is used to detect protein-protein interactions in vivo.32 Advantages include 
the fact that it is technically straightforward and can be carried out rapidly. 
Furthermore, the sequence of two interacting proteins can be read off directly from the 
DNA sequence of the plasmids encoding them and does not depend on the identity of 
the interacting proteins and is therefore generally applicable.  
The yeast two-hybrid system consists of two protein chimeras and a reporter gene 
downstream from the binding site for the transcriptional activator (See Figure 1.12). If 
two proteins of interest (X and Y) interact, they dimerise the DNA-binding protein 
chimera (DNA-binding domain, DBD-X) and the transcriptional activation protein 
chimera (AD-Y). This dimerisation of DBD and transcriptional AD help recruit 
transcription machinery to a promoter adjacent to the binding site for the 
transcriptional activator, therefore activating transcription of the reporter gene. 
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Figure 1.12 Yeast Two-hybrid System 
This method was initially used for verifying positive protein-protein interactions but is 
also well suited to screening libraries of proteins to identify new activities. Cornish et 
al33 have developed a high-throughput assay, which has built upon the ideas of the 
yeast two-hybrid system and can be applied to a wide range of chemical reactions. They 
termed this Chemical Complementation, a method that uses a yeast three-hybrid assay 
to link enzyme catalysis to reporter gene transcription in vivo and was successfully used 
to develop variants of both -lactamase34 and glycosynthase35 enzymes.  
Chemical Complementation detects enzyme catalysis of bond formation or cleavage 
reactions based on covalent coupling of two small molecule ligands in vivo. The 
heterodimeric small molecule reconstitutes a transcriptional activator, turning on the 
transcription of a downstream reporter gene. Bond formation is detected as activation 
of an essential reporter gene, whilst bond cleavage by repression of a toxic reporter 
gene (See Figure 1.13). In both enzyme systems, Cornish has utilised 
dexamethasone-methotrexate derivatives (Dex-Mtx) as the heterodimeric ligand. 
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Figure 1.13 Chemical Complementation. A reaction-independent complementation assay for enzyme 
catalysis based on the yeast three-hybrid assay. Copyright (2002) © by the National Academy of Sciences 
A heterodimeric small molecule bridges a DNA-binding domain-receptor fusion 
protein and an activation domain-receptor fusion protein, activating transcription of a 
downstream reporter gene in vivo. Enzyme catalysis of either cleavage or formation of 
the bond between the two small molecules can be detected as a change in transcription 
of the reporter gene. 
The assay is high-throughput because it can be run as a growth selection where only 
cells containing a functional enzyme survive. The assay can be readily extended to new 
chemistry simply by synthesising small molecule heterodimers with different chemical 
linkers as the enzyme substrates.  
1.3.7 Fluorescence Activated Cell Sorting (FACS) 
Cytometry is a process for measuring the physical and chemical characteristics of 
biological cells. In flow cytometry, the measurements are made as cells flow through 
the instrument in a fluid stream. This section will detail fluorescence activated cell 
sorting (FACS), a technique in which cells are sorted by electrical and/or mechanical 
means to divert and collect cells with measured fluorescence that fall within a 
user-selected range of values.36  
FACS has been used to screen for improved antibodies. In the directed evolution of 
antibodies cell-surface display techniques are used which involve the creation of large 
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DNA libraries encoding for randomly mutated antibodies.37 These proteins are 
expressed and displayed on a scaffold and favourable variants are selected from the 
pool. Such scaffolds include bacteriophage, E. coli and yeast. Wittrup and co-workers 
engineered a fluorescein-binding single-chain Fv, achieved through four rounds of 
epPCR and FACS screening, with a dissociation constant (Kd) of 48 fM.38 However, 
limitations on the surface expression of enzymes and constraints on substrate design 
make this approach fairly specialised.39 
To overcome these constraints a technique known as in vitro compartmentalisation has 
been developed. In vitro compartmentalisation (IVC) is based on water-in-oil emulsions 
where the water phase is dispersed in the oil phase to form microscopic aqueous 
compartments. Each droplet contains a single gene and serves as an artificial cell in 
enabling transcription, translation and the activity of the resulting proteins, to take 
place within the compartment. The oil phase remains largely inert and restricts the 
diffusion of genes and proteins between the compartments. The droplet volume enables 
the detection of a single enzyme molecule. The high capacity of the system (> 1010 in 
1 ml of emulsion), the ease of preparing emulsions and their high stability over a broad 
range of temperatures render IVC an attractive system for high-throughput screening. 
The selection of enzymatic activity requires a link between the desired reaction product 
and the gene. One such method is to have the substrate, and therefore the product, of 
the desired enzymatic activity physically linked to the gene. Active enzyme-encoding 
genes can then be isolated by virtue of their attachment to the product, whilst other 
genes that encode an inactive enzyme carry the unmodified substrate (See Figure 1.14). 
Sorting of these enzymes can be achieved by fluorescent activated cell sorting (FACS). 
This technique was used to select a bacterial phosphotriesterase which exhibited a 63-
fold improved turnover number towards the substrate paraoxon compared to the wild-
type.40 Despite the obvious advantages, this mode of selection is restricted, as it must be 
performed under defined pH, buffer, ionic strength and metal ion composition.  
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Figure 1.14 Creation of microbead-display libraries and selection for catalysis by 
compartmentalisation. A) Creation of microbead-display libraries. Genes are linked to streptavidin 
coated beads (1), which are then compartmentalised in a water-in-oil emulsion to give one bead per 
compartment (2) and transcribed and translated in vitro thereby linking the gene to the protein. The 
emulsion is broken (4) and microbeads are isolated (5). B) Enzyme selection by compartmentalisation. 
Microbead-displays are compartmentalised (1) and a soluble substrate attached to biotin is added. 
This substrate is converted to the product in compartments containing active enzymes (2). The 
emulsion is then irradiated to uncage the biotin (3) and the product becomes attached to the gene via 
the bead (4). The emulsion is broken (5) and the beads are incubated with anti-product antibodies and 
a fluorescently labelled antibody (6) and enriched using flow cytometry. Reprinted by permission from 
Macmillan Publishers Ltd: EMBO Journal (22, 24-35), copyright (2003) 
There are a huge number of techniques available for the screening and selection of 
improved biocatalysts, with each one having their own advantages and disadvantages. 
1.4 Transgenic Hosts 
Bacterial transformation is the process by which bacterial cells take up DNA 
molecules.41 If the foreign DNA has an origin of replication recognised by the host cell 
DNA polymerases, the bacteria will replicate the foreign DNA along with their own 
DNA. When transformation is coupled with antibiotic selection techniques, bacteria can 
be induced to uptake certain DNA molecules, and those bacteria can be selected for. 
Bacteria which are able to uptake DNA are called competent and are made so by 
treatment with CaCl2 in the early log phase of growth. The bacterial cell membrane is 
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permeable to chloride ions but is non-permeable to calcium ions. As the chloride ions 
enter the cell water molecules accompany the charged particle. This influx of water 
causes the cells to swell and is necessary for the uptake of DNA. The exact mechanism 
of this uptake is unknown. It is known, however, that the CaCl2 treatment be followed 
by heat. When E. coli are subjected to 42 °C heat, a set of genes are expressed which aid 
the bacteria in surviving at such temperatures. This set of genes is called the heat shock 
genes. The heat shock step is necessary for the uptake of DNA. At temperatures above 
42 °C, the bacteria's ability to uptake DNA becomes reduced, and at extreme 
temperatures the bacteria will die. 
Due to their ease of transformation, including high transformation efficiency, relative 
low cost of use and wide number of publications describing a multitude of protocols, 
bacteria are the most commonly used transgenic host. However, when attempting to 
express plant-based biocatalysts in bacteria problems can arise. This is often due to the 
absence of critical co-factors which are needed for catalysis to take place. Advances in 
plant transformation technology potentially allow protoplasts to be used as transgenic 
hosts.42 Details regarding plant protoplasts, along with recent studies utilising these as 
transgene hosts are described in the following sections. 
1.4.1 Protoplasts 
Plant protoplasts are plant cells which have had the cell wall removed by treatment 
with digestion enzymes, such as fungal cellulases and pectinases.43 Despite the 
enzymatic treatment step, protoplasts maintain many of the same physiological 
responses and cellular activities as intact plants, such as active photosynthesis and 
respiration.42 Since the first recorded instance of protoplast isolation,44 they have been 
used to study a huge range of cellular mechanisms including auxin signalling,45 
membrane transport,46 cell death47 and cell wall regeneration.48 Figure 1.15 shows 
protoplasts isolated from Arabidopsis thaliana. These cells are spherical, single entities, 
surrounded by a single membrane. 
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Figure 1.15 Protoplasts isolated from Arabidopsis thaliana. The large, green organelles seen are 
chloroplasts. 
1.4.2 Transformation techniques 
Several different techniques exist for the transformation of protoplasts including 
polyethylene glycol (PEG), electroporation, particle gun and Agrobacterium tumefaciens. 
The following section will describe each one in turn highlighting both the advantages 
and disadvantages. 
1.4.2.1 Polyethylene glycol (PEG) 
Transformation methods using polyethylene glycol (PEG) are commonly used in 
combination with many other transformation techniques. Following the initial period of 
exposure to DNA, PEG is usually added in high concentrations, up to around 10 
volumes of 40% PEG 4000.49 The effect of PEG is to increase the membrane permeability 
to allow the uptake a large DNA molecules.50 The tolerance of protoplasts against PEG 
is known to vary amongst species. A variety of optimum transformation yields have 
been reported, which include 28% in Nicotiana tabacum,51 20% in Arabidopsis thaliana52 
and 13% in Brassica napus.53 PEG-mediated transformation has been used to successfully 
transform mesophyll protoplasts of Brassica oleracea with marker genes carrying 
resistance to kanamycin.54 An optimum transformation yield of 30% was achieved 
using 15% PEG 4000 at 42 °C. In addition to this successful plant regeneration was seen 
when transformed protoplasts were grown in a kanamycin environment, Figure 1.16.  
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Figure 1.16 a) Developed green plants growing on medium with 10 mg/l kanamycin for rooting; b) 
Following rooting the transgenic plant (right) was grown in soil in a greenhouse. The left plant is a 
control plant, grown directly from seeds in soil in a greenhouse. Radchuk V.V., Ryschka U., Schumann G. 
and Klocke E. Genetic transformation of cauliflower (Brassica oleracea var. Botrytis) by direct DNA uptake into 
mesophyll protoplasts, Physiol. Plant., 2002, 114, 429-438. Copyright Wiley-Blackwell. Reproduced with 
permission. 
Tiwari et al have found that transformation of protoplasts with PEG lead to their 
expansion in size from around 20 μm to 80 – 120 μm, with 10 – 20% bursting after 5 
days in culture.55 It has also been reported that the transformation rate is also affected 
by variations in the efficiency of different batches of cell wall-degrading enzymes in the 
preparation of protoplasts and in some cases can be too low for certain applications.56 
1.4.2.2 Electroporation 
This technique is based on the reversible permeabilisation of biological membranes 
induced by a short duration, high amplitude electric field. The membrane changes that 
occur during an electric pulse allow the uptake of DNA, which in turn can result in 
molecular transformation.50 Electroporation of protoplasts can result in transformation 
yields as high as 50%. Fromm et al  found this method to be useful in the transformation 
of maize protoplasts with a gene encoding for a neomycin phosphotransferase.57 
However, Meyer reported that electroporation was inappropriate for transforming 
Aspergillus giganteus due to the very low transformation yield.56 This technique is 
therefore not universally applicable and can only be used for specific species. 
1.4.2.3 Particle bombardment 
This technique involves the introduction of DNA particles into intact cells through the 
use of high-velocity microprojectiles which are able to penetrate cell walls and 
membranes.58 These microprojectiles are typically spherical particles, composed of high 
a) b) 
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density metals such as tungsten or gold and usually 0.4 – 2.0 μm in diameter. DNA is 
carried on the surface of the particles. Particle bombardment devices make use of 
macroprojectiles which can be accelerated to a high speed and thereby able to accelerate 
the microprojectile which is placed on its surface. Typically macroprojectiles are bullet-
like plastic cylinders or a disk-like metallic film. Advantages of this technique include 
the ability to transform a wide variety of tissue types, it is a rapid and simple procedure 
and able to transform organelles such as chloroplasts.59 However, special 
instrumentation is required and transformation yields are lower when compared to 
techniques such as electroporation, typically around 5%. For example, Christou and co-
workers were able to transform soyabean plants (Glycine max L.) using DNA-coated 
gold particles with a transformation efficiency between 0.1 – 5%.60 
1.4.2.4 Agrobacterium tumefaciens 
Agrobacterium tumefaciens is a bacteria present in soil, which is able to infect plants and 
cause crown gall disease.61 It does this by transferring a particular DNA segment, T-
DNA, of the tumour-inducing plasmid (Ti) into the nucleus of the plant cell, 
whereupon it is incorporated into the genome and transcribed, causing crown gall. T-
DNA contains two types of genes: oncogenic genes which are responsible for the 
tumour formation and genes responsible for the synthesis of opines, compounds 
formed by the condensation of amino acids and sugars and form the carbon and 
nitrogen source for A. tumefaciens. The ability of A. tumefaciens to transfer its DNA into a 
host plant cell make it an attractive option for plant biotechnology for a number of 
reasons, including the T-DNA only being transcribed in plant cells not taking part in 
the transfer process. However, most importantly, any foreign DNA inserted into the T-
DNA segment can be transferred to plant cells.62 There are now a number of vector and 
bacterial strain systems available for plant transformation.63  
1.5 Reactivity Probes 
1.5.1 Introduction 
To be able to perform directed evolution on a protein, that protein must first be isolated 
from a cell or complex mixture of proteins. One technique to achieve this makes use of 
small molecules known as reactivity probes.64 Reactivity probes consist of three distinct 
parts: a reactive unit for covalent attachment to the enzyme, a linker unit that may 
modulate the activity of the reactive group and a tag to allow identification and 
isolation of modified proteins (See Figure 1.17). Reactivity probes are designed to 
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interact with active-site residues of proteins resulting in the formation of a stable 
covalent bond. The following section describes recent advances in the use of reactivity 
probes, with specific examples highlighted. 
TAG
LINKER
REACTIVE
GROUP  
Figure 1.17 Cartoon representation of the general structure of a reactivity probe, which contains a 
reactive group, linker and tag. 
1.5.2 Reactive Group 
1.5.2.1 Mechanism-based reactivity probes 
Mechanism-based reactivity probes are the most common class of probes used as the 
reactive group closely resembles the natural substrate or inhibitor for the enzyme, 
therefore allowing the synthesis of relatively simple molecules.  
Dijkstra used the well known serine hydrolase inhibitor, fluorophosphonate, as the 
basis for the mechanism-based reactivity probe, 11.65 The fluoride leaving group was 
replaced with a p-nitrophenyl group and a dansyl fluorophore was included to allow 
for easy identification of labelled proteins. Upon reaction of 11 with the enzyme, a 
yellow colour was observed due to release of the p-nitrophenyl group, which allowed 
the inhibition times to be monitored. 
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Incubation of 11 with the lipase cutinase, resulted in inhibition of the enzyme, with the 
rate constant calculated as 0.13 min-1. After full inhibition was obtained, monitored by 
the release of p-nitrophenol, the protein-inhibitor constructs were purified and analysed 
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by ESI-MS. Formation of 11-labelled proteins could be seen: mw(cutinase) = 20619 Da, 
mw(cutinase-11) = 21070 Da (See Figure 1.18). 
 
Figure 1.18 Formation of 11-labelled proteins: mw(cutinase) = 20619 Da, mw(cutinase-11) = 21070 Da. 
Org. Biol. Mol., 2008, 6, 523 - Reproduced by permission of The Royal Society of Chemistry  
In a similar approach, Bogyo et al have been able to monitor cysteine protease activity 
in a crude protein mixture.66 12 has previously been shown to an inhibitor of cysteine 
protease activity and this was used as the scaffold for the reactivity probe 13. The 
peptide backbone is used as a recognition unit for the enzyme, whilst the electrophilic 
epoxide reacts with the thiol group of the cysteine residue resulting in a labelled, 
inactive protein. By making use of the biotin tag, labelled proteins can be visualised 
following SDS-PAGE/Western blotting with streptavidin-based antibodies. 
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Incubation of 13 with dendritic cell extracts successfully resulted in protein labelling, as 
seen by Western blotting, Figure 1.19. A pre-heating control was used and revealed 
non-specific labelling, with the assumption that denatured proteins modified by 13 
represented non-specific modifications. All labelling of proteins in the 20 – 40 kDa 
region was lost upon heat denaturation, illustrating that enzymatic activity is needed 
for labelling to occur. This suggested that these bands correspond to major proteases 
within the cell extract. 
 
Figure 1.19 Immunoblotting of dendritic cells incubated with 13. Labelling of active proteases can be 
seen (20 – 40 kDa range), which was lost upon heat inactivation. Reprinted from Chemistry & Biology, vol 
7, Greenbaum D., Medzihradszky K.F., Burlingame A. and Bogyo M., Epoxide electrophiles as activity-dependent 
cysteine protease profiling and discovery tools, 569-581, Copyright (2000), with permission from Elsevier. 
Active 
proteases 
13     13 
 Δ   
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Interleukin-1β converting enzyme (ICE) is a cysteine protease that is responsible for the 
activation of interleukin-1β, an important mediator of inflammation. ICE is a unique 
cysteine protease, lacking sequence homology with all other known enzymes in this 
class. Peptide (acyloxy)methyl ketones are known potent irreversible inhibitors of ICE, 
with inactivation proceeding via expulsion of the aryl carboxylate leaving group to 
form a thiomethylketone with the active site cysteine. In an effort to isolate ICE, the 
(acyloxy)methyl ketone reactivity probe 14 was synthesised, which also contained a 
biotin affinity tag.67 
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THP.1 cells, where ICE levels were less than 0.001% of the total protein, were incubated 
with 14 (200 nM) for 10 minutes, followed by SDS-PAGE, Western blotting and 
visualisation by 125I-streptavidin. Figure 1.20 shows that only one protein was labelled 
(lane 2), which co-migrates with the affinity-purified ICE (lane 1). Labelling could be 
completely prevented by including the potent aldehyde inhibitor, Ac-Tyr-Val-Ala-Asp-
CHO, in the reaction mixture (lane 3), indicating that an active enzyme is needed for 
effective labelling to occur.  
 
Figure 1.20 Labelling of ICE protein visualised by 125I-streptavidin. Lane 1 – purified ICE, lane 2 – ICE 
labelled with 14, lane 3 – inhibition of labelling by treatment with ICE inhibitor. Reprinted with 
permission from Biochemistry, 1994, 33, 3934-3940. Copyright (1994) American Chemical Society 
     1             2            3 
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1.5.2.2 Suicide-based reactivity probes 
This class of probes is similar to the mechanism-based reactivity probes in that a 
reaction relies on an active enzyme, which is able to react with the reactive group of the 
probe. However, this class contain a masked electrophile, which is only uncovered 
when the enzyme has reacted with a different part of the probe. One such example of a 
suicide-based probe is the β-galactosidase probe 15.68 
O
OH
HO
OH
O
CHF2
N
H
S
N
OO
OH
15  
Upon reaction of 15 with the enzyme, the β-galactose unit is hydrolysed from the probe, 
with the postulated release of HF. The highly electrophilic intermediate then reacts with 
a nucleophilic residue in close proximity to the active site, yielding a fluorescently 
tagged protein. Isolation of the protein was achieved by initial protease digestion and 
subsequent elution of the peptides from an antidansyl antibody column. MALDI 
TOF/TOF analysis allowed the identification of the exact modified residue, which was 
shown to be arginine.  
1.5.2.3 Affinity-based reactivity probes 
A major difference between affinity-based probes and probes such as 13, 14 and 15, 
described previously, is that fact that the former do not require an active enzyme for 
modification. This class of probes contain a group which has a high affinity for the 
enzyme but is not modified by it. Subsequent cross-linking of these probes to the 
protein is achieved by the presence of a group which, after treatment by either chemical 
or photochemical means, generates a highly reactive intermediate such as a carbene or a 
nitrene. These species are able to react with a residue within the protein resulting in a 
covalent link. The reaction is relatively indiscriminate with a wide range of chemical 
groups and therefore able to react with a much larger number of amino acids than the 
electrophilic suicide labels which generally react with nucleophilic residues. 
Yao et al have utilised this class of reactivity probes in the isolation of 
metalloproteases.69 These enzymes are able to hydrolyse peptide bonds by the 
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interaction of a catalytic zinc(II) ion coordinated to three amino acid residues, usually 
His and Glu, and a water molecule. During hydrolysis the tetrahedral peptide 
intermediate formed is coordinated to the zinc but not covalently bound to the enzyme 
and as such no mechanism-based irreversible inhibitors are known. Consequently the 
development of mechanism-based reactivity probes is very challenging. By making use 
of the zinc binding group hydroxamic acid, the affinity-based probe 16 was designed. 
Diazirine was chosen as the photolabile group, which upon irradiation at 360 nm, 
cleaves to form a triplet carbene that is able to insert into any C-H bonds close by. In 
addition, the fluorophore Cy3 was used as a fluorescent tag to allow for easy 
identification of labelled metalloproteases. 
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Using thermolysin, a bacterial 35 kDa extracellular endopeptidase, as a model 
metalloprotease optimisation of the enzyme labelling conditions was performed. It was 
found that an optimum level of labelling could be achieved with 500 nM 16. Above this 
concentration nonspecific labelling occurred. In addition, irradiation times were also 
investigated. No labelling was seen in the absence of UV, indicating that photolysis is 
essential for protein labelling, Figure 1.21. 
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Figure 1.21 Fluorescence image of SDS-PAGE gel showing that the optimum level of labelling of 
thermolysin was 500 nM. In addition, no labelling was seen in the absence of UV. Reprinted with 
permission from Journal of the American Chemical Society, 2004, 126, 14435-14446. Copyright (2004) American 
Chemical Society 
Incubation of 16 with yeast cell lysates containing several known metalloproteases, 
resulted in fluorescent labelling of these proteins as visualised by SDS-PAGE analysis, 
highlighting the applicability of this class of probes in the isolation of metalloproteases. 
1.5.3 Linker unit 
The linker unit of the reactivity probe connects the reactive unit to the tag (See Figure 
1.17) and serves several purposes in the overall probe design. In many cases, it simply 
provides space between the reactive unit and the tag and often takes the form of an 
alkyl or PEG chain. An alkyl chain brings about hydrophobicity to a probe, thereby 
enabling entry into a cell, whereas a PEG chain can confer solubility to hydrophobic 
probes in aqueous environments.70 
The linker can also contain specificity elements that target the probe towards a 
particular class of enzymes. This is commonly seen in the form of peptide structures, 
particularly in probes which are designed to isolate proteases. In one such example, 
probe 17 was used to isolate a class of protease known as caspases.71 These enzymes are 
involved in apoptosis pathways. Fluoromethylketone-containing peptides are known to 
covalently react with the active site residues of caspases and the linker unit was used to 
direct the specificity of the probe towards individual caspases. A linker unit consisting 
of a simple alkyl chain was chosen, which was approximately the length of the 
tripeptide sequence in a typical caspase inhibitor but at the same time will not impose 
any specificity upon a particular caspase. By using this simple linker unit, probe 17 was 
able to efficiently react with caspase enzymes, yielding a fluorescently tagged protein. 
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In order to test the selectivity of 17 towards caspase, three other non-caspase proteases 
were used as controls and analysed at the same time. Figure 1.22 shows that only 
caspase was labelled by 17 following incubation for 30 minutes. In addition, 
inactivation of caspase by heat, followed by incubation with 17 resulted in no labelled 
protein seen, therefore indicating that enzymatic activity is required for labelling to 
occur. Other linkers may be chosen when needed to fine-tune the specificity of the 
probes against their targeting enzymes. 
 
Figure 1.22 Fluorescence image of SDS-PAGE gel showing specificity of 17 towards the caspase 
enzyme. a) caspase-1, b) papain, c) chymopapain, d) bromelain. Reprinted from Tetrahedron Letters, vol. 
44, Zhu Q., Huang X., Chen G.Y.J. and Yao S.Q., Activity-based fluorescent probes that target phosphatases, 1043-
1046, Copyright (2003), with permission from Elsevier 
As well as bringing substrate specificity, linker units can also assist in the breakdown of 
the probe. The penicillin amidase probe, 18 contains a N-acylhemithioaminal linker, 
which upon enzymatic cleavage of the phenylacetamide moiety, self-cyclises to form 19 
with concomitant release of umbelliferone, Scheme 1.6.72 Incubation of 18 with 
penicillin G amidase resulted in an increase in fluorescence at 460 nm, indicating the 
cleavage of carboxamide group and generation of free umbelliferone (See Figure 1.23). 
a     b     c     d 
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Scheme 1.6 Upon reaction with penicillin amidase the self-immolative linker breaks down causing 
release of methylumbelliferone fluorophore 
 
Figure 1.23 Fluorescence emission of 18 incubated with penicillin G amidase at 460 nm. Reprinted with 
permission from Organic Letters, 2008, 10, 1517-1520. Copyright (2008) American Chemical Society 
1.5.4 Isolation/identification tag 
1.5.4.1 Isotope tags 
Isotope tags are commonly used to monitor biological processes as they require 
minimal equipment for production, provide a very sensitive signal with low 
background and are easy to detect using simple autoradiography methods. The 
radioisotope 125I is often used due to its relatively small size, which results in minimal 
modification of the parent inhibitor and has been used to study proteasome activity in 
living cells.73 Mammalian proteasomes have been shown to contain three distinct 
catalytic subunits (β1, β2 and β5). In addition to this, upon exposure to γ-interferon 
another set of catalytic subunits are expressed (β1i, β2i and β5i). These new subunits form 
a new particle, the immunoproteasome. Each of these catalytic subunits has slightly 
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different substrate specificities, which makes activity profiling difficult to achieve. 
Tetrapeptide vinyl sulfones, such as 20, are known proteasome inhibitors and studies 
using fluorogenic derivatives have indicated differences in the catalytic subunits. 
However, studies with natural protein substrates have shown a more complicated 
cleavage preference, with considerable overlap seen. 
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Using probes based on the structure of 21, which have been extended at the N-terminus 
and include a 125I tag for identification, inhibition is enhanced. In addition to this, 
subunit specificity is largely unseen, which reflects the extensive overlap seen with in 
vitro protein degradation, Figure 1.24. 
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Figure 1.24 1D and 2D SDS-PAGE analysis of EL-4 lysate labelled with 21 showed that most 
proteasomal subunits were labelled equally well. Reprinted from Chemistry & Biology, vol. 8, Kessler B.M., 
Tortorella D., Altun M., Kisselev A.F., Fiebiger E., Hekking B.G. Ploegy H.L. and Overkleeft H.S., Extended 
peptide-based inhibitors efficiently target the proteasome and reveal overlapping specificities of the catalytic β-
subunits, 913-929, Copyright (2001), with permission from Elsevier. 
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Although radiolabelling offers advantages there are several disadvantages associated 
with its use. These include the relatively short half-life of 125I (57.4 days74), which means 
probes cannot be stored for long periods of time and require more care in handling. 
Also, these tags offer no direct means to isolate labelled proteins and therefore most 
radiolabelled probes are used for profiling known protein targets. 
1.5.4.2 Affinity tags 
In an effort to overcome the limitations of radioisotopes, affinity tags are often used as 
this enables the isolation of labelled proteins. Biotin is the most commonly used affinity 
tag in reactivity probes, with numerous publications documenting its use. Isolation of a 
biotin-labelled protein makes use of the strong affinity of biotin towards the protein 
streptavidin, having a association constant of ~ 1015 mol/L.75 Various methods are used 
which include elution columns containing streptavidin-coated beads and ELISA 
methods. 
A biotinylated fluorophosphonate, 22 was used to isolate serine hydrolases from a 
crude protein mixture.76 Soluble fractions of rat testis were incubated with 22 and 
following SDS-PAGE/Western blotting analysis, more than 10 labelled proteins were 
detected. Importantly, heating of the protein sample to 80 °C for 5 minutes before 
treatment with 22 blocked nearly all protein labelling, indicating that this probe reacts 
with serine hydrolases in an activity-dependent manner.  
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However, there are disadvantages to the use of biotin. It has a low cell permeability and 
therefore cannot be used in vivo, restricting its applications to in vitro experiments to 
isolate targets from cell or tissue extracts. Although, the biotin-streptavidin affinity 
system makes the isolation of biotin-labelled proteins relatively easy, it is often bound 
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so tightly that elution requires harsh conditions that release non-specific, unlabelled 
background proteins. 
As an alternative to biotin, short peptide sequences that recognise specific antibodies 
can be used as an affinity tag. This form of tag was used to isolate deubiquitinating 
enzymes (DUBs), which form part of the ubiquitin-proteasome system.77 The use of the 
hemaglutinin (HA) tag as part of the reactivity probe 23 allowed identification and 
isolation of a tagged DUB following treatment with a HA-antibody during SDS-
PAGE/Western blotting techniques. 
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Although this technique allows for selective detection of labelled proteins, the peptide 
tags are often large and generally block cell permeability of the probe. 
1.5.4.3 Fluorescent tags 
Fluorescent tags make use of small molecule fluorophores which allow for direct 
imaging of labelled proteins and ease of detection in gel-based analysis. There is a large 
diversity of commercially available fluorophores which have a wide range of structural 
and photophysical properties, increasing the scope for their use in reactivity probes.78 
There are a huge number of examples in the literature of fluorescent reactivity probes. 
In an extension to the work on cysteine proteases using the biotinylated probe, 13, 
several fluorescent probes, 24 – 27 were synthesised.79 Following incubation of 24 – 27 
with total rat liver homogenate four different cysteine proteases were labelled, as could 
be seen in the SDS-PAGE gels, Figure 1.25. These BODIPY based probes were shown to 
be cell permeable and able to selectively isolate cysteine proteases in vivo, which 
represents an advantage over the biotin-based probe 13, Figure 1.26a and b. 
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Figure 1.25 All four BODIPY probes labelled all proteins, with only slight differences in intensity 
seen. Copyright © 2002, by the American Society for Biochemistry and Molecular Biology 
 
Figure 1.26 a) shows HeLa cells incubated with 27. These cells were then homogenised and the 
resulting suspension was analysed using SDS-PAGE. b) The gel revealed a number of proteases had 
been labelled by 27, indicated by numbers 1 – 5. Copyright © 2002, by the American Society for Biochemistry 
and Molecular Biology 
a) b)  b) 
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The extremely high sensitivity of fluorescent tags is exemplified by the serine hydrolase 
probe 28, in which detection levels were as low as 100 attomolar.80 Purified fatty acid 
amine hydrolase (FAAH) was incubated with 28. Serial dilutions were performed and 
these were analysed using SDS-PAGE, with fluorescent bands seen at extremely low 
concentrations, Figure 1.27 
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Figure 1.27 SDS-PAGE analysis showing the low attomolar levels of detection of FAAH using 28. 
Patricelli M.P., Giang D.K., Stamp L.M. and Burbaum J.J. Direct visualisation of serine hydrolase activities in 
complex proteomes using fluorescent active site-directed porbes, Proteomics, 2001, 1, 1067-1071. Copyright Wiley-
VCH Verlag GmbH & Co. KGaA. Reproduced with permission. 
To combine the advantages of both affinity and fluorescent tags would result in a probe 
which, upon protein labelling, would result in a high level of detection sensitivity and 
ease of isolation. 29 is an example of such a probe, in which both biotin and rhodamine 
are used.81 
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This probe was utilised in the isolation of a membrane-associated protein, 3β-
hydroxysteroid dehydrogenase/Δ5-isomerase-1 (3HSD1), which is an NAD+ 
dependent integral membrane protein found predominately in the adrenal glands and 
gonads. Following treatment of rat testis with 29 and solubilisation using Triton X-100 
the membrane proteins were separated using Q chromatography. Fluorescence imaging 
of the resulting gel, revealed a band at 40 kDa (See Figure 1.28). Those fractions 
containing this protein were pooled and enriched using a streptavidin column. MALDI 
mass spectrometry revealed the identity of the protein to be that of 3HSD1. 
 
Figure 1.28 Fluorescence image of SDS-PAGE gel showing band corresponding to 3HSD1 at 40 kDa. 
Copyright © 2002, by the American Society for Biochemistry and Molecular Biology 
1.5.5 Bio-orthogonal labelling 
Despite the many advantages offered by both biotin and fluorophores in the detection 
and isolation of protein targets, there are disadvantages to their use, in particular the 
often large, sterically hindered molecules used. This may impede not only the cellular 
uptake, but also reduce their affinity for certain protein targets. In an effort to overcome 
these problems, strategies have been developed in which the tag of the reactivity probe 
has been replaced by a surrogate tag. Once protein labelling has occurred, it is then 
reacted with either biotin or a fluorophore by a bio-orthogonal ligation reaction, 
resulting in labelled protein targets that can be isolated or visualised, See Figure 1.29. 
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Figure 1.29 Cartoon representation of reactivity probes utilising bio-orthogonal labelling 
The most commonly used bio-orthogonal labelling strategy employs the Cu-catalysed 
[3+2] azide-alkyne cycloaddition, which has been termed ‘click chemistry’.82 In this 
approach, the tag is replaced with either an azide or alkyne group. In the ligation step, a 
chemically modified tag which is coupled to either an alkyne or azide, is used to 
produce a 1,4-disubstituted triazole that connects the probe-labelled protein to the 
reporter tag. The overall reaction can be seen in Scheme 1.7. 
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Scheme 1.7 
Bio-orthogonal click-chemistry has been used to isolate the enzyme enoyl CoA 
hydratase (ECH-1).83 By using an azide-derivatised phenyl sulfonate, 30 and an alkyne-
rhodamine tag, 31, ECH-1 was isolated both in vitro and in vivo, See Figure 1.30. The 
labelling was shown to be heat sensitive, indicating that enzyme activity is vital for 
protein labelling. In addition, no labelling was seen in the absence of CuSO4. 
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Figure 1.30 Labelling of ECH-1 in mice. The phenyl sulfonate-azide probe was administered to mice 
(0, 10, 20 mg/kg; i.p.) and after 1 hr the animals were sacrificed and heart tissue removed and analysed 
following reaction with the alkyne-rhodamine tag. The in vitro lane shows labelling of ECH-1 in 
mouse heart homogenate. Reprinted with permission from Journal of the American Chemical Society, 2003, 125, 
4686-4687. Copyright (2003) American Chemical Society 
1.6 Project Aims 
Work undertaken within the group has shown that flow cytometry can be used to sort 
plant protoplasts performing specific biotransformations.84 Using the cell viability stain 
methylumbelliferyl acetate (MUA), the activity of endogenous esterases was visualised 
through the hydrolysis of MUA to the fluorescent molecule, 4-methylumbelliferone (4-
MU), Scheme 1.8. 
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Scheme 1.8 
Subsequent transformation of the gene encoding for the esterase AtSFGH which 
contained a single point mutation (Cys59Ser) was attempted using PEG-mediated 
methods. Despite transformation levels being as low as 5%, cells remained viable and 
did not clump together as was seen when electroporation techniques were employed. 
AtSFGH is not inhibited by the organofluorophosphonate paraoxon85 and therefore in 
order to abolish all background esterase activity, cells were treated with 1 mM 
paraoxon prior to incubation with MUA. Following this treatment, a population of 
400,000 wild-type cells was spiked with 8,000 atsfgh(C59S)-expressing cells and the total 
suspension was sorted based on 4-MU fluorescence. A population which exhibited 
approximately 10-fold greater fluorescence was observed (Figure 1.31) and a sample of 
cells from populations 1 and 2 were collected. 
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Figure 1.31 Flow cytometry analysis of atsfgh(C59S)-expressing cells showing population 2 which 
exhibited increased fluorescence 
Analysis of the cells collected from population 2 was undertaken with PCR using 
primers directed to the start and end of the atsfgh sequence. After 20 cycles of 
amplification an 800-bp product was present, which was absent from population 1 (See 
Figure 1.32). Sequencing confirmed the band at 800-bp to be that of the atsfgh mutant. 
However, no intact protoplasts were recovered from the sorting. 
 
Figure 1.32 PCR analysis showing the present of atsfgh only in population 2 
This work by Cummins has shown that methylumbelliferyl esters can be utilised as 
probes for esterase activity with the subsequent activation of fluorescence being 
detected by FACS. However, a number of areas remained to be investigated: 
       +ve        Popn      Popn   Total 
       control     2             1  
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1. The synthesis of profluorescent, methylumbelliferyl-based probes of AtSFGH, 
expanding the library of compounds to include amino acid derivatives, with the aim 
of synthesising a probe capable of selecting an optimised esterase. 
2. The development of random mutagenesis techniques towards the directed evolution 
of AtSFGH and another esterase enzyme, AtCXE12. 
3. The improvement of FACS screening protocols to enable the successful isolation and 
sorting of individual protoplasts. 
4. The synthesis of reactivity probes based on phenylacetylene and BODIPY 
fluorophores to isolate biotransformation enzymes such as oxidative cytochrome 
p450. 
This thesis now describes research involving the synthesis of novel profluorescent 
reactivity probes used for the isolation of specific enzymes, directed evolution 
experiments to enable the optimisation and/or alteration of the wild type activity and 
the subsequent screening using FACS techniques. Chapter 2 begins with approaches 
towards the synthesis of probes to be used for the directed evolution of the esterase 
enzyme AtSFGH.  
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2  STUDIES TOWARDS THE DIRECTED EVOLUTION OF ESTERASES 
This chapter details the work undertaken in the broad area of directed evolution and in 
particular the studies undertaken on two enzyme systems, AtSFGH and AtCXE12. The 
aim of this work was to utilise mutagenesis methods to produce and select a variant 
enzyme with desired properties. Work undertaken on AtSFGH will be discussed first, 
followed by the results obtained with AtCXE12. 
2.1 S-Formylglutathione Hydrolase 
2.1.1  Introduction 
This section will deal with S-formylglutathione hydrolase (SFGH), one of the enzyme 
systems of interest, to which the technique of directed evolution will be applied. It will 
cover aspects of its role in nature and recent developments in both its cloning and 
characterisation. 
Formaldehyde is a toxic compound that plant cells encounter either as an atmospheric 
pollutant or as a product of endogenous demethylating reactions. In order to prevent its 
accumulation to phytotoxic concentrations, formaldehyde is rapidly chemically coupled 
to glutathione (GSH) to form S-hydroxymethylglutathione. This resulting compound is 
subsequently oxidised by the action of a glutathione-NAD-dependent formaldehyde 
dehydrogenase (FMDH) to form the thioester S-formylglutathione, 32. The activity of S-
formylglutathione hydrolase (SFGH) regenerates GSH and renders formate available to 
the C1 pathway.86 C1 metabolism is essential in plants and supplies the C1 units needed 
for the synthesis of proteins, nucleic acids and many methylated compounds. The role 
of SFGH is therefore crucial in formaldehyde detoxification and recycles GSH, thereby 
preserving the pool of this detoxification compound (See Figure 2.1). This discussion 
focuses solely on plants, although it is worth noting that GSH is ubiquitous in all living 
cells. 
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Figure 2.1 Detoxification pathway of formaldehyde using SFGH 
Glutathione (GSH), 33, is a tripeptide consisting of γ-glutamyl-cysteinylglycine and is 
the major source of non-protein thiol in most plant and mammalian cells. It is 
synthesised from standard amino acids in two steps. γ-Glutamyl-Cys synthetase 
combines Glu and Cys in an ATP-dependent reaction to form γ-glutamyl-Cys, with a 
second enzyme, glutathione synthetase, catalysing the ATP-dependent reaction 
between γ-glutamyl-Cys and Gly to generate GSH.87 
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The nucleophilic character of the thiol group is important in the formation of 
disulphide bonds with cytotoxic electrophilic species. This is particularly important in 
detoxification processes within the cell. A class of enzymes known as glutathione S-
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transferases (GST) mediate the reaction between GSH and any xenobiotics present, 
exporting the GSH-conjugate product into the vacuole.88 The thiol group has a redox 
potential of -0.24 V at pH 7, which allows it to act as an electron acceptor and donor for 
many biological reactions. Along with this reactivity, its relative stability and high 
water solubility make GSH an excellent molecule in the protection of plants against 
oxidative stress and certain endogenous and exogenous chemicals. Mutation studies by 
Xiang et al have shown that GSH is essential in protecting plants from heavy metal 
toxicity.89 
2.1.2 Enzymology 
2.1.2.1 Characterisation of SFGH 
SFGH was first studied in humans and termed esterase D.90 This enzyme hydrolyses 
glutathione esters, particularly s-formylglutathione, and was found to have high 
activity towards methylumbelliferone esters. The human form also has sialic acid 
O-acylesterase activity. It has been shown that SFGH in both humans and E. coli is 
highly conserved, with the formaldehyde detoxification pathway also conserved in 
prokaryotes and eukaryotes.91 
Edwards and co-workers have studied SFGH in the plant Arabidopsis thaliana and found 
a single SFGH-like sequence. AtSFGH has previously been cloned and characterised 
from Arabidopsis thaliana and it has been shown that the purified recombinant enzyme 
was a dimer composed of 31-kDa subunits.92 Inhibition studies using 1 mM N-
ethylmaleimide, a compound which alkylates sulfhydryl groups, has shown that a thiol 
group is essential for hydrolytic activity. Supporting evidence for this finding was 
shown in further inhibition studies using metal ions which bind to SH groups, such as 
0.01 mM CuCl2 and 0.01 mM ZnSO4, which reduced catalytic activity by 90 and 50% 
respectively. Esterase activity towards p-nitrophenylacetate (pNPAc), the model 
substrate used in their experiments, was unaffected by 1 mM phenylmethylsulfonyl 
fluoride, (PMSF) an inhibitor of catalytic serine residues.  
SFGH has previously been cloned from human tissues93 and shown to be identical to a 
non-specific carboxylesterase, which exhibited high activity towards 4-
methylumbelliferone acetate (4-MUA). Kordic assessed AtSFGH esterase activity 
against various substrates and using kcat/Km calculations determined the order of 
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substrate preference to be 4-MUA, closely followed by S-formylglutathione and S-
acetylglutathione (See Table 2.1). 
Substrate 
Specific activity  
(nkatmg-1) 
Km 
(mM) 
vmax 
(nkatmg-1) 
kcat/Km 
(mM-1s-1) 
s-formylglutathione 174 0.13 219 46 
s-acetylglutathione 242 0.15 311 133 
p-nitrophenyl acetate 95 1.02 185 2.9 
α-naphthyl acetate 254 0.57 350 14 
β-naphthyl acetate 21 0.54 22 1.3 
Fluorescein diacetate 2 0.03 3 2.3 
4-methylumbelliferyl acetate 605 0.12 714 158 
Table 2.1 Hydrolysing activities of the purified recombinant AtSFGH cloned from Arabidopsis 
thaliana 
Recent studies have resulted in the crystallisation of AtSFGH and enabled detailed 
active site data to be gained. These studies show AtSFGH to be a serine hydrolase 
containing a classical Ser-His-Asp triad. In addition, a non-catalytic cysteine (Cys59) is 
located a short distance from this triad which regulates enzyme activity in vitro through 
a gatekeeper role. Importantly mutation of this residue to Ser allows a wider range of 
substrates to be accepted by this enzyme (See Figure 2.2 and Figure 2.3).85 
50 
 
 
Figure 2.2 X-ray crystal structure of AtSFGH.94 Ser-His-Asp are coloured red, Cys59 is coloured yellow. 
 
Figure 2.3 AtSFGH active site showing Cys, His, Ser and Asp residues 
2.1.2.2 Substrate Mapping 
Previous work within the group involved the production of a library of 
methylumbelliferyl probe substrates based on simple alkyl esters. These compounds 
were synthesised using standard chemistry techniques by the reaction of the 
appropriate acyl chloride with 4-MU.95 Each substrate was screened against the 
AtSFGH-C59S mutant allowing a model of the active site conformation to be 
established. The assay was undertaken with λex 350 nm and λem 450 nm. Substrate 
concentrations were in the range 500 μM to 10 μM. The assay was performed in Tris 
Asp 
His 
Ser Asp 
Cys 
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buffer (0.1 M, pH 7.4) and a 1:1 ratio of substrate to enzyme. All measurements were 
recorded at 37 °C. Table 2.2 shows the results of these assays. 
Methylumbelliferyl esters 
Specific activity (nkatmg-1  
protein) 0.33 mM substrate  
at 37 °C 
PLE AtCXE18 AtSFGH 
AtSFGH  
Km (mM) 
AtSFGH  
kcat/Km 
(mM-1s-1) 
ArO
O
34
 
2120 ± 33 238 ± 4 588 ± 12 0.08 283 
ArO
O
35
 
1796 ± 78 218 ± 14 399 ± 9 0.08 202 
ArO
O
36
 
3566 ± 124 225 ± 13 437 ± 11 0.07 264 
ArO
O
37
 
4135 ± 228 388 ± 32 330 ± 8 0.05 291 
ArO
O
38
 
8645 ± 241 474 ± 9 604 ± 15 0.09 243 
ArO
O
39
 
1374 ± 62 105 ± 2 162 ± 2 0.04 217 
ArO
O 40
 
587 ± 35 0 49 ± 7 0.03 98 
ArO
O 41
 
0 0 0   
ArO
O
42
 
1143 ± 41 8 ± 0.5 265 ± 8 0.09 132 
ArO
O
43
 
1989 ± 42 8 ± 0.2 230 ± 3 0.08 103 
ArO
O
44
 
794 ± 13 45 ± 4 34 ± 4 0.08 19 
ArO
O
45
 
220 ± 27 7 ± 0.5 11 ± 1 0.06 9 
52 
 
ArO
O
46
 
427 ± 9 3 ± 0.4 7 ± 1 0.1 3 
ArO
O
47
 
1948 ± 67 4 ± 0.3 9 ± 1 0.1 4 
ArO
O
48
 
12 ± 2 0 12 ± 3 0.09 5 
ArO
O
49
 
1971 ± 54 344 ± 28 226 ± 1 0.04 224 
ArO
O
50
 
158 ± 18 63 ± 2 76 ± 0 0.05 68 
ArO
O
O
51
 
988 ± 112 272 ± 34 186 ± 6 0.08 97 
ArO
O
52
 
117 ± 22 0 4 ± 1 0.05 3 
ArO
O
OH
53
 
281 ± 14 NA 49 ± 12 0.06 33 
ArO
O
O
54
 
2635 ± 53 NA 226 ± 3 0.08 110 
ArO
O
O
O
55
 
1267 ± 133 114 ± 4 258 ± 27 0.07 141 
Table 2.2 Hydrolysing activity of methylumbelliferyl esters against PLE, AtCXE18 and AtSFGH 
The kcat/Km measurements of the array show the hexanoate ester, 38 has the greatest 
activity. Increases in the chain length or the presence of bulky substituents lead to 
diminished activity, whilst heteroatoms in the α-position do not appear to be tolerated 
by AtSFGH. Interestingly, the binding affinity (Km) was little affected by changes in the 
substrates, whereas a profound effect was seen on turnover (kcat). 
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Enzymology studies have shown that 4-methylumbelliferone esters are suitable probes 
for AtSFGH. In addition, large differences in activity can be seen, with compound 38 
shown to be the most active. In an effort to gain a greater understanding of the active 
site conformation of AtSFGH, a large library of 4-MU esters containing a wide variation 
in the substitution pattern were to be synthesised. Details of this are described in the 
following section. Previous work carried out on the synthesis of 4-MU esters involved 
the reaction of commercially available acyl chlorides with 4-MU. In an attempt to 
produce a large library of multiply substituted esters a larger selection of acyl chlorides 
were needed. Although a selection of these substituents was commercially available 
many were not and therefore efforts were directed towards the synthesis of multiply 
substituted 4-MU esters. 
2.1.3 4-methylumbelliferone (4-MU) esters 
The following sections will detail the results achieved, which have built upon the 
previous results attained with 4-methylumbelliferone (4-MU) derivatives (See Section 
2.1.2.2). The results obtained with amino acid derivatised 4-MU will also be discussed. 
2.1.3.1 Previous Results 
Previous results within the group have involved the parallel synthesis of a series of 
4-methylumbelliferone (4-MU) esters. A selection of these, along with their relative 
activities was shown in Table 2.2.  
Analysing the biological results showed that the highest activity was achieved with a 
n-hexyl chain, but it was not clear as to whether the enzyme active site would 
accommodate a methyl group at the C2 position of the alkyl chain. The following 
sections deal with the synthesis of a variety of novel 4-MU esters. 
2.1.3.2 Synthesis of 4-MU esters 
In order to compare the biochemical results achieved from screening any novel 
substrates with those previously attained it was necessary to synthesise compounds 34 
and 38.  
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OHOO OOO R
ORCOCl, Et3N
DMAP, DCM, 0 oC
34 R = CH3, 94%
38 R = C5H11, 61%  
Scheme 2.1 
In order to synthesise a library with a large variety of 4-MU esters the retrosynthetic 
strategy shown in Scheme 2.2 was used. To achieve the target C2 substituted 
compound, 4-methylumbelliferyl propionate 35 was synthesised, using the conditions 
in Scheme 2.1. 35 was successfully isolated as a white solid in a 89% yield. Mass spectral 
data confirmed the product with a single mass peak at 233.1, [M+H+]. 
OO O
O
R
OO O
O
OO OH
35
 
Scheme 2.2 Retrosynthetic analysis of 4-methylumbelliferyl esters bearing a C2 methyl substituent 
2.1.3.2.1 Lithium Enolates 
Enolate chemistry has been used in the synthesis of alkyl-substituted esters and was 
employed here as it opened up the ability for a wide array of C2 substituted 
methylumbelliferyl esters. The general scheme for the reaction can be seen in Scheme 
2.3 below. 
OO O
O
OO O
O
i
i) LDA, THF, -78 oC then RX
35
R
 
Scheme 2.3 General reaction scheme for the synthesis of alkyl-substituted esters using lithium enolate 
chemistry 
Following generation of the enolate by treatment of ester 35 with LDA at -78 °C, 
1-iodobutane was added and the reaction allowed to attain ambient temperature, 
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Scheme 2.4. However, upon work-up no product was detected. Both 1H NMR and 
LC-MS data indicated that the starting material 35 had been regenerated. 
OO O
O
OO O
Oi
i) LDA, THF, -78 oC then 1-iodobutane
35 56
 
Scheme 2.4 
It was thought that the increase in temperature during the reaction may be responsible 
for the failure of the enolate alkylation. To test this, the reaction temperature was 
maintained at –78 °C for the entire reaction, however, again only starting material was 
recovered. A common problem encountered with ester enolates is the formation of the 
Claisen condensation product,96 which occurs when the enolate reacts with the 
unenolised starting material. This proposed formation of compound 57 is shown below 
in Scheme 2.5. However, 1H NMR data did not show any evidence for this product. 
OO O
O
OO O
O
35, THF
O
57  
Scheme 2.5 Claisen condensation reaction 
Lithium bases are known to form aggregates in solution which lowers their basicity. 
The addition of complexing or chelating reagents such as HMPA, DMPU or TMEDA 
break up these aggregates and serves to promote the basicity and hence reactivity 
towards enolate production.97 Three separate reactions were carried out using HMPA 
(23% vol.), DMPU (19% vol.) and TMEDA (1.2 eq), however, these reagents were 
ineffective, with only starting material recovered. Due to the repeated attempts towards 
the synthesis of 56 being unsuccessful, this method was abandoned and an alternative 
approach was sought. 
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2.1.3.2.2 Carboxylic Acid Dianion Chemistry 
A second reason for the failure of the above reaction may be due to the bulky nature of 
the 4-MU group hindering the reaction. In an effort to circumvent this problem this was 
removed and the use of a carboxylic acid starting material was explored. This approach 
has considerable precedent in the works of Pfeffer who has shown that such species 
have increased nucleophilicity when compared to simple ester enolates.98 One example 
is shown in Scheme 2.6. It was shown that treatment of acid 58 with two equivalents of 
LDA gave the dianion as determined by deuterium oxide and carbon dioxide 
quenching. Following this, alkylation with 1-bromopropane afforded 59 in a 78% yield. 
HO
O
HO
O
i
i) LDA (2.2 eq), HMPA (1 eq), THF, -78 oC 
  then 1-bromobutane
58 59
 
Scheme 2.6 Functionalisation of carboxylic acids using dianion chemistry 
Using the above conditions, synthesis of 59 was attempted. Unfortunately, following 
addition of 1-bromobutane no functionalised carboxylic acid product was formed and 
therefore could not be reacted with 4-MU. At this stage in order to advance the project a 
selected number of the required carboxylic acids were obtained from commercial 
sources. 
Each methylhexanoic acid derivative was then combined in a two step procedure 
involving initial conversion to the acyl chloride using (COCl)2 and a catalytic amount of 
DMF. Following complete conversion to acid chloride as observed through the IR 
spectra addition of 4-MU proceeded smoothly (See Scheme 2.7). Product formation was 
confirmed by the splitting patterns observed in the 1H NMR spectra. 
HO
O
R
O
O
R
OO
i, ii
i) (COCl)2, cat. DMF, DCM, rt
ii) 4-MU, Et3N, DMAP, DCM, 0 
oC
R1
R1
R = Me, R1 = H, 56, 72%
R = H, R1 = Me, 60, 76%
 
Scheme 2.7 Preparation of methylhexyl 4-MU derivatives, 56 and 60 
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2.1.3.2.3 Amino Acid Derivatives 
Given the difficulties in the preparation of the substituted alkyl esters an alternative 
approach was explored. It was proposed that a substrate based on an amino acid would 
allow a more accurate description of the key interactions within the active site. These 
interactions include covalent bonds, electrostatic, π-stacking, hydrophobic, H-bonding 
and dipole-dipole interactions. With this in mind a series of arrays were designed. The 
synthetic strategy involved the sequential coupling of Boc-protected amino acids and is 
outlined in Scheme 2.8. Three amino acid derivatives were synthesised and the general 
reaction scheme for the synthesis of these derivatives is shown in Scheme 2.9.  
OO OH OO O
O
NHBoc
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  step 1
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Scheme 2.8 Synthetic strategy for the production of amino acid derivative probes 
OO OH OO O
O
NHBoc
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i
i) EDCI, DMAP, N-Boc-R, DCM
R = H, 61, 70%
R = (R)-Me, 62, 25%
R = (S)-Me, 63, 25%
 
Scheme 2.9 Preparation of amino acid derivatised 4-MU esters 
The first step of this reaction scheme involves the conjugation of an amino acid to 
4-MU. The synthesis of 61 involved the reaction of 4-MU with N-Boc-protected glycine, 
in the presence of a coupling agent and DMAP, and was achieved in a 70% yield, 
following purification by recrystallisation from hot EtOAc (Scheme 2.9). Using the same 
conditions compounds 62 and 63 were synthesised using N-Boc-L-alanine and N-Boc-
D-alanine respectively. The yields for these two compounds were lower than that of 61 
at 25 and 26%. 
Although many coupling agents exist EDCI was chosen as it forms the water-soluble 
by-product 1-[3-(dimethylamino)propyl]-3-ethylcarbodiimide urea, 64, which can be 
easily removed during an aqueous work-up. This was to be utilised during the library 
synthesis to enable much easier purification of the products. 
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Compounds 61 – 63 were to be used as starting materials for the coupling of a second 
amino acid, using the coupling techniques outlined previously. A wide selection of 
amino acids, with differing electronic and steric side chains would hopefully give a 
greater indication of the active site environment. 
As previous results with alkyl-derivatised 4-MU esters were unable to produce a 
substrate which was able to bind strongly enough to allow co-crystallisation with the 
enzyme AtSFGH, it was hoped that this could be gained with amino acid derivatives. If 
an x-ray crystal structure with the substrate bound in the active site could be achieved it 
would enable the identification of the key interactions and residues, allowing a better 
understanding of the enzymes modes of action and hence the design of further probes. 
Before any peptide derivatives were synthesised, it was deemed necessary to have an 
indication as to the ability of the enzyme to hydrolyse 4-MU esters containing an amide 
bond within the chain. As the previous studies had shown that the n-hexyl chain had 
the greatest activity, compound 65 was identified as a suitable model bearing an amide 
bond in the middle.  
OO O
O
H
N
O65  
Initial attempts used 61 as the starting material, which was treated with TFA to remove 
the Boc group, followed by reaction with DIPEA, EDCI and propionic acid to afford the 
product (See Scheme 2.10). Unfortunately no product was formed, with only 4-MU 
observed. 
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Scheme 2.10 Attempted preparation of 65 from 61 
The TFA salt of 61 was stirred with DIPEA to yield the free amine, which was then 
reacted with propionyl chloride in the presence of Et3N at rt. However, this did not lead 
to the desired product, with only decomposition seen. 
Due to the reactivity of the product as an activated ester, it was decided to synthesise 
the amide chain first with the final step being the ester formation with 4-MU.  To this 
end, a solution of glycine in DCM was reacted with two equivalents of propionyl 
chloride in the presence of DIPEA. However, despite repeated efforts no product was 
formed. Repeating the reaction in DMF or a DMF/H2O (1:1) solution did not affect the 
reaction, with no product being formed. (See Scheme 2.11).  
H2N COOH N
H
OH
O
O
i
i) propionyl chloride (2 eq), DIPEA, DCM or DMF or DMF/H2O
66
 
Scheme 2.11 Attempted synthesis of 66 from glycine 
It was thought that the low solubility of glycine was responsible for the lack of reaction 
and therefore attention turned to the use of the methyl ester of glycine, 67. Pleasingly, 
the reaction of 67 with propionyl chloride yielded the desired product, 68. However, 
the yield for the reaction was disappointingly low and therefore the reaction was 
repeated in DMF, which yielded enough material for further manipulation. 
N
H
OMe
O
O
i
i) propionyl chloride, Et3N, DMAP, DMF, rt, 13%
H2N
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Scheme 2.12 Synthesis of 68 from the methyl ester of glycine, 67 
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Before coupling to 4-MU could be carried out, hydrolysis of the methyl ester was 
undertaken to reveal the carboxylic acid. This was attempted several times using 1 M 
and 3 M NaOH and 1 M LiOH, however, no reaction was seen with any of these 
hydroxide ion sources. Changing the solvent from H2O to THF/H2O did not have any 
effect. Due to the failure of the reaction an alternative route was sought. There was 
literature precedent for the production of the desired compound 66 by the reaction of 
glycine with propionic anhydride in a sodium hydrogen carbonate solution as shown in 
Scheme 2.13.99 
N
H
OH
O
O
i
i) propionic anhydride, sat. NaHCO3, reflux, 4 h, 60%
H2N COOH
66
 
Scheme 2.13 Synthesis of 66 from glycine 
Repeating this reaction yielded the product in a 60% yield, with the melting point being 
in agreement with that of the paper (126 °C, Lit. value99 128 °C). LC-MS also confirmed 
the formation of the product by the appearance of the mass peak at 132.2 [M+H+]. 
Compound 66 was coupled with 4-MU using the standard coupling conditions of EDCI 
and DMAP in DCM to yield the desired product 65 in an 80% yield.  
In order to see what effect a methyl substituent in the α-position would have on 
enzyme activity of these amide derivatives, the analogous compound 69 was 
synthesised. Initial attempts to couple the TFA salt of 62 with propionic acid using 
EDCI failed. Interestingly, whereas attempts to synthesise 65 from its monopeptide 
derivative failed, the reaction of 62 with propionyl chloride successfully afforded 69, 
albeit in a low yield of 29% (See Scheme 2.14). 
OO O
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O
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O
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i) TFA, DCM then Et3N, propionyl chloride, DCM, rt, 29%
62 69
 
Scheme 2.14 Synthesis of 69 from 62 
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The small library of compounds 56, 60, 61 – 63, 65 and 69 were assayed against AtSFGH 
in order to gain an insight into their activity before any further compounds were 
synthesised. 
2.1.3.3 AtSFGH Enzyme assays 
Compounds 56 and 60 were tested for activity against purified AtSFGH, along with the 
amino acid and amide derivatives, 61 – 63, and 65 and 69 to ascertain the ability of the 
enzyme to hydrolyse methylumbelliferyl esters containing an amide bond. The assay 
was undertaken on a fluorimeter equipped with a plate reader (FLASHScan®), with λex 
350 nm and λem 450 nm. Substrate concentrations were in the range 500 μM to 10 μM. 
The assay was performed in Tris buffer (0.1 M, pH 7.4) and a 1:1 ratio of substrate to 
enzyme. All measurements were recorded at 37 °C. Table 2.3 shows the results of these 
assays. 
Methylumbelliferyl esters 
Specific activity  
(nkatmg-1 protein)  
0.33 mM substrate at 37 °C 
PLE AtSFGH 
AtSFGH  
Km (mM) 
AtSFGH  
kcat/Km 
(mM-1s-1) 
ArO
O
60
 
210 ± 47 9 ± 2 0.05 5 
ArO
O
56
 
476 ± 51 ------- ------- ------- 
ArO
O
NHBoc 61
 
11 ± 1 3 ± 0.5 0.15 0.12 
ArO
O
NHBoc 62
 
3 ± 0.7 2 ± 0.2 0.62 0.03 
ArO
O
NHBoc 63
 
5 ± 1 2 ± 0.5 0.27 0.44 
62 
 
ArO
H
N
O
O
70
 
NA 0.2 ± 0.1 0.78 0.06 
ArO
H
N
O
O
65
 
NA 0.4 ± 0.2 0.34 0.16 
Table 2.3 Hydrolysing activity of amide derivatives against purified AtSFGH and PLE. Ar = 
4-methylumbelliferyl (NA = not assayed) 
From the specific activity results, 60 can be seen to be a poor substrate for both PLE and 
AtSFGH when compared to that of the n-hexyl derivative 38. When 56 was screened 
against AtSFGH the rate of hydrolysis was seen to decrease with increasing substrate 
concentration (See Figure 2.4). This type of pattern is typical for product inhibition, 
which is known to occur in enzymes such as galactase which is inhibited by 
galactose.100  
 
Figure 2.4 Rate of hydrolysis of 56 screened against AtSFGH 
In order to show that product inhibition was occurring with 56, a variety of inhibition 
studies were performed, with the aim of attaining altered Km or vmax figures. The 
product of the hydrolysis of 56 is 2-methylhexanoic acid and therefore this was used as 
the inhibitor. Compound 38 was chosen as the substrate as this showed the greatest 
activity with AtSFGH, with varying concentrations of 2-methylhexanoic acid used (0 – 
1 mM). Assays were undertaken using the same methodology as that used previously. 
No change in rate was observed with the reaction of 38 and inhibitor. This may be due 
to the high affinity of 38 for AtSFGH which may prevent inhibition from occurring. For 
this reason two other ester derivatives were chosen as substrates, 34 and 46. 34 is a good 
substrate for AtSFGH, whereas 46 is relatively poor. Unfortunately, using 2-
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methylhexanoic acid in the presence of these substrates no change in rate and hence 
inhibition was observed. From these results it would suggest that product inhibition 
between 56 and 2-methylhexanoic acid was not occurring.  
Using 56 as the inhibitor with 34 as the substrate it was seen that at high concentrations 
(above 450 μM) a slight decrease in rate was observed. This result suggests that excess 
substrate inhibition may be the cause for this decrease in rate. This type of inhibition is 
seen in around 20% of all known enzymes, e.g. the enzyme invertase is inhibited at high 
concentrations of sucrose.101 However, no conclusive evidence was obtained to identify 
the reason for the decrease in rate when using only 56. 
The results from the amide and amino acid derivatives screened also revealed a number 
of interesting features. Due to the presence of the large Boc group, low hydrolytic 
activity is seen with both AtSFGH and PLE for the 4-MU amino acid substrates. 
Therefore, the Boc group was removed using standard deprotection techniques, with 
the resulting TFA salt produced used without further purification. The white solid 
formed was analysed using 19F NMR spectroscopy which showed the presence of a 
single peak at -77.78 ppm, indicating that the TFA salt had been formed. Unfortunately, 
these TFA salts were unstable to the assay conditions and no meaningful data could be 
obtained. When 65 and 69 were assayed, very low activity was seen. This suggests that 
AtSFGH is unable to hydrolyse these esters due to the lack of conformational rotation 
which is brought about by the introduction of the rigid amide bond. This indicated that 
a library of dipeptides would have very low, if any, activity with AtSFGH and for this 
reason further work was not undertaken with a dipeptide series.  
2.1.3.4 Assays In Planta 
Although a general representation of AtSFGH activity in vitro was established with the 
substrate mapping experiments, an idea of the corresponding activity within whole 
plant cells was needed. This would allow the activity of AtSFGH in whole cells to be 
established. It would also enable the comparison of AtSFGH and PLE activity with the 
activity of esterases in planta. Current techniques for predicting the rates of ester 
hydrolysis uses PLE,102 a mammalian serine hydrolase which contains the classic α/β 
structural fold and the catalytic motif GXSXG,103 which is similar to that in AtSFGH. 
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A protein extract of Arabidopsis leaves was performed (See Experimental Section for 
details) and using Bradford’s reagent the concentration was calculated to be 2.4 mg/ml. 
A selection of substrates bearing the alkyl substituents were selected and assayed 
against the protein extract. The amino acid derivatives were not assayed due to the 
poor specific activity seen with AtSFGH. The order of preference for the substrates 
roughly correlated with the results from the screen against the purified enzyme (See 
Table 2.4). 
Methylumbelliferyl esters 
Specific activity (nkatmg-1 protein) 0.33 mM 
substrate at 37 °C 
PLE AtCXE18 AtSFGH 
At protein  
extract 
ArO
O
34
 
2120 ± 33 238 ± 4 588 ± 12 15 ± 2 
ArO
O
35
 
1796 ± 78 218 ± 14 399 ± 9 1 ± 0.1 
ArO
O
36
 
3566 ± 124 225 ± 13 437 ± 11 7 ± 2 
ArO
O
37
 
4135 ± 228 388 ± 32 330 ± 8 1 ± 0.25 
ArO
O
38
 
8645 ± 241 474 ± 9 604 ± 15 21 ± 1 
ArO
O
39
 
1374 ± 62 105 ± 2 162 ± 2 0 
ArO
O
43
 
1989 ± 42 8 ± 0.2 230 ± 3 2 ± 0.5 
ArO
O
44
 
794 ± 13 45 ± 4 34 ± 4 1 ± 0.4 
ArO
O
45
 
220 ± 27 7 ± 0.5 11 ± 1 0.2 ± 0.1 
ArO
O
47
 
1948 ± 67 4 ± 0.3 9 ± 1 0 
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ArO
O
48
 
12 ± 2 0 12 ± 3 0 
ArO
O
49
 
1971 ± 54 344 ± 28 226 ± 1 6 ± 1 
ArO
O
50
 
158 ± 18 63 ± 2 76 ± 0 6 ± 3 
ArO
O
O
51
 
988 ± 112 272 ± 34 186 ± 6 3 ± 0.2 
ArO
O
O
54
 
2635 ± 53 NA 226 ± 3 9 ± 6 
Table 2.4 Methylumbelliferyl ester substrate activity against PLE, AtSFGH, AtCXE18 and At protein 
extract. Ar = 4-methylumbelliferyl (NA = not assayed) 
The results of this study, in addition to the larger range of esters assayed previously, 
suggest that the acyl binding pocket of AtSFGH is more constrained than that of PLE 
(6.2 x 4.7 x 3.1 Å3).104 This probably accounts for the ability of PLE to hydrolyse longer 
chain esters (compounds 39 – 41). Therefore AtSFGH probably has a smaller binding 
pocket due to the complete lack of activity with substrates bearing an alkyl chain longer 
than C6.  
Figure 2.5 clearly shows that AtSFGH activity more closely resembles the activity seen 
in whole cells, i.e. protein extract activity. These results indicate that AtSFGH is a better 
determinant of hydrolysis of methylumbelliferyl esters in planta than PLE.95  
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Figure 2.5 Comparison of AtSFGH and PLE enzyme activity and protein extract activity against 4-MU 
substrates 
34    35     36     37     38    39     43     44     45     47     48     50     51    54     
 34    35     36     37     38    39    40     44     45    47     48     50    51    54     
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2.1.3.5 Screening in protoplasts 
With the substrates being screened against the purified enzyme and protein extract, i.e. 
in vitro, the next step was to show that this trend could be seen in vivo, i.e. in whole, 
living cells. Several challenges exist in the screening of whole cells with the main 
obstacles being uptake of substrates and autofluorescence.105 In order to avoid uptake 
issues across plant cell walls protoplasts were used in this experiment. Protoplasts 
uptake compounds by passive diffusion and can therefore be used in the FLASHScan 
experiment, using the same protocol as for the purified enzyme screens.  
The usual method used in the group for harvesting protoplasts from leaves was to use 
an enzyme solution containing 1.5% cellulase and 0.4% pectinase,84 which causes 
degradation of the cell wall. However, this cellulase based solution produced a very 
low concentration of protoplasts and the complete degradation of many of the cells. A 
variety of conditions were tested, however, protoplast formation occurred with the 
greatest success when a Driselase enzyme solution was used. Employing this 
methodology with 200 mg of leaf material, concentrations in the region of 3 x 105 
protoplasts/ml were commonly achieved. 
2.1.3.5.1 Uptake of Substrates 
Protoplasts were suspended in sucrose solution and assayed against MU-A, 33 and the 
n-hexyl methylumbelliferyl substituent, 37. Unfortunately no fluorescence was detected 
using the FLASHScan equipment with a concentration of 1 x 105 protoplasts/ml. 
Increasing this concentration had no affect. The substrates were also prepared in DMSO 
to determine if changing the carrier solvent had any affect. However, no fluorescence 
was detected.  
34 is broken down by esterase enzymes to form 4-MU, which emits in the blue region 
(maxima 452 nm). Using fluorescence microscopy no fluorescence was seen with a 
solution of 34 incubated with protoplasts. Initially it was thought that the 
autofluorescence seen in the cells was preventing any 4-MU fluorescence being 
detected. A major problem associated with the measurement of fluorescence, and hence 
substrate hydrolysis, within whole protoplasts is autofluorescence. Using a fluorescence 
microscope camera linked to a spectrophotometer the autofluorescence spectrum 
showed two distinct bands; one broad band from 430 – 540 nm and one sharp band at 
700 nm. The latter band can be attributed to the chlorophyll present in the chloroplasts 
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within the cell. The band in the blue-green region of the spectrum may be due to a 
variety of compounds naturally occurring in plants cells, e.g. flavinoids. As the emission 
maximum for 4-MU falls within this region any fluorescence measurements may be 
inaccurate. However, upon placing a suspension of protoplasts into a solution of 34 (1:1 
ratio) and measuring the fluorescence over time on a fluorimeter, no increase at 452 nm 
was seen. This lead to the possibility of uptake problems and experiments using 
fluorescein diacetate were undertaken to test this. 
Fluorescein diacetate (FDA) is often used as a viability test within cell biology.106 Cells 
that are alive and have an intact cellular membrane, readily uptake FDA whereupon 
esterases present within the cell hydrolyse it to form the highly fluorescent compound 
fluorescein, which is retained within the cell. This retention is achieved by the cell 
maintaining membrane integrity. Fluorescein has an excitation maximum at 490 nm 
and an emission maximum at 514 nm and can be visualised by fluorescence 
microscopy. Any protoplasts which do not fluoresce green in an FDA solution are 
assumed to be dead. Before testing uptake of 34, the protoplasts were incubated with 
FDA and observed under the fluorescence microscope. Bright green fluorescence was 
seen in the vast majority of cells indicating they were viable. When incubating 
protoplasts with 34 first, followed by FDA green fluorescence was still observed, 
demonstrating that 34 does not inhibit the uptake and hydrolysis of FDA. Previous 
results have shown that the specific activity of AtSFGH towards FDA is very low92 and 
therefore the fluorescence seen within the cells is due to other esterases hydrolysing 
FDA. This was proven by the addition of 1 mM PMSF to a suspension of protoplasts, 
followed by incubation with FDA and upon analysis, no fluorescence was detected. 
Attention now turned to the technique of flow cytometry, which may enable the 
detection of 4-MU fluorescence within protoplasts, where other techniques have failed. 
This technique allows for the interrogation of particles (usually cells) in solution at rates 
of up 100,000 events per second. The cells in suspension are passed as a core stream, 
surrounded by another wider stream which contains phosphate-buffered sheath fluid. 
The principle of hydrodynamic focussing ensures that the cells stay in the centre of the 
stream. The cells are forced into a single line and pass through up to three lasers at 
which point they are interrogated. The equipment utilised in this project will be the 
DakoCytomation MoFlo®, which has an optics platform that allows the detection of up 
to 9 fluorescent channels, in addition to forward scatter (FSC) and side scatter (SSC). 
The latter two give an indication of the cell’s size and granularity respectively.  
69 
 
The sorting feature of a flow cytometer is the ability to select any population defined by 
a logical combination of regions, known as gates, and to isolate this population from the 
sample. Achievable sorting rates on the MoFlo® are in the region of 30,000 events per 
second. This high-throughput screening can be undertaken with purity levels in excess 
of 99%. Populations of cells can be sorted both 2- and 4-ways, with the option of sorting 
into micro well plates. 
 
Figure 2.6 Fluorescent Activated Cell Sorting (FACS) 
Cell separation can be achieved by breaking the sample stream into droplets, using a 
piezoelectric sensor at a set frequency and amplitude. The point at which droplets 
break off from the main stream is kept at a fixed distance downstream from the 
observation point. Between the time the cell passes through the laser until it reaches the 
droplet break off point, the measured parameter values (fluorescence, SSC or FSC) are 
recorded and used to generate a sort decision signal. 
If the cell is to be sorted the decision signal is applied to drop charging circuitry, which 
applies a voltage to the stream at the time at which the cell should lie somewhere in the 
droplet breaking off from the stream. This leaves an electric charge on those droplets 
selected for sorting. The stream passes through the electrically charged plates, to which 
high voltages of opposite polarities have been applied. Charged droplets, which contain 
those cells to be sorted, are deflected out of the stream towards the plate bearing the 
opposite charge. Uncharged droplets are not deflected and pass into the waste collector 
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(See Figure 2.6). Flow cytometry has found application in a variety of areas, examples of 
which are highlighted in the following section. 
Abscisic acid (ABA) receptors have been investigated using flow cytometry.107 ABA is 
involved in developmental processes in plants, such as stomatal closure and the 
inducement of dormancy. A biotin-labeled abscisic acid derivative, 70 was synthesised 
and was incubated with barley aleurone protoplasts cells, which are often used as 
model systems for ABA studies. 
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Protoplasts were incubated with 70, followed by addition of fluorescently labeled 
streptavidin. Analysis of the subsequent fluorescent population was achieved using 
flow cytometry, with an increase in fluorescence clearly seen in those cells treated with 
70, Figure 2.7. 
 
Figure 2.7 Flow cytometric analysis of cells treated with 70 (black line) showing an increased level of 
fluorescence compared to the control cells (grey line). Reprinted from Bioorganic & Medicinal Chemistry, 
vol. 13, Kitahata N., Nakano T., Kuchitsu K., Yoshida S. and Asami T., Biotin-labeled abiscisic acid as a probe for 
investigating abscisic acid binding sites on plasma membranes of barley aleurone protoplasts, 3351-3358, Copyright 
(2005), with permission from Elsevier. 
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Flow cytometry has been used to analyse the link between cell cycle control and 
programmed cell death of BY-2 tobacco cells following treatment with cryptogein.108 
Cryptogein is known to induce the production of reactive oxygen species (ROS), cause 
protein phosphorylation and cell death. BY-2 cells were incubated with aphidicolin, 71 
and propyzamide, 72 which causes the cell cycle to stop at the M phase. Following 
removal of these compounds, the cells were monitored using flow cytometry and DAPI 
staining and treated after 0.5 h and 5.5 h with cryptogein (500 nM). Figure 2.8 shows the 
histograms which highlight the ability of cryptogein to induce cell cycle arrest during 
the G1 phase. Changes in the cell cycle occurred after 6 h, whereas cell death was 
detected after 10 h, which shows that cell cycle arrest occurs before cell death. 
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Figure 2.8 Flow cytometric analysis of non-treated cells (control) and cells treated with cryptogein in 
the M (0.5 h) or G1 (5.5 h) phase. Kadota Y., Watanabe T., Fujii S., Higashi K., Sano T., Nagata T., Hasezawa S. 
and Kuchitsu K., Crosstalk between elicitor-induced cell death and cell cycle regulation in tobacco BY-2 cells, Plant 
J., 2004, 40, 131-142. Copyright Wiley-Blackwell. Reproduced with permission.  
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A major advantage of the MoFlo® is that autofluorescence can be removed by the 
process of compensation. Using statistical methods, compensation allows for the 
removal of unwanted fluorescence signals from any of the detection channels. By 
dedicating one channel to autofluorescence and compensating for it across the others, 
the problem can be overcome.109 Hence, any increase in fluorescence can be attributed 
to the hydrolysis of 34. Fluorescence detection can be amplified on the MoFlo® and it is 
therefore very sensitive to small changes in fluorescence. 
In order to visualise the hydrolysis of 34 a plot of 450/60 nm against computed time 
was plotted. If uptake and hydrolysis occurred an increase in fluorescence intensity 
would be seen. However, no increase was detected (See Figure 2.9) and this would 
suggest uptake was not occurring. 
 
Figure 2.9 450/60 nm against computed time for the hydrolysis of 34 
In order to show uptake and hydrolysis could be detected on the MoFlo® the 
suspension of protoplasts was incubated with FDA and the increase in fluorescence 
intensity over time recorded. In the plot below (Figure 2.10) an increase in fluorescence 
over time can clearly be seen. The fluorescence intensity levels off after 12 minutes, 
showing that no further hydrolysis of the substrate is occurring. 
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Figure 2.10 Addition of FDA with increase in fluorescence at 530/40 nm over time recorded 
The above results indicate that methylumbelliferyl esters are not hydrolysed within 
protoplasts and therefore attention turned to synthesising alternative probes.  
2.1.4 Alternative Probes 
Previous results have shown that AtSFGH shows activity towards both α- and 
β-naphthyl acetates 73 and 74 (See Table 2.1). These two compounds were synthesised 
in good yields from acetyl chloride (See Scheme 2.15). Mass spectra confirmed synthesis 
in both cases (187.1 and 186.9, [M+H]+). 
i
i) Et3N, DMAP, acetyl chloride, 0 
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Scheme 2.15 Acetylation of α- and β-naphthol 
2-(2-hydroxyphenyl)benzoxazyl acetate 75 was also synthesised by the reaction of 
2-(2-hydroxyphenyl)benzoxazole and acetyl chloride, using identical conditions to 
those in Scheme 2.15, in a 99% yield  
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α 73, 64 % 
β 74, 87 % 
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 In order to examine the uptake and subsequent hydrolysis within cells of 73 – 75, these 
compounds were incubated with protoplasts and observed using fluorescence 
microscopy.  With 73 and 74, fluorescence was seen within the protoplasts, although it 
was much less intense than that seen with FDA. Moreover, photobleaching occurred 
with both compounds after 2 minutes. Unfortunately, when 75 was incubated with a 
suspension of protoplasts, no fluorescence could be seen.  
2.1.5 Summary 
* The synthesis of 56 could not be achieved via enolate or carboxylic dianion chemistry, 
with the addition of complexing or chelating agents proving ineffective. 
* The reaction of the appropriate alkyl halide with 4-MU produced 56 in 72% yield, 
with the isomer 60 synthesised in 76% yield. 
* Synthesis of 61 involving the reaction of 4-MU with the Boc-protected glycine was 
achieved in a 70% yield. A lower yield of 25 and 26% were obtained when synthesising 
62 and 63 from Boc-protected L-alanine and D-alanine respectively. 
* Those derivatives which contained an amide bond were poor substrates for both PLE 
and AtSFGH when compared to that of the n-hexyl derivative, 38. This suggests that 
some sort of conformational flexibility within the substrate is needed. 
* AtSFGH activity towards a variety of methylumbelliferyl esters more closely 
resembles the activity seen in whole cells than that seen with PLE. This indicates that 
AtSFGH is a better determinant of hydrolysis of these compounds in planta than PLE. 
* The methylumbelliferyl esters did not appear to be taken up by the protoplast cells 
and hence no fluorescence was seen. However, the protoplasts readily hydrolysed FDA 
with the resulting fluorescence being detected on a fluorescence microscope and the 
MoFlo®. 
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2.2 AtCXE12 
2.2.1 Introduction 
This section will introduce another esterase isolated from A. thaliana, AtCXE12. Some of 
the background research undertaken on the enzyme will be discussed and work 
undertaken to apply the technique of directed evolution will be presented. 
2.2.2 Previous Research 
Carboxylesterases (CXE), of which AtCXE12 is an example, are a large class of enzymes 
that hydrolyse short-chain esters to the corresponding carboxylic acid. They belong to 
the α/β hydrolase fold superfamily of proteins110 and contain a conserved structural 
core consisting of eight β-strands, with connecting α-helices and loops interspersed 
within and around the eight β-strand core (See Figure 2.11).103 This sheet of β-strands is 
highly twisted and bent so that it forms a half-barrel, with the first strand at almost 90° 
to the last. 
 
Figure 2.11 Schematic representation of the structural core of the α/β hydrolase fold proteins. Reprinted 
from Structure, vol. 7, Heikinheimo P., Goldman A., Jeffries C. and Ollis D.L., Of barn owls and bankers: a lush 
variety of α/β hydrolases, R141-R146, Copyright (1999), with permission from Elsevier. 
They also contain the classic serine hydrolase catalytic triad of a nucleophilic residue 
(serine or cysteine), histidine and aspartic acid (although in some cases this can be 
glutamic acid) and an oxyanion hole which is able to stabilise the substrate-enzyme 
intermediate during hydrolysis. The nucleophilic residue is located after β5 in an area 
called the nucleophilic elbow, which is the best conserved feature across the α/β 
hydrolases. The twist of the central β-sheet allows the catalytic triad residues to be 
brought close together to form the active site. 
76 
 
Marshall and co-workers used RT-PCR experiments to determine the expression of 20 
CXEs present within A. thaliana in a variety of tissues within the plant.111 AtCXE12 was 
detected across all tissue types and this can be seen in Figure 2.12.  
  
Figure 2.12 Expression pattern of AtCXE12 in a variety of tissues as determined by RT-PCR a) young 
root, b) mature root, c) 2 leaf seedling, d) 4 leaf seedling, e) 6 leaf seedling, f) leaf, g) stem, h) flower 
bud, i) flower, j) young silique, k) mature silique, l) negative control, m) positive control. With kind 
permission from Springer Science+Business Media: Journal of Molecular Evolution, The Carboxylesterase Gene 
Family from Arabidopsis thaliana, 57, 2003, 487, Marshall S.D.G., Fig 4. 
Work within the Edwards group has shown AtCXE12 to be sensitive to inhibition by 
the fluorophosphonate paraoxon, an inhibitor of serine hydrolases. They have also 
demonstrated that AtCXE12 is the principal enzyme responsible for the hydrolysis of 
methyl-2,4-dichlorophenoxyacetate, 76.  
O
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76 is a pro-herbicide, which is hydrolysed to the phytotoxic compound 2,4-
dichlorophenoxyacetic acid and is commonly used in the control of dicotyledonous 
weeds.112 Gershater et al used the trifunctional probe 77 to detect and isolate four 
carboxylesterases which hydrolysed 76.113 The reactivity probe contained a 
fluorophosphonate group which was able to selectively modify the serine residue 
present in the catalytic triad, a biotin tag to aid isolation and a fluorescent moiety 
(rhodamine) for detection and quantification.  
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Figure 2.13 Trifunctional probe, 77 used to isolate AtCXE12 
Three of the serine hydrolases identified (AtCXE5, AtCXE12 and AtCXE20) were cloned 
and recombinantly expressed. Following purification each of these enzymes were 
assayed against 76 with hydrolysis only seen with AtCXE12. 
2.2.3 Directed Evolution of AtCXE12 
As previous work had shown that AtCXE12 was a classic serine hydrolase which shows 
high activity within plants (both from the protein extract and in planta) this enzyme was 
used as the model enzyme system to test the directed evolution methodology outlined 
in Section 1.2. Due to the mechanistic similarities of esterase and lipase action, the aim 
was to evolve AtCXE12 from an esterase to a lipase-like enzyme, i.e. show a greater 
activity towards long chain esters. 
2.2.3.1 Hormone Sensitive Lipase 
Work undertaken by Wei et al on the carboxylesterase Brefeldin A Esterase (BFAE) 
revealed similarities to the human enzyme Hormone Sensitive Lipase (HSL).114 BFAE 
and HSL have different substrate specificities, with the latter preferring longer chain 
esters. HSL is larger than most α/β hydrolases with the C-terminal domain containing 
the catalytic machinery.115 Wei performed sequence alignment with BFAE and HSL and 
found 45% alignment between the two sequences.  Figure 2.14 shows the catalytic sites 
for both BFAE and HSL, with the high sequence identity clearly identifiable.  
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Figure 2.14 Catalytic sites of BFAE and HSL, with the catalytic triad of Ser202, His 338 and Asp308 in 
BFAE and Ser424, His723 and Asp693 in HSL. Reprinted by permission from Macmillan Publishers Ltd: 
Nature Structural Biology (1999, 6, 340-345), copyright (1999) 
Sequence alignment and the catalytic site diagrams suggest that Ala454 in human HSL 
is located at a site which is occupied by Try233 in BFAE. This tyrosine residue is 
thought to fold over the binding site of BFAE and prevent long chain esters from being 
hydrolysed. In order to gain evidence for this the residue Ala454 in HSL was mutated 
to phenylalanine, which is a more bulky residue. This was achieved using site-directed 
mutagenesis and using Western blotting the A454F mutant was shown to be expressed 
at similar levels to the wild type enzyme. When the A454F mutant was screened against 
a range of p-nitrophenyl esters it was shown to have similar levels of activity with p-
nitrophenylbutyrate (C4), valerate (C5) and caproate (C6) as that seen with the wild 
type. However, the A454F mutant was completely inactive towards p-nitrophenyl 
caprylate (C8), trolein and a dioleylglycerol analogue. The authors postulate that this 
result indicates the role of Tyr233 in esterase activity within BFAE. 
Looking at the sequence alignment of BFAE and AtCXE12, several overlaps can be seen 
to occur, Figure 2.15. Producing a homology diagram of the two enzymes to show the 
tertiary structure clearly identifies the Tyr233 in BFAE is occupied by Tyr198 in 
AtCXE12 (See Figure 2.16). 
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Figure 2.15 Structure-aided sequence alignment of amino acid sequences of BFAE and AtCXE12. The 
sequences were first aligned using Scratch Protein Predictor116 and then manipulated manually to 
achieve maximum similarity within the secondary structure. Boxes represent α-helices as determined 
from the BFAE structure. 
 
Figure 2.16 Predicted tertiary structure of a) AtCXE12 and b) BFAE using homology alignment. The 
catalytic triad can be seen in both cases, along with the tyrosine residues (Tyr233 in BFAE and Tyr198 
in AtCXE12). * α helix which joins these two points has been removed for clarity 
Using this information studies were undertaken to mutate Tyr198 in AtCXE12 to a less 
bulky residue with the aim of producing a more lipase-like enzyme. However, before 
a) b) 
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any mutagenesis and screening could be performed, probe molecules were designed 
and synthesised to enable the selection of an improved enzyme. The following section 
details the synthesis and preliminary assays which were undertaken. 
2.2.3.2 AtCXE12 probe molecules 
Previous work with AtSFGH had highlighted several issues with using 
methylumbelliferyl esters as probes for directed evolution studies. These included 
problems with emission profiles overlapping with cellular autofluorescence and limited 
uptake within protoplasts. As FDA is readily taken up by protoplasts and the 
hydrolysis product fluorescein is highly fluorescent at wavelengths beyond 
autofluorescence, probes were developed based on the fluorescein moiety.  
2.2.3.2.1 Fluorescein probes 
Using the data gathered in the AtSFGH substrate mapping experiments, four 
fluorescein derivatives were chosen for synthesis. These were FDA, fluorescein 
dihexanoate, fluorescein didecanoate and fluorescein di-(2,2-dimethyl)butanoate. All 
derivatives, except FDA which was purchased from Aldrich, were synthesised under 
identical conditions by the treatment of fluorescein with the appropriate acyl chloride 
in the presence of pyridine (See Scheme 2.16). 
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    = n-decyl 79, 75%
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Scheme 2.16 
Synthesis was confirmed in each case by the appearance of signals with the correct 
integration corresponding to the alkyl protons in the 1H NMR spectrum and the 
presence of two carbonyl signals in the 13C NMR spectrum at 171.9 and 169.3 ppm. 
Compounds 78 – 80 and FDA were then assayed against purified AtCXE12, with the 
results outlined in the following section.  
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2.2.3.2.2 AtCXE12 in vitro assays 
The synthesised fluorescein esters, 78 – 80 and FDA were screened against purified 
AtCXE12. This was undertaken on a FLASHScan®, with λex 490 nm and λem 512 nm. 
Substrate concentrations were in the range 500 μM to 10 μM. The assay was performed 
in Tris buffer (0.1 M, pH 7.4) and a 1:1 ratio of substrate to enzyme. All measurements 
were recorded at 37 °C. However, no meaningful data could be identified from the 
screen and upon investigation it could be seen that a white precipitate had formed 
during the analysis. This was thought to be due to the relatively low solubility of the 
fluorescein esters within acetone. For this reason, the solvent was changed to DMSO 
and the assay repeated. Disappointingly, this change did not affect the outcome and 
again solubility issues were a concern.  
Due to the solubility issues at high concentrations, it was decided to lower the 
concentration of the fluorescein derivatives to below 10 μM and four different 
concentrations were produced in DMSO: 2.5 μM, 5 μM, 7.5 μM and 10 μM. When these 
compounds were assayed against AtCXE12, data relating to the catalytic activity of the 
enzyme was gathered. Table 2.5 shows this data.  
Substrate 
Specific Activity 
(nkatmg-1) 
Km  
(mM) 
Fluorescein diacetate, FDA 479 ± 31 0.003 
Fluorescein dihexanoate, 78 54.3 ± 2 0.004 
Fluorescein didecanoate, 79 23.8 ± 6 0.001 
Fluorescein di(2,2-dimethyl)butanoate, 80 29.1 ± 2 0.001 
                             Table 2.5 Fluorescein ester substrate activity against AtSFGH 
2.2.3.2.3 Flow cytometry screening 
With a difference in activity seen with 78 – 80, efforts now concentrated on the ability to 
distinguish between this activity using the flow cytometer. In order to achieve this, a 
simple screening experiment was performed. Using protoplasts harvested from 
Arabidopsis leaves, each of the probes were incubated with the solution and analysed 
using the MoFlo®. Incubation time was 30 minutes, with probe concentration at 5 μM. 
An example of a typical histogram obtained, before and after addition of the substrate 
can be seen in Figure 2.17. 
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Figure 2.17 Increase in fluorescence at 530/30 nm upon incubation with FDA 
A plot of 530/40 nm against 580/30 nm clearly shows a new population forming upon 
addition of the fluorescein probe, Figure 2.18. This population has an increased 
fluorescence and is the result of esterases present within the protoplasts hydrolysing 
the ester to form fluorescein.  
 
Figure 2.18 Plot of 530/40 nm against 580/30 nm showing the population which exhibits increased 
fluorescence 
78 – 80 were incubated as for FDA and a relative rate of hydrolysis against AtCXE12 
was recorded. The dot plots below (Figure 2.19) show that the cells turn over the longer 
chain substrates at a slower rate as seen by the smaller side population which shows 
increased fluorescence. 
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Figure 2.19 Dot plots showing the difference in hydrolysis of substrates 78 – 80  
The order of hydrolysis was found to be FDA > 78 > 79 ≈ 80. When observing the rate of 
hydrolysis over time, an increase can clearly be seen for FDA, with much slower rates 
seen with increasing chain length (See Figure 2.20). 
 
Figure 2.20 Addition of FDA and 78 – 80 with increase in fluorescence at 530/40 nm over time recorded 
Importantly, the relative rates of hydrolysis within protoplasts were the same as that 
observed with purified AtCXE12 and therefore compounds 78 and 79 could be used as 
probes for the directed evolution experiments. In addition to this, when viewed under 
the fluorescent microscope excellent uptake of all substrates was observed with no 
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interference seen from cellular autofluorescence. Attention now focussed on 
mutagenesis techniques with the aim of producing an improved lipase-like enzyme. 
2.2.3.3 Site directed mutagenesis 
As discussed in Section 2.2.3.1, both AtCXE12 and BFAE contain a tyrosine residue in 
the analogous position within the respective protein. With HSL no longer exhibiting 
lipase activity with a smaller alanine residue in the analogous position, it was 
hypothesised that mutation of Tyr198 to alanine would result in the ability of AtCXE12 
to hydrolyse longer chain esters. Experiments were undertaken to affect this mutation 
using site directed mutagenesis. 
Site directed mutagenesis is a technique which is able to introduce specific mutations at 
a desired point within a DNA sequence and is discussed in Section 1.2.3. The Quick 
Change II kit from Stratagene was used with the DNA polymerase Pfu turbo and 
oligonucleotides which contained two nucleotide base changes (T – G, A – C), which 
caused the amino acid change from tyrosine to alanine. Gel electrophoresis (Figure 2.21) 
showed a single band of the correct size. Following transformation in E. coli and 
subsequent plasmid purification using the Promega Wizard MiniPrep kit, DNA 
sequencing confirmed the successful mutation of tyrosine to alanine. 
 
Figure 2.21 Gel electrophoresis of AtCXE12 Y198A 
The mutated Y198A protein was overexpressed using tuner(DE3)pRARE cells and 
purified using a nickel chelate column. The purified protein was then used in screening 
experiments with the fluorescein ester probes. The screening conditions employed were 
identical to those used for the previous AtCXE12 wild-type enzyme. Unfortunately, no 
activity was seen with any of the substrates, even with FDA. In order to show that the 
lack of activity was not due to problems with protein expression, analysis was 
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undertaken to show this. Expression of the AtCXE12 Y198A mutant was shown using 
SDS-PAGE and Western blot analysis. Following lysis of the bacteria by sonication both 
the soluble and insoluble fraction were heated to 90 °C in SDS loading buffer. These 
were loaded onto an SDS-PAGE gel alongside the soluble and insoluble fraction of the 
wild-type enzyme for comparison. Bands could be seen in all four lanes (Figure 2.22). 
Western Blot analysis using the monoclonal anti-His tag antibody conclusively proved 
that expression had occurred in both the soluble and insoluble fraction by the presence 
of a single band in all four lanes (Figure 2.23). The levels of expression were comparable 
in both the wild-type and the Y198A mutant.  
 
Figure 2.22 SDS-PAGE analysis showing bands corresponding to AtCXE12 in all four lanes 
 
Figure 2.23 Western blot showing expression of AtCXE12 and AtCXE12 Y198A mutant 
The lack of activity of the Y198A mutant was therefore not due to problems with 
expression but suggested that the Tyr198 residue is critical for catalytic activity. 
          wt   Y198A 
      sol    insol        sol                insol 
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Due to the disappointing result, efforts now concentrated on the use of random 
mutagenesis techniques in the directed evolution studies. Error-prone PCR was chosen 
as the preferred method and the work undertaken is described in the following section. 
2.2.3.4 Error-prone PCR 
Error-prone polymerase chain reaction (epPCR) is a random mutagenesis technique in 
which mutations are deliberately introduced during PCR through the use of error-
prone DNA polymerases and reaction conditions (See Section 1.2.4). The error-prone 
polymerase which was used in these studies was developed by the Connolly group at 
Newcastle University.117 A mutant of the high-fidelity DNA polymerase from 
Pyrococcus furiosus (Pfu-pol) was developed, which was able to introduce random errors 
using the same conditions as with the wild type enzyme. Pfu-pol contains 3’-5’ proof 
reading activity in which any incorrectly placed nucleotides are removed and replaced 
with the correct base.118  
DNA polymerases are multi functional proteins. They contain a pol domain, which 
consists of three sub-domains termed the palm, fingers and thumb. These sub-domains 
are responsible for DNA replication, with the fingers playing an important role in 
dNTP recognition. This finger sub-domain is highly conserved in archeal polymerases, 
of which Pfu-pol is an example. It contains two long anti-parallel α-helices separated by 
a loop region (See Figure 2.24). A number of amino acids present on both of the a-
helices are brought in close proximity to each other as a result of the folding of the 
helix-loop-helix motif. Due to the highly conserved nature of these helix-loop-helix 
motifs a similar mechanism of dNTP recognition and accurate DNA replication can be 
inferred. The crystal structure of a viral polymerase enzyme/primer/template-dNTP 
complex has been solved and clearly showed a larger movement in the fingers sub-
domain upon dNTP binding.119 In addition to this, kinetic studies120 have indicated that 
DNA polymerase fidelity is highly dependent on protein conformational changes.  It 
shows that this involves the transient association of any dNTP with the enzyme-bound 
primer/template, with a conformational change triggered only when the incoming 
dNTP forms a Watson-Crick base pair. This change allows the assembly of the active 
site and subsequent polymerisation. In this way any incorrect dNTPs are rejected and 
fidelity is maintained.121 
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Figure 2.24 Structure of the finger sub-domain of the DNA polymerase from Thermococcus species 
9°N-7. The amino acid residues shown in green are those present in the loop region, with the highly 
conserved amino acid residues present in the α-helices which are brought together on the same side of 
the motif shown in red. Biles B.D. and Connolly B.G., Low-fidelity Pyrococcus furiosus DNA polymerase 
mutants useful in error-prone PCR, Nucleic Acids Research, 2004, 32,  e176, by permission of Oxford University 
Press. 
In an attempt to produce a low-fidelity Pfu-pol, Connolly first removed the 3’-5’ proof-
reading activity with the mutation D215A. Three amino acid residues were then 
targeted for mutation: T471, Q472 and D473. These are all present within the loop 
region in Pfu-pol. Using site-directed mutagenesis all three targeted amino acids were 
changed to both alanine and glycine in the hope that these smaller residues would give 
increased flexibility within the loop region. In order to assess the accuracy of the 
mutant DNA polymerases, a lacIOZα fidelity assay was performed. This assay makes 
use of the fact that DNA polymerases which make no mistakes copying the lacI gene 
result in an active lac repressor which prevents the transcription of the lacZα gene. 
Therefore, those E. coli strains which are transformed with the amplified product cannot 
express an active β-galactosidase and plaques are unable to hydrolyse X-Gal and 
appear white. If the polymerase introduces errors into lacI this may give rise to a 
repressor unable to bind DNA and therefore subsequent transcription of lacZα results 
in the production of β-galactosidase and blue plaques. The number of mutations which 
give rise to an inactive repressor in the lacI gene is known122 and therefore the ratio of 
blue and white plaques can be converted to a mutation load and hence error rate of the 
polymerase. Screening the mutant Pfu-pol using this method showed that the mutants 
Q472A/G and D473A/G gave the highest error-rate.  
D473G was then used to amplify the entire plasmid pET17b[Pfu-pol]. Following 
plating, 19 plasmids were isolated and sequenced over an identical stretch of 500 
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nucleotides, corresponding to the first 167 amino acids in the Pfu-pol gene. From the 
total 9500 bases sequenced, 68 mutations occurred across the whole stretch of DNA, 
with no hot spots observed. Table 2.6 shows the mutational bias of the D473G as 
compared to that of Taq in previous studies undertaken.117 
Mutation Pfu-pol(exo-) 
D473G 
Taq-pol (Mn2+/ 
unbalanced dNTPs) 
Taq-pol (unnatural 
mutagenic bases) 
A→T/T→A 28 40.9 0.2 
A→C/T→G 7.4 7.3 8.4 
A→G/T→C 19.2 27.6 78.3 
G→A/C→T 22 13.6 13.2 
G→C/C→G 7.3 1.4 0.7 
G→T/C→A 10.3 4.5 0.0 
Insertion 2.9 0.3 ~0 
Deletion 2.9 4.2 ~0 
Table 2.6 Mutation spectra for D473G and Taq-pol in error-prone PCR117 
An ideal, unbiased error-prone polymerase would exhibit all mutations with an equal 
frequency of 16.7%, preferably with no deletions or insertions. The mutational spectrum 
of D473G was shown not to be completely random, however, it did show much less 
bias than those of Taq-pol. Using this mutant polymerase, error-prone PCR methods 
were developed with the aim of mutating AtCXE12. 
2.2.3.4.1 epPCR methodology development 
In order to ascertain the optimal reaction conditions for epPCR, several reactions were 
carried out using a variety of D473G and AtCXE12 template dilutions, with the 
subsequent PCR products being analysed by gel electrophoresis. Dilutions were carried 
out using dH2O (See Experimental Section for full details of PCR cycling parameters). 
Table 2.7 below shows the different dilutions used in the test reactions. Another DNA 
polymerase, V93Q(exo-), which simply lacks the 3’-5’ proof-reading activity was also 
used as a comparison. 
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TUBE D473G(exo-) V93Q(exo-) AtCXE12 template 
A1 1/10 ------ 1/10 
A2 1/100 ------ 1/10 
A3 1/1000 ------ 1/10 
A4 1/10 ------ 1/100 
A5 1/100 ------ 1/100 
A6 1/1000 ------ 1/100 
B1 ------ 1/10 1/10 
B2 ------ 1/100 1/10 
B3 ------ 1/1000 1/10 
B4 ------ 1/10 1/100 
B5 ------ 1/100 1/100 
B6 ------ 1/1000 1/100 
Table 2.7 Conditions employed for the test reaction to optimise the error-prone PCR reaction 
Following analysis, it can clearly be seen from the gel (Figure 2.25) that the reaction 
containing 1/10 dilution of D473G(exo-) and 1/100 of AtCXE12 template gave the best 
result. 
 
Figure 2.25 Fluorescent image of conditions tested for the epPCR reaction showing 1/10 dilution of 
D473G and of 1/100 AtCXE12 template (Lane A4) gave the best result. 
The reaction was repeated on a larger scale to produce a large quantity of the AtCXE12 
megaprimer. The PCR products were purified using a Perfectprep Gel Cleanup Kit 
(Eppendorf). The concentration of the megaprimer was 134 ng/μL, as determined by a 
NanoDrop 1000 (Thermo Scientific).  
The next step was the clone reaction, and again test reactions were performed to 
determine the optimal reaction conditions. A variety of megaprimer:AtCXE12 template 
  A1 A2 A3 A4 A5 A6 B1  B2 B3 B4  B5 B6 
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ratios were prepared and the full set of reaction conditions can be see in the table below 
(Table 2.8). 
 Megaprimer AtCXE12  
template 
dNTPs 10x buffer dH2O Phusion  
Pol 
Control 1 250 ng (2 μL) 100 ng (1 μL) 1 μL 5 μL 41 μL ------ 
Reaction 1 250 ng (2 μL) 100 ng (1 μL) 1 μL 5 μL 41 μL 1 μL 
Control 2 250 ng (2 μL) 300 ng (2.5 μL) 1 μL 5 μL 39.5 μL ------ 
Reaction 2 250 ng (2 μL) 300 ng (2.5 μL) 1 μL 5 μL 39.5 μL 1 μL 
Control 3 250 ng (2 μL) 500 ng (4 μL) 1 μL 5 μL 38 μL ------ 
Reaction 3 250 ng (2 μL) 500 ng (4 μL) 1 μL 5 μL 38 μL 1 μL 
Reaction 4 500 ng (4 μL) 100 ng (1 μL) 1 μL 5 μL 39 μL 1 μL 
Reaction 5 500 ng (4 μL) 300 ng (2.5 μL) 1 μL 5 μL 37.5 μL 1 μL 
Reaction 6 500 ng (4 μL) 500 ng (4 μL) 1 μL 5 μL 36 μL 1 μL 
Table 2.8 Reaction conditions for clone reaction tested. AtCXE12 template concentration was 123 ng/μL 
Control reactions in which no DNA polymerase was added were performed as a 
negative control. Following PCR, the products were purified using a Qiagen PCR kit 
and the original DNA template was removed by DpnI digestion. The DpnI digestion 
product was transformed into E. coli and the number of colonies on each plate was 
recorded. There were no colonies present on any of the control plates, nor from reaction 
1. Reaction 3 was deemed to give the optimal results and therefore these ratios were 
used in all subsequent reactions (See Figure 2.26).  
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Figure 2.26 Fluorescent image of gel showing reaction conditions for clone reaction, with R3 giving 
optimal results. 
A selection of individual colonies was taken and the resulting purified plasmid was 
sequenced. Pleasingly, mutations had occurred in all the sequences and importantly 
were spread across the whole of the AtCXE12 gene. The mutational frequency was an 
average of 7.5 mutations per reaction. Table 2.9 below shows the mutations that were 
achieved.  
Mutation 
Pfu-pol(exo-) 
D473G 
A→T/T→A 22.5 
A→C/T→G 6.3  
A→G/T→C 13.8 
G→A/C→T 40.0 
G→C/C→G 6.3 
G→T/C→A 8.8 
Insertion 1.3 
Deletion 1.3 
Table 2.9 Mutational bias of D473G polymerase in the error-prone PCR of AtCXE12 
Another criteria in the assessment of mutational bias is the transition:transversion 
(Ts/Tv) ratio. Transition mutations are purine to purine changes (A and G) and 
pyrimidine to pyrimidine changes (T and C), while transversions are purine to 
pyrimidine and pyrimidine to purine changes. There are eight possible transversions 
and four possible transitions and an enzyme completely lacking any bias would have a 
Ts/Tv ratio of 0.5. Mutational bias can also be assessed by calculating the ratio of 
transition mutations, which for an unbiased enzyme should equal 1.0 and by 
comparing the frequency of mutating A and T vs. the frequency of mutating G and C, 
which should ideally be equal. Table 2.10 below shows these additional criteria and 
compares them to those of Taq polymerase, obtained from a study by Shafikhaui et al.8 
R1  C1  R2  C2 R3  C3 R4  R5 R6 
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Bias indicators Pfu-pol(exo-) D473G Taq polymerase 
Ts/Tv 1.2 0.8 
AT→GC/GC→AT 0.4 1.9 
AT changes 47.2% 75.9% 
GC changes 49.1% 19.6% 
Mutational frequency 7.5 4.9 
Table 2.10 Bias indicators for D473G and Taq polymerase 
As the D473G mutant has a lowered ability to correctly recognise the incoming dNTPs 
it was decided to test whether the concentration of dNTPs in the initial PCR would 
have an effect on the mutational bias of the enzyme. To this end, the concentration of 
the dNTPs were reduced to 25% of the original amount, with all other factors kept 
constant. The clone reaction was carried out under identical conditions as described 
previously and 10 of the resulting colonies were picked and plasmid purification 
performed. The purified plasmids were sequenced and the mutational frequency and 
bias was determined and can be seen in the table below. 
Mutation 
Pfu-pol(exo-) D473G  
with 25% dNTPs 
A→T/T→A 22.4 
A→C/T→G 10.3 
A→G/T→C 8.6 
G→A/C→T 37.9 
G→C/C→G 3.4 
G→T/C→A 15.9 
Insertion 1.7 
Deletion 0.0 
Ts/Tv 0.9 
AT→GC/GC→AT 0.23 
AT changes 41.4 
GC changes 56.9 
Mutational frequency 5.6 
Table 2.11 Mutagenesis bias and frequency exhibited with lower dNTP concentration 
It can be seen that decreasing the concentration of dNTPs causes a decrease in the 
mutational frequency during epPCR, but does not have a profound effect on the 
mutational bias. In this way, the mutational frequency of the D473G mutant can be 
controlled simply by altering the dNTP concentration. 
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2.2.3.4.2 On-plate screening 
Before studies regarding protoplast transformation were carried out, screening in 
bacteria was performed in the hope of isolating an improved biocatalyst directly from 
bacterial cells. Two techniques were tested, both of which utilised on-plate screening. 
The first technique was based on previous work by Kunkel123,124 in which the screening 
for specific activity was carried out directly on the agar plate. This method was 
repeated using colonies containing AtCXE12 mutants, AtCXE12 wild-type and pET28a 
(the latter two as positive and negative controls). Colonies were picked and streaked 
across a specific area, using the grid in Figure 2.27 as a template.  
 
Figure 2.27 Grid template used for on-plate screening of recombinant esterases 
Two duplicate plates were prepared and were incubated overnight at 37 °C. A 
nitrocellulose (NC) membrane was cut to size and 1 ml of a 1 mM solution of 79 in 
acetone was poured onto the membrane. Unfortunately this caused the NC membrane 
to dissolve. EtOH, MeOH and iPrOH were found to be suitable for the NC membrane, 
however, 79 showed poor solubility in these solvents. Chloroform was found to be the 
most suitable solvent and this was used in all subsequent on-plate screening 
experiments. 79 in chloroform (1 mM) was poured onto the NC membrane and blotted 
onto one of the plates. Disappointingly, when viewed under a UV lamp all the colonies 
exhibited fluorescence. This indicated that the background activity within the E. coli 
was too high to allow any meaningful results to be gained.  
The second method, based on work done by Senn and Wolosiuk125 screening for 
phosphatase activity in bacteria, was then investigated. In this method bacteria were 
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plated out directly on a NC membrane which had been placed on top of an agar plate 
(See Figure 2.28).  
 
Figure 2.28 Outline of the procedure for screening catalytic activity. A) Bacteria are plated directly 
onto a NC membrane. B) Appropriate inducer is added to the agar plate. C) NC membrane is placed, 
colonies side up, on a Whatman filter paper soaked in water. D) Whatman filter paper, pre-soaked in 
the catalytic solution, replaces the paper used in the previous step. Reprinted from Analytical 
Biochemistry, Senn A.M. and Wolosiuk R.A., A high-throughput screening for phosphatises using specific 
substrates, 150-156, Copyright (2005), with permission from Elsevier 
This was repeated using the mutant AtCXE12 library and the AtCXE12 wild-type on 
separate plates. Again, when the colonies were viewed under a UV lamp they all 
fluoresced. Due to these poor results, all future efforts were concentrated on direct 
transformation and screening in protoplasts. 
2.2.3.5 Agrobacterium-mediated transformation 
Previous work within the group had focussed on the use of electroporation and PEG-
mediated transformation of protoplasts. However, transformation yields were often as 
low as 5% and for this reason attention turned to the technique of Agrobacterium-
mediated transformation of plants, with subsequent protoplast isolation being carried 
out on transformed plants. For a more detailed description of Agrobacterium-mediated 
transformation see Section 1.4.2.4. Before this transformation technique could be 
utilised molecular biology experiments were undertaken to clone AtCXE12 into the 
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appropriate vectors necessary for this form of transformation. The work undertaken is 
described in the next section. 
2.2.3.5.1 Cloning of AtCXE12 into binary vectors 
All previous experiments were undertaken with AtCXE12 present in the pET24(d) 
bacterial vector. However, in order to transform plants AtCXE12 needed to be cloned 
into a binary vector. Binary vectors are able to transform both E. coli and Agrobacterium 
and therefore AtCXE12 was cloned into the correct binary vector. 
The vector chosen for Agrobacterium-mediated transformation was the BIN-STRP3 
vector. This contains a streptavidin tag which is used for purification of the resulting 
plasmid/protein by making use of the biotin-streptavidin affinity system.75 However, 
direct cloning into this vector was not possible due to the absence of the appropriate 
restriction sites in the AtCXE12-pET24(d) construct. Therefore, initial experiments 
involved the introduction of the necessary cloning sites. The flowchart in Figure 2.29 
highlights the required steps necessary for cloning into BIN-STRP3. 
 
Figure 2.29 Flowchart of cloning experiments necessary to produce the AtCXE12 binary vector 
construct 
The first step was to introduce a NdeI site at the beginning of the AtCXE12 sequence 
and a stop codon at the end. The expression of AtCXE12 from pET24(d) places a His tag 
pET24(d)-AtCXE12 
pET24(d)-AtCXE12 
pET-STRP-AtCXE12 
BIN-STRP3-AtCXE12 
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at the end of the sequence, which is used for purification of the protein. However, the 
BIN-STRP3 vector places a streptavidin tag onto the protein and therefore the His tag is 
no longer required. The stop codon placed at the end of the sequence prevents the His 
tag from being translated during protein overexpression. Two primers were designed 
with the appropriate nucleotide base changes and following PCR with KOD DNA 
polymerase, gel electrophoresis confirmed the successful reaction. The sequence 
changes were conclusively proven following DNA sequence analysis. 
The modified pET24(d)-AtCXE12 construct was then cloned and ligated into the pET-
STRP3 vector. Digestion was achieved by incubating the AtCXE12 construct with NdeI 
(1 μL) and XhoI (1 μL) restriction enzymes at 37 °C for 2.5 hours. In addition to this the 
pET-STRP3 vector was incubated with NdeI (1 μL) and SalI (1 μL). The digestion 
products were analysed by gel electrophoresis (See Figure 2.30) and the bands 
corresponding to the purified AtCXE12 insert and pET-STRP3 vector were excised and 
purified using a QIAquick Gel Extraction kit (QIAgen).  
 
Figure 2.30 Gel electrophoresis of AtCXE12 insert and pET-STRP3 vector following digestion with 
NdeI/XhoI and NdeI/SalI respectively. Lanes 1 and 4 correspond to 100 bp and 1 kb ladder markers 
respectively. 
Ligation was achieved using T4 DNA ligase (1 μL) and a 1:1 ratio of insert:vector, with 
incubation at 16 °C for 2.5 hours. As a control, the ligation was performed without an 
insert present. Following transformation into Top10 competent cells and overnight 
incubation, colonies were achieved for the ligation mixture, with no colonies present on 
the control plate. In order to check the presence of the AtCXE12 insert, a NdeI/XhoI 
digest was undertaken. The purified pET-STRP3-AtCXE12 was incubated with NdeI 
and XhoI as done previously and analysed by gel electrophoresis. Figure 2.31 clearly 
 1     2    3     4    5    6 
       AtCXE12        pET-STRP3 
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shows two products in Lane 1, which correspond to the insert and vector indicating 
successful digestion and hence presence of AtCXE12 insert. Again DNA sequencing 
showed that AtCXE12 was present and, importantly, without errors. 
 
Figure 2.31 The AtCXE12 insert and vector can clearly be seen as two products in Lane 1. Lane 2 
contains 1 kb ladder markers 
In order to check that AtCXE12 retained activity in the pET-STRP3 vector, the protein 
was overexpressed from tuner(DE3)pRARE cells and grown to kanamycin and 
chloramphenicol resistance. Several of the resulting colonies were incubated in LB 
media at 37 °C, with shaking, for 5 hours. IPTG was added to induce expression and 
following pelleting and lysis by sonication, the supernatant was tested for esterase 
activity against pNPAc. The colourless solution became a yellow colour rapidly, 
indicating that AtCXE12 was still active in the pET-STRP3 vector. 
The final step involved the cloning and ligation of AtCXE12 into the binary vector, BIN-
STRP3. However, several problems were encountered during this step. Initially, both 
PacI and BstXI were incubated together with pET-STRP3-AtCXE12 in NE Buffer 2. 
However, gel electrophoresis indicated that the digestion enzyme PacI had not cut the 
construct. The digestion was repeated using only PacI, again in NE Buffer 2. This time, 
analysis showed that PacI did cut, as can be seen by the presence of two bands in Figure 
2.32. Lane 2 contains the control reaction in which no PacI was added. However, this 
did show that PacI digestion was not 100% successful. This was probably due to NE 
Buffer 2 not being the optimal buffer for PacI digestion. The PacI/BstXI digestion was 
repeated; however, again analysis indicated that PacI was not cutting. Due to the 
disappointing results when both restriction enzymes were used together and the fact 
that using PacI only seemed to result in a successful reaction, it was decided to perform 
   1     2 
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this reaction in two separate steps. In this way optimal buffers for each individual 
restriction enzyme could be used.  
 
Figure 2.32 Lane 3 shows two products from successful PacI digestion. 
To this end, digestion of pET-STRP3-AtCXE12 using PacI in NE Buffer 1 was 
successfully achieved, following incubation at 37 °C for 3 hours. The digestion product 
was then purified before BstXI digestion was attempted. 2.5 volumes of 100% EtOH 
was added to the PacI digestion mixture and the solution was incubated on ice for 10 
mins. This was then centrifuged at 14,000 rpm for 10 mins and the resulting 
supernatant removed. 100 μL 70% EtOH was added to the pellet to remove any traces 
of salts. Following centrifugation, the supernatant was removed and the DNA pellet 
was left to dry and then resuspended in dH2O. BstXI was added to an aliquot of the 
purified DNA in NE Buffer 3 and incubated at 55 °C for 3 hours. After analysis by gel 
electrophoresis, excision of the bands and subsequent purification was performed and 
the solution was dried on the freeze-drier and resuspended in dH2O. Ligation using T4 
DNA ligase was performed and following transformation three colonies grew. Plasmid 
mini-preps were performed on each of these colonies and the resulting plasmids were 
analysed by gel electrophoresis following digestion with PacI/BstXI (See Figure 2.33). 
Lanes 2 and 3 show successful ligation and these plasmids were taken forward in the 
next steps.  
 1      2     3 
99 
 
 
Figure 2.33 Fluorescent image of gel electrophoresis following digestion with PacI/BstXI. Lanes 2 and 
3 show successful digestion. M = 1 kb markers 
2.2.3.5.2 Transformation and infiltration 
BIN-STRP3-AtCXE12 plasmid was transformed into XL-10 competent cells and the 
plasmid was recovered and purified using a Wizard Mini-Prep kit (Promega). This was 
then used to transform Agrobacterium by electroporation methods and following 
plating, they were incubated for 48 hours. One colony was picked and grown up in 10 
ml LB media with overnight incubation. At this time, a plasmid containing p19 was also 
transformed into Agrobacterium. In plants, post-transcriptional gene silencing (PTGS) 
acts as a defence system against virus infection.126 It does this by recognising foreign 
RNAs and causes their degradation in the cytoplasm. Some plant viruses have 
suppressors to counteract PTGS and one such example is p19. p19, a 19K protein from 
Tomato bushy stunt virus (TBSV), is a viral protein that has been identified as a PTGS 
suppressor.127 In order to prevent the plant’s defence system degrading the infiltrated 
Agrobacterium, a 1:1 mixture of Agrobacterium-transformed AtCXE12 and Agrobacterium-
transformed p19 were mixed together. After centrifugation, the resulting pellet was 
resuspended in 20 ml dH2O and this suspension was used for infiltrating N. 
benthamiana leaves. This was achieved using a 1 ml syringe placed against the 
underside of the leaf. Through the use of slight pressure, the suspension is forced into 
the leaf, whereupon transfer into the leaf cells can take place. A control plant, in which 
a suspension of only Agrobacterium transformed with p19 was present, was also 
prepared. All infiltrated plants were left for 4 days in the greenhouse.  
After this time, several leaves were removed and the transformation and activity was 
checked. This was achieved by incubating a protein extract from the leaves with 
pNPAc. The protein concentration was determined by Bradford assay and found to be 
3.36 mg/ml for AtCXE12 infiltrated leaves and 2.42 mg/ml for the p19 control leaves. 
5 μL of pNPAc was added to 1 ml of protein and the absorbance was recorded in 
M   1   2   3 
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duplicate at 400 nm. AtCXE12 protein extract was found to have a rate of 0.6322±0.008 
min-1 with the p19 control being 0.0320±0.003 min-1. This result showed that those 
leaves that had been infiltrated with AtCXE12 had been successfully transformed and 
pleasingly, that the rate of hydrolysis of pNPAc was 20-fold higher than the 
background activity. This meant that during the screening process, background activity 
would have a negligible effect and the chance of false positives would be greatly 
reduced. 
With AtCXE12 now successfully cloned into the binary vector and Agrobacterium-
mediated transformation proving to be a viable method, efforts now concentrated on 
using epPCR techniques on the BIN-STRP3-AtCXE12 construct to produce a 
recombinant library. 
2.2.3.5.3 BIN-STRP3-AtCXE12 recombinant library 
Using the optimised epPCR conditions described previously, efforts to introduce 
random errors into the AtCXE12 gene in the BIN-STRP3 construct were undertaken. 
Unfortunately, despite numerous attempts, the first step of the methodology was 
unsuccessful, with no megaprimers ever isolated from the PCR mixture. Due to time 
constraints this work was not completed. 
2.2.4 Summary 
* Fluorescein esters 78 – 80 were shown to be hydrolysed by AtCXE12 in the order FDA 
> 78 > 79 ≈ 80, with 78 and 79 identified as potential probes in directed evolution 
experiments. 
* Tyrosine198 was targeted as a possible residue for mutation. This was successfully 
mutated into alanine by site-directed mutagenesis. 
* When 78 – 80 were screened against the AtCXE12 Y198A mutant no activity was seen, 
even with FDA. Western blotting analysis revealed that the lack of activity was not due 
to expression problems and therefore Tyr198 is critical for enzyme activity. 
* Error-prone PCR techniques were employed in an effort to create a recombinant 
library. Protocol development revealed a 1/10 dilution of D437G(exo-) and 1/100 of 
101 
 
AtCXE12 template gave the best mutation results, with the clone reaction employing a 
1:2 ratio of megaprimer:AtCXE12 template. 
* The mutational frequency of the D473G polymerase could be controlled by altering 
the dNTP concentration. 
* On-plate screening in E. coli indicated that the background activity was too high to 
allow any meaningful results to be gained. 
* AtCXE12 was successfully cloned into the Agrobacterium vector BIN-STRP3. 
* Nicotiana benthamiana leaves infiltrated with Agrobacterium containing the BIN-STRP3-
AtCXE12 vector have been successfully transformed and the rate of hydrolysis of 
pNPAc was 20-fold higher than the background activity. 
* Efforts to introduce random errors into the atcxe12 gene contained within the BIN-
STRP3 construct were unsuccessful.  
2.3 Conclusions 
To enable an improved mutant of an enzyme to be identified, relatively poor substrates 
selected from the enzyme kinetic studies are used as probes. Using directed evolution 
techniques to generate recombinant biocatalysts, a much improved enzyme can be 
identified as one which hydrolyses the probe molecule at a faster rate than the wild 
type. The model system first chosen to develop this process was AtSFGH.  
Enzyme kinetic experiments with AtSFGH have shown that an increase in the chain 
length beyond C6 or the presence of bulky substituents led to diminished activity, 
whilst heteroatoms in the α-position do not appear to be tolerated by the enzyme. In 
addition to this, compounds containing a peptide bond were also poorly hydrolysed 
which may have been due to a lack of conformational rotation. 
Efforts to evolve AtSFGH were unsuccessful as the methylumbelliferyl ester derivatives 
were not uptaken by the protoplasts and therefore these were not deemed to be viable 
probes for the directed evolution and screening experiments. Although the naphthyl 
esters were uptaken by the cells the low intensity of fluorescence seen indicated that 
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longer chain esters would have no activity and would therefore be difficult to use in 
screening experiments. Based on the excellent ability of the protoplasts to uptake FDA, 
four fluorescein-based probes were targeted for synthesis, with their structure chosen 
using the data from the AtSFGH assays. As AtSFGH has a low activity towards FDA, 
another esterase enzyme, AtCXE12 was used in the directed evolution experiments. 
AtCXE12 has shown to be a classic serine hydrolase responsible for the hydrolysis of a 
variety of esters, including 76, within plant cells. The aim was to evolve this enzyme, 
which shows no activity towards long chain esters, to a more lipase-like enzyme, which 
will readily hydrolyse these compounds. A difference in activity was seen between 
AtCXE12 and the different probes when screened in vitro and in vivo and therefore the 
fluorescein esters were shown to be applicable as probes in the directed evolution 
experiments. 
Mutagenesis techniques included site directed mutagenesis, in which Tyr198 was 
successfully mutated to Ala198. Unfortunately, this change abolished all enzyme 
activity and was therefore postulated to be critical in the activity of the enzyme. Efforts 
turned towards the use of random mutagenesis techniques, in particular error prone 
PCR (epPCR). Using an error prone DNA polymerase, D473G(exo-), epPCR techniques 
were optimised and shown to randomly introduce errors throughout the AtCXE12 
sequence, at an average rate of 7.5 errors per PCR round. Attempts to screen in bacteria 
proved unsuccessful due to the high background enzyme activity rate. 
Transformation of Nicotiana benthamiana plants using Agrobacterium tumefaciens was 
shown to be successful and following cloning into the appropriate binary vector, 
AtCXE12 was transformed into Nicotiana plants. Subsequent activity assays of the 
transformed leaves showed them to have a 20-fold increase in activity towards pNPAc 
over the background activity. Unfortunately, efforts to introduce random errors in the 
binary construct were unsuccessful and due to time constraints no recombinant 
AtCXE12 library was produced. 
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3 REACTIVITY PROBES 
3.1 Introduction 
This chapter will consider the work undertaken on the isolation of proteins from cells 
by the use of reactivity probes. It will detail the rationale of the probe design, along 
with the synthesis, analysis and biological experiments undertaken with the aim of 
isolating specific enzymes from within a plant cell. 
3.1.1 Previous research 
The reactivity probes discussed in the following sections can be described as 
mechanism-based probes, which make use of an electrophilic part of the molecule 
which is able to specifically react with catalytic residues within the vicinity of the active 
site. In these cases probes only bind to active forms of the target enzyme and 
subsequent measurement of probe modification can be used as an indication of the 
enzyme activity. 
3.1.1.1 p-Quinone methide systems 
Several groups have made use of the quinone methide moiety as a trapping reagent. 
Tsai et al128 reported on the use of 81 as a probe towards β-glucosidase activity. 
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This probe does not contain a fluorophore but instead has a biotin group which allows 
the isolation of covalently modified proteins using the biotin-streptavidin affinity 
system. Using 19F NMR spectroscopy it was shown that fluoride was released due to 
the appearance of a peak at -122 ppm, which supported the 1,6-elimination reaction. 
Following SDS-PAGE and Western Blotting analysis, a biotinylated β-glucosidase was 
isolated, although it was unable to be shown that this enzyme still retained its activity, 
which suggests either active site labelling or multiple labelling of the protein had 
occurred.  
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In an attempt to isolate phosphatase enzymes, Janda129 designed the reactivity probe 83, 
which was able to react with phosphatase enzymes by active site modification, 
resulting in an inactive enzyme.  
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82 was synthesised in four steps in an overall yield of 30%. Upon addition of 82 to a 
phosphotriesterase enzyme, a precipitate began to form after three minutes. Using LC-
MS it was observed that multiple modifications were occurring. The number of enzyme 
site modifications ranged from one to four and this can be seen in the MS profile in 
Figure 3.1. 
 
Figure 3.1 MS profile of 82-labelled phosphotriesterase proteins. Reprinted from Bioorganic & Medicinal 
Chemistry Letters, Lo L-C., Lo C-H.L., Janda K.D., Kassel D.B. and Raushel F.M., A versatile mechanism based 
reaction probe for the direct selection of biocatalysts, 2117-2120, Copyright (1996), with permission from Elsevier 
In an extension to this work Zhu and co-workers utilised a p-quinone methide trapping 
reagent to selectively bind phosphatase enzymes130 with a fluorescent molecule 83. As 
with 82, the leaving group employed was a fluoride ion and 83 was successfully shown 
to covalently link to a variety of phosphatases from different sources. In addition to this 
no labelling was seen when 83 was incubated with different classes of proteases or 
lipases, which highlights the selectivity of 83 (Figure 3.2). By making use of the 
fluorescent moiety Cy3, the fluorescent bands within the gel can easily be visualised 
and excised from the gel for further manipulation. However, due to the permanent 
state of fluorescence of 83, sensitivity issues or false positives may be encountered. 
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Figure 3.2 Fluorescent image of SDS gel following incubation with 83. Lanes 1 – 3 contain 
phosphatases with lanes 4 – 8 contain proteases and lanes 9 – 10 lipases. Reprinted from Tetrahedron 
Letters, vol 44, Zhu Q., Huang X., Chen G.Y.J. and Yao S.Q., Activity-based fluorescent probes that target 
phosphatises, 2669-2672, Copyright (2003), with permission from Elsevier 
In an adaption to the techniques described above Komatsu et al developed a reactivity 
probe which upon binding to the enzyme resulted in a spectral change.131. This allows 
for the easy visualisation of enzyme activity upon the probe and overcomes the issues 
which may be associated with probes such as 83. The probe 84 was synthesised in 10 
steps from the commercially available 4-hydroxymandelic acid. By utilising Förster 
resonance energy transfer (FRET), 84 can undergo a spectral change when a structural 
change has occurred. 84 has two fluorophores, 7-hydroxycoumarin and fluorescein 
which are able to undergo FRET. 7-hydroxycoumarin acts as the energy donor, with 
fluorescein acting as the energy acceptor. In the intact probe, the two fluorophores are 
spatially close together and FRET occurs efficiently, with emission seen only from the 
fluorescein moiety. Following enzymatic action, the β-galactopyranosyl group is 
removed, which results in loss of the carbamate linked fluorescein group in an 
analogous way to the loss of the fluoride ion seen in previous probes. This now results 
in the loss of FRET and emission from the 7-hydroxycoumarin is now observed.  
 1    2   3   4   5   6   7   8   9   10 
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It was calculated that the efficiency of FRET was greater than 93%. Upon addition of a 
β-galactosidase a rapid increase in the emission of 7-hydroxycoumarin and a 
corresponding rapid decrease in the emission of fluorescein was observed (See Figure 
3.3). Using SDS-PAGE it was shown that 84 selectively bound β-galactosidase in the 
presence of β-glucosidase. When the gel was illuminated with 365 nm light, blue 
fluorescence was observed. 
 
Figure 3.3 Fluorescent spectrum of β-galactosidase incubated with 84, with the change in fluorescence 
that can clearly be observed. Reprinted with permission from Journal of the American Chemical Society, 2006, 
128, 15946-15947. Copyright 2006 American Chemical Society. 
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3.1.1.2 Fluorescently quenched reactivity probes 
Although the use of FRET allows for a spectral change to be observed with 84 the 
ability to switch from a non-fluorescent probe to a fluorescent one upon enzyme 
activation would allow potentially overcome the disadvantages seen with the above 
mentioned probes. In this way it combines the advantages of 83 and 84 in that a change 
in emission gives increased sensitivity, with the ease of visualisation that comes from 
the use of a fluorescent tag.  
The first example of a fluorescently quenched reactivity probe was published in 2005.132 
Due to the limitations of intrinsically fluorescent reactivity probes which include 
general fluorescence both when bound to an enzyme target and when free in solution, 
Blum et al designed a fluorescently quenched probe, 85. This probe offers the advantage 
that it only becomes fluorescent after covalent modification by a protease enzyme. 
Using 85, the authors claim that the experimental investigation of tumour 
pathophysiology can be achieved. 
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The acyloxymethyl ketone (AOMK) group was utilised as the recognition head for a 
class of proteases known as the cysteine cathepsins. Upon removal of this recognition 
head by the enzyme, the fluorescent quencher group, in this case QSY7, is eliminated 
and the fluorescence from the BODIPY analogue can be observed. Upon treatment in 
NIH-3T3 cells, 85 shows strong fluorescence in specific areas, which were later shown 
to be lysosomes. In contrast a control probe, which did not contain QSY7, shows diffuse 
fluorescence, which was removed by washing to show the specific fluorescence seen 
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with 85. This highlights the advantage of using a fluorescently quenched reactivity 
probe. Following SDS-PAGE analysis, the authors were able to show that 85 forms 
covalent linkages to the cathepsins by the appearance of a fluorescent band at the 
correct molecular weight. 
In a further study,133 Blum et al modified 85 to allow it to be used in animal screening 
experiments. They showed that the modified probe 86 (Figure 3.4) was able to localise 
and fluoresce within tumours present within mice, which may highlight the ability of 
86 to monitor cathepsin activity (See Figure 3.5). An increase in cathepsin enzyme 
activity has been shown been shown to be a marker for certain cancers.134  
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Figure 3.4 Modified probe 86. Cy5 was utilised as the fluorescent moiety, with QSY21 being employed 
as the fluorescent quencher group 
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Figure 3.5 Optical imaging of tumours in live mice. Tumour cells were injected subcutaneously into 
the back of BALB/c nude mice 2 wks before imaging. 86 (2 mg g–1) dissolved in DMSO/PBS was 
injected intravenously via the tail vein and fluorescent images of the dorsal side of living mice were 
taken at various time points after injection. Images are presented using a colorimetric scale based on 
photons per second per square centimetre per steradian (p s–1 cm–2 sr–1) overlaid on bright-light 
images. Reprinted by permission from Macmillian Publishers Ltd: Nature Chemical Biology (2007, 3, 668-677), 
copyright (2007). 
3.2 Probe Design 
The design of the reactivity probes discussed in this chapter is based on previous work 
carried out within the group which utilises the reactivity of a p-quinone methide. The 
probe contains a recognition head which is able to selectively react with specific 
enzymes and a fluorescent moiety to allow for easy visualisation. It also contains a 
fluorescent quencher group which prevents any emission from the fluorophore. Upon 
removal of the recognition head by enzymatic activity, the molecule undergoes a 1,6-
elimination with loss of the fluorescent quencher group and generates the reactive 
quinone methide. This intermediate serves as the trapping device and due to its highly 
electrophilic nature is able to react with nearby nucleophilic residues present within the 
protein (See Figure 3.6). 
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Figure 3.6 Mechanism of action of the reactivity probes. RH recognition head, F* fluorophore, FQ 
fluorescent quencher, Nu nucleophilic residue present within the protein 
The fluorophore was based on phenylacetylene, with p-nitrophenylisocyanate utilised 
as the fluorescent quencher. This was based on work done within the group, which 
110 
 
made use of this fluorescent quencher, albeit with the different fluorophore, dansyl 
chloride (unpublished results), 87. 
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3.3 TBS probe 
In order to test the design and action of the proposed reactivity probe, the current work 
synthesised a proof-of-concept probe based on a TBS protected phenol. This group was 
chosen as removal of the TBS group could easily be affected by treatment with TBAF. 
This would therefore allow the breakdown of the molecule by a 1,6-elimination to be 
confirmed. 
3.3.1 Synthesis 
The TBS probe was synthesised as shown in Scheme 3.1 
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i) TBSO
CHO
i) TBS-Cl, Et3N, DMAP, DCM, 0 
oC, 2 h, 65%; ii) n-BuLi, phenylacetylene, THF, -78 oC, 1 h, 16%; iii) p-
nitrophenylisocyanate, Et3N, rt, 1 h, 35%
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Scheme 3.1 Synthesis of 91 
4-hydroxybenzaldehyde, 88, was treated with TBS-Cl in the presence of Et3N and 
DMAP to afford 89 as a pale yellow oil in almost quantitative yield. The presence of the 
TBS group was confirmed in the 1H NMR spectrum by the appearance of peaks 
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corresponding to the t-butyl group (0.97 ppm, 9H) and the two methyl groups (0.22 
ppm, 6H). 89 was subsequently reacted with nBuLi followed by phenylacetylene to 
furnish the propargylic alcohol 90 in a moderate yield of 16%. Two distinctive doublets 
that coupled to each other in the 1H NMR spectrum corresponding to the OH (2.24 
ppm, d 3J 7) and the propargylic proton (5.62 ppm, d 3J 7) confirmed the structure. 
Finally reaction with p-nitrophenylisocyanate in the presence of a catalytic amount of 
Et3N afforded the probe molecule 91. Confirmation of the structure was obtained from 
the shift of the propargylic proton from 5.62 ppm to 5.52 ppm and a peak in the HRMS 
of 502.1918 (M+, C28H30N2O5Si requires 502.1924). UV/Vis analysis revealed 91 to have 
an absorption maximum at 371 nm (See Figure 3.7). 
 
Figure 3.7 Absorption profile of 91 
3.3.2 1,6-elimination analysis 
Having successfully prepared the probe the next stage was to test the hypothesis for the 
activation of the probe. Consequently, TBAF (100 μL) was added to a solution of 91 
(1 mg/ml in acetone) in water and the resulting increase in fluorescence was recorded, 
Figure 3.8. 
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Figure 3.8 Fluorescence change of 91 after treatment with TBAF 
This shows that the probe is broken down as hypothesised and that an increase in 
fluorescence can be detected. In order to show that the probe was able to react with 
nucleophiles as predicted 91 was treated with TBAF followed by a biotin derivative 92 
Scheme 3.2. Subsequent purification using streptavidin labelled beads would allow for 
the isolation of any fluorescently labelled biotin, 93. 
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Scheme 3.2 
Unfortunately 93 was not isolated from the reaction mixture. Changing the order of 
addition of TBAF and 91 had no effect. However, analysis of the LC-MS spectra 
revealed two peaks at 225.1 and 345.2 which was attributed to the H2O quenched 
product, 94 and the 4-nitro-aniline quenched product, 95. This products may form due 
to the close proximity of both water and the fluorescent quencher group to the reactive 
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quinone methide. Despite this, efforts now turned to the synthesis and use of a probe 
capable of isolating specific enzymes.  
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3.4 Esterase Probe 
As previous work had focused on esterases, as discussed in Chapter 2, a probe, 96, was 
designed and synthesised which would be able to react and isolate these from a protein 
mixture or cell. Work undertaken towards this is described in the following sections. 
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3.4.1 Synthesis 
Initial attempts to synthesise 96 began by the acylation of 4-hydroxybenazaldehyde, 
which was successfully achieved using acetyl chloride in the presence of Et3N and 
DMAP, in a near quantitative yield, Scheme 3.3. 
HO
CHO
O
CHO
O
       Et3N, DMAP
acetyl chloride, quant.
97  
Scheme 3.3 
97 was then subjected to treatment with nBuLi and phenylacetylene, however, despite 
repeated attempts no product, 98 was detected by either 1H NMR or LC-MS, Scheme 
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3.4. Table 3.1 below shows the various conditions and reagents employed in the 
attempted synthesis of 98. 
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Scheme 3.4 
REACTION  REAGENTS SOLVENT RESULT 
A nBuLi, phenylacetylene THF No product 
B nBuLi, phenylacetylene, ZnBr2 THF No product 
C iPrMgBr, phenylacetylene THF No product 
D iPrMgBr, phenylacetylene, ZnBr2 THF No product 
Table 3.1 Reagent conditions for the attempted synthesis of 98 
Carriera has shown that phenylacetylene can undergo direct nucleophilic addition to 
substituted benzaldehydes in the presence of Zn(OTf)2 to give the corresponding 
secondary alcohols.135 In one example, the product 99 was prepared from the starting 
material iso-proponal in the presence of a chiral agent, (+)-N-methyl ephedrine, with a 
92% ee, Scheme 3.5. 
i-Pr H
O
H Ph i-Pr
OH
Ph
+
N-methyl ephedrine
Et3N, Zn(OTf)2
toluene, 96% (92% ee)
99  
Scheme 3.5 
Using the conditions described the synthesis of 98 was attempted, Scheme 3.6. 
However, this failed to give the desired product. From the above reactions only 
decomposition products were seen, which included 4-hydroxybenzaldehyde. It was 
thought that due to the reactivity of the phenolate ion, preferential attack at the ester 
was occurring. Due to the instability of the molecule under the reaction conditions an 
alternative route was investigated.  
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Scheme 3.6 
As the ester moiety was unstable, it was therefore decided that the initial step would 
involve the formation of the propargylic alcohol 94 before acetylation was attempted. 
94 was obtained using 2 eq of nBuLi with a slight excess of phenylacetylene and 
successfully isolated in a moderate 45% yield as a pale yellow solid (See Scheme 3.7). A 
doublet in the 1H NMR at 5.53 ppm corresponding to the propargylic proton confirmed 
synthesis of 94.  
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94
 
Scheme 3.7 Synthesis of 94 
The challenge now faced was to selectively acylate the phenolic hydroxyl group in the 
presence of the secondary alcohol. This was attempted using the weak base K2CO3, 
which makes use of the pKa differences between the two hydroxyl groups (phenolic 
OH ~11, 2° OH ~16). The reaction was undertaken with 1 eq of acetyl chloride; however 
no product was detected within the 1H NMR spectrum. The reaction was repeated, 
replacing K2CO3 with Et3N. The reaction gave a mixture of two products, 98 and 100 
(See Scheme 3.8).  
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Scheme 3.8 
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Attempts to stop the reaction at the mono-aceylated product, 98 were unsuccessful, 
despite the use of 1 eq and using a much shorter reaction time (15 minutes compared to 
1 hour). Isolation of the desired compound, 98 was achieved using flash column 
chromatography. Evidence of formation was seen by the presence of a carbonyl signal 
in the 13C NMR spectrum (169.9 ppm) and a peak at 2.30 ppm (3H, s, Me) in the 1H 
NMR spectrum. Subsequent reaction with p-nitrophenylisocyanate and Et3N afforded 
the final probe molecule, 96 (See Scheme 3.9). Photophysical analysis revealed 96 to be 
non-fluorescent, with an absorption maxima at 331 nm. 
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Scheme 3.9 
3.4.2 1,6-elimination analysis 
The ester functionality of probe 96 allows it to be used as an esterase probe. 96 can 
therefore undergo a 1,6-elimination to release the fluorescent quencher either 
biologically by esterase enzymes or chemically using a hydroxide source. The following 
sections describe the experiments which were undertaken to show whether this was 
indeed the case. 
3.4.2.1 Chemical-mediated 1,6-elimination 
Using NaOH and KOH solutions (both at 1 M), an increase in fluorescence was seen 
indicating the proposed 1,6-elimination of 96 was occurring (See Figure 3.9 and Figure 
3.10). A 1 M solution of the appropriate hydroxide source in water was added to a 
solution of 96 in Tris buffer (1% in acetone). This was excited at 331 nm and the 
subsequent emission was recorded at regular intervals until a plateau in fluorescence 
was observed.  
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Figure 3.9 Increase in fluorescence seen when 96 is treated with KOH (1 M) over time 
 
Figure 3.10 Increase in fluorescence observed when 96 is treated with NaOH (1 M) over time 
3.4.2.2 Enzymatic-mediated 1,6-elimination 
Having shown that treatment with a hydroxide source afforded the activated 
fluorescent probe, attention now turned to the enzymatic-mediated activation of 96. 
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3.4.2.2.1 Porcine Liver Esterase (PLE) 
A 1 mg/ml solution of PLE in Tris buffer was added to a solution of 96 in Tris buffer 
(1% in acetone). This was excited at 331 nm and the subsequent emission was recorded 
every 5 minutes for one hour, followed by a reading at 90 minutes and 120 minutes. An 
increase in fluorescence at 508 nm was observed (Figure 3.11). Initial hydrolysis 
occurred rapidly with a plateau reached after around 1 hour (Figure 3.12).  
 
Figure 3.11 Increase in fluorescence over time when 96 is treated with PLE 
 
Figure 3.12 Change in fluorescence at 508 nm over time 
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3.4.2.2.2 Binding studies 
As an increase in fluorescence occurred upon treatment of 96 with PLE it was a clear 
indication that the probe was undergoing a 1,6-elimination, with concomitant loss of 
the fluorescent quencher group. Attention now turned to gaining evidence for the 
enzyme binding to 96 and hence isolation of a fluorescently tagged protein.  
In order to prove that enzymatic action on 96 resulted in a fluorescently tagged protein, 
mass spectrometry studies were carried out. To this end, 3 μL of 96 (in acetone) was 
added to 1 ml of PLE (1 mg/ml in 0.1 M Tris buffer, pH 7.4) and incubated for one hour 
at rt. 300 μL was transferred to a clean eppendorf and four volumes of acetone was 
added. This was incubated for one hour at 4 °C. The tube was spun down and the 
supernatant removed. The resulting white pellet was resuspended in MeCN/H2O and 
subjected to MS (positive electrospray) analysis. Unfortunately, MS showed that PLE is 
highly impure and contains many isoenzymes. This made analysis extremely difficult 
and the isolation of a peak corresponding to a 96-labelled protein was not possible. 
Due to the impure nature of PLE SDS-PAGE techniques were employed with the aim of 
isolating a pure PLE enzyme. The method undertaken was the same as for the mass 
spec experiment described above and following incubation at 80 °C with SDS loading 
buffer, the sample was ran out on the gel. Unfortunately, following imaging no 
fluorescent bands could be seen. Repeating this without the incubation period at 80 °C 
still did not result in any fluorescent bands being detected. Staining with Coomassie 
Blue revealed a multitude of bands within all lanes (See Figure 3.13). 
 
Figure 3.13 SDS-PAGE analysis of 96 treated with PLE. Lane 1 and 2 are PLE + 96, Lane 3 is a negative 
control (PLE only), M markers. 
M      1       2       3 
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Two bands were chosen, as indicated by the arrows in Figure 3.13, for further 
experimentation. Following washing of the gel with dH2O, both bands were excised 
and destained. Several treatments with MeCN resulted in a small white ball of gel. 
After cooling on ice for 30 seconds, 25 μL of working trypsin was added and incubated 
overnight at 34 °C. The supernatant was removed and the peptide material extracted. 
The resulting dried peptide material was then dissolved in acetone and MALDI MS 
experiments were performed.  
Pleasingly, analysis of the peptides showed that the trypsin digest had been successful 
due to the detection of the peaks at 1117.5, 1434 and 2193 which were attributed to 
autosomal trypsin digestion.136 Disappointingly no evidence was gained for the probe 
binding to the enzyme. Despite repeated attempts, no real differences between the 
negative control samples and the 96 treated samples could be seen. This indicated that 
treatment with 96 was not resulting in a covalently modified protein. 
In support of this recent work by Wang et al towards the isolation of DNA through 
forming crosslinks with quinone methide electrophiles has highlighted the reversible 
nature of the resulting covalent bond137. Using an ortho-quinone methide they were able 
to show the reversible nature of the DNA alkylation and the subsequent irreversible 
quenching by H2O. The reversibility of quinone methide alkylation is sensitive to the 
electronics of the π-system of the quinone methide and the strength of the departing 
leaving group and incoming nucleophile138. In addition to this, Zhou and Turnbull139 
were able to show that p-quinone methides also exhibit reversibility upon alkylation by 
phosphodiesters (Scheme 3.10). The reversible nature of this reaction may account for 
the lack of any fluorescently labelled PLE due to the apparent transient nature of the 
covalent bond.  
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Scheme 3.10 
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3.5 p450 O-demethylation probe 
Concurrent to the previously described work, efforts were also directed towards the 
synthesis of a probe capable of isolating cytochrome p450 O-demethylation enzymes. 
The following sections introduce this class of enzymes and describe both the synthesis 
and photophysical analysis of the probe molecule. 
3.5.1 p450 O-demethylation enzymes 
p450 O-demethylating enzymes detoxify xenobiotics by demethylation reactions, which 
renders the substrate more polar and therefore easier to extrude from cell. This class of 
enzymes is used to affect the O-demethylation of a wide variety of compounds 
including the NSAID Naproxen, 101,140 the pesticide methoxychlor, 102,141 the 
topoisomerase II inhibitor etoposide, 103142,143 and the reporter molecule 7-
methoxyresorufin, 104144 (See Figure 3.14). The p450 O-demethylation enzyme p450 
1A2 isolated from humans has been subjected to random mutagenesis techniques and 
the triple mutant E163K/V193M/K170Q has a 5-fold higher kcat than the wild type 
towards the O-demethylation of 7-methoxyresorufin.144 
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Figure 3.14 The variety of compounds which are acted upon by p450 O-demethylation enzymes 
The mechanism of action of this class of p450 enzymes is similar to that of oxidative 
p450s (See Chapter 4). O-demethylation proceeds via direct oxidation of the carbon 
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adjacent to the oxygen as the oxygen oxidation potential is too high for electron 
abstraction. In addition to this, oxygen transfer to the oxygen does not occur.145 
The reactivity probe 105 designed to isolate this class of enzymes from plant cells has 
the same structure as the esterase probe 96 with the exception of the recognition head, 
which is a methoxy substituent. The following sections detail the work undertaken in 
the synthesis and photophysical evaluation of this probe. 
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3.5.2 Synthesis  
The synthesis of 105 was achieved in two steps, starting from the commercially 
available p-anisaldehyde in an overall 13% yield, Scheme 3.11. 
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i) n-BuLi, phenylacetylene, THF, 49%; ii) p-nitrophenylisocyanate, Et3N, DCM, 47%
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106
 
Scheme 3.11 
Characterisation techniques used to confirm synthesis included 1H and 13C NMR 
spectroscopy, along with mass spectrometry. Reagents and conditions were employed 
as for the previous two probes 91 and 96 and photochemical analysis showed the probe 
to be non-fluorescent. 
3.5.3 Chemical-mediated 1,6-elimination Analysis 
In order to show that this probe also undergoes the 1,6-elimination mechanism, several 
chemical reactions were undertaken to remove the methyl group and result in loss of 
the fluorescent quencher group. The first attempted utilised BBr3 based on a method by 
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McOmie et al.146 105 was treated with one equivalent of BBr3 and the reaction allowed to 
stir for 16 hours (See Scheme 3.12). Unfortunately, the product 94 was not detected from 
the reaction. A product was isolated which retained the methoxy signal within the 1H 
NMR spectrum (3.79 ppm, 3H, s), however, the exact structure could not be elucidated 
at the time. 
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Scheme 3.12 Attempted demethylation of 105 using BBr3 
Due to failed use of BBr3 to afford 94, an alternative reaction was sought. A search of 
the literature revealed the use of L-Selectride as a demethylating agent, see Scheme 
3.13.147 This was attempted under identical conditions with 105, however, only a 
complex mixture of products was formed, which could not be separated by FCC.  
H
MeO OMe
OMe
H
HO OMe
OMe
i
i) L-Selectride (3 eq), THF, 67 oC, 24 h, 90%  
Scheme 3.13 
A final attempt used thiophenol in the presence of a catalytic amount of KF, which has 
been shown to remove the methyl group from a wide range of substrates, Scheme 
3.14.148 
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i
i) PhSH (1 eq), KF (10 mol%), NMP, reflux, 1 h, 80%
OMe OH
 
Scheme 3.14 
This reaction was attempted with 105 and a product was isolated from the reaction. 
However, upon investigation of the data it could be seen from the 13C NMR spectrum 
that there were no alkyne carbons present. Furthermore, the methoxy signal remained 
in both the 13C and 1H NMR spectra. IR spectroscopy showed a carbonyl stretching 
band at 1668 cm-1, and a signal due to a carbonyl carbon could be seen in the 13C NMR 
spectrum. HRMS analysis suggested a molecular mass of 349.1257, with a distinctive 
splitting of a peak two mass units higher, indicative of a sulfur atom, Figure 3.15. 
 
Figure 3.15 HRMS spectrum of 105 showing the splitting of the peak at 351.1214 
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The molecular formula to give this mass is C22H21O2S, which requires 349.1257. This 
data, coupled with the splitting patterns in the 1H NMR and correlations in both HSQC 
and HMBC spectra are consistent with the possible structure 107 (See Scheme 3.15). 
O
O
O
H
N
NO2
O
O
i
i) PhSH, KF, NMP, 100 oC, 1 h, 49%
S
105 107
 
Scheme 3.15 
A possible reason for this reaction may be the high temperatures employed. Therefore 
the reaction was repeated at room temperature, Scheme 3.16. 1H and 13C NMR spectra 
showed the presence of the methoxy group and the 13C NMR spectrum indicated that 
the two alkyne carbons had remained. However, the mass (331.11533) did not correlate 
to the expected product 94, but to the molecular formula C22H19OS. Analysing the 
correlations within the 2D NMR showed that 108 is the likely structure for the isolated 
compound. 
O
O
O
H
N
NO2
O
S
i
i) PhSH, KF, NMP, rt, 1 h, 52%
105
108
 
Scheme 3.16 
This gave some insight to the BBr3 reaction (Scheme 3.12). Referring back to this 
reaction and the resulting product isolated, data analysis now indicated that a similar 
reaction had occurred, giving rise to the suggested product 109. 
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O
109 O  
This was evidenced by the presence of two doublets which couple to each other at 7.72  
and 7.35 ppm in the 1H NMR spectrum. The latter of these shows HMBC correlations to 
the carbonyl signal at 201.6 ppm in the 13C NMR spectrum. It was thought that 109 
formed by the elimination of a bromo alcohol initially formed in the reaction. In order 
to test this 108 was subjected to reaction with Et3N and the reaction heated to encourage 
elimination, Scheme 3.17.  Product 109 was isolated from the reaction mixture and this 
therefore gives evidence for the initial formation of the proposed bromo alcohol. 
109
O
S
O
O
108
Et3N, 
49%
 
Scheme 3.17 
As none of the attempted demethylation reactions were successful, a further probe was 
synthesised. This probe was to be used to show that removal of the methoxy group 
could still affect the 1,6-elimination and subsequent loss of the quencher group. The 
reactive group within this probe was based on the MOM protecting group, which is 
easily removed using acidic conditions.149 
3.6 MOM Probe 
3.6.1 Synthesis 
Scheme 3.18 shows the route used for the synthesis of 112 which was synthesised in an 
overall 16% yield. Protection of the hydroxyl functionality with MOM150 was achieved 
in a quantitative yield as shown by LC-MS and the product, 110, was used without 
further purification. The following two steps were carried out in an identical fashion to 
those for the previous probes 91, 96 and 105. Characterisation of each compound was 
undertaken using NMR and LC-MS. Photochemical analysis showed 112 to be non-
fluorescent.  
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96%; iii) p-Nitrophenylisocyanate, Et3N, DCM, rt, 1 h, 35%
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Scheme 3.18 
3.6.2 1,6-elimination analysis 
112 was treated with HCl (1 M) and the change in fluorescence was recorded over time. 
The increase in fluorescence can clearly be seen in Figure 3.16. 
 
Figure 3.16 Increase in fluorescence at 490 nm upon addition of 1 M HCl to 112 
This result shows that the MOM probe 112 and hence the methoxy probe 105 undergo a 
1,6-elimination in the expected way, releasing the fluorescent quencher group and 
allowing the fluorescence emission from the phenylacetylene group. Due to time 
constraints its use in biological systems was not explored. 
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3.7 Summary 
* Probe 91 was successfully synthesised and adding TBAF to a solution of this resulted 
in an increase in fluorescence. 
* The esterase probe 96 was successfully synthesised in a 16% yield. Photophysical 
analysis revealed it to be non-fluorescent, with an absorption maximum of 331 nm. 
* Treatment of 96 with NaOH or KOH resulted in an increase in fluorescence indicating 
that the proposed 1,6-elimination was occurring. 
* Adding a solution of PLE (1 mg/ml) in Tris buffer to a solution of 96 resulted in an 
increase in fluorescence at 510 nm. Isolation of a fluorescently-labelled PLE protein was 
unsuccessful. No evidence was gained for the binding of 96 to PLE. 
* 105 was synthesised in an overall 13% yield, however attempts to chemically remove 
the methoxy group were unsuccessful. 
* The MOM probe 112 was synthesised and shown to breakdown upon treatment with 
1 M HCl, resulting in the release of the fluorescent quencher group and a concomitant 
fluorescence increase.  
3.8 Conclusions 
The design, synthesis and biological use of reactivity probes to react with, and isolate, 
proteins from plant cells has had mixed success. Fluorescently quenched reactivity 
probes based on p-quinone methide chemistry were successfully synthesised with a 
variety of different recognition heads. They were all shown to be non-fluorescent until 
the appropriate reaction, either chemically or biologically, removed the recognition 
head and restored fluorescence. 
Unfortunately, attempts to covalently modify a protein, in particular using 96 with PLE 
did not succeed. Despite repeated attempts, including modified reaction conditions, a 
fluorescently tagged PLE was never observed, either by SDS-PAGE or MALDI MS. This 
may be due to the covalent bond being relatively weak and unstable to SDS-PAGE 
analysis, or that there is not sufficient space between the bulky fluorescent quencher 
group and the nucleophilic residue to allow attack to occur. 
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4   Oxidative Cytochrome p450 
4.1 Introduction 
A probe which can isolate oxidative p450 enzymes would be invaluable as this class of 
enzymes is able to detoxify a huge variety of compounds, by catalysing a large 
diversity of reactions such as hydroxylations, epoxidations, and peroxygenations151. 
This chapter describes efforts directed towards the synthesis of a molecule able to 
isolate oxidative cytochrome p450 enzymes. The following section describes the 
enzymology and mechanism of action of this class of enzymes.  
4.1.1 Mechanism of action 
Cytochrome p450 is a haemoprotein containing iron protoporphyrin, which uses 
NADPH as a co-factor. The transfer of electrons from NADPH to p450-reductase and 
then to p450 leads to the reductive activation of molecular oxygen followed by the 
insertion of one oxygen atom into the substrate. The second oxygen atom is converted 
to H2O. This is summarised below in Scheme 4.1. 
 
RH + NADPH + O2
p450
2H+
NADP+ + H2O + ROH
 
Scheme 4.1 
The haem unit of p450 is bound to the rest of the protein through an axially-ligated 
cysteinal sulphur. The resting state contains Fe3+, although it exists as an equilibrium 
mixture of low spin (6 co-ordinate) and high spin (5 co-ordinate). This perturbation 
takes place upon substrate binding. Figure 4.1 below shows the catalytic cycle of p450, 
with oxygenation of a substrate, RH into a product, ROH.152 
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Figure 4.1 Mechanism of action of cytochrome p450. RH substrate, CPR cytochrome p450 reductase, 
ROH product. Mol. Biosyst., 2006, 2, 462 – Reproduced by permission of The Royal Society of Chemistry  
4.1.2 Evolution of the Enzyme 
The use of p450s in biotransformation techniques has been limited due their low 
activity, poor stability, high substrate specificity and the need for cofactors. In order to 
overcome this several groups have applied molecular biology techniques with the aim 
of producing p450 variants with modified enzymatic properties.  
Much of the work carried out on p450 has focussed on p450 BAM from Bacillus 
megaterium due to their high expression levels in E. coli.153 Wild-type p450 BAM 
catalyses the hydroxylation of long chain (C12 – C22) saturated fatty acids, with 
virtually no activity seen towards those bearing a shorter chain. Hydroxylation usually 
takes place at the ω-1, ω-2 or ω-3 position. Oliver et al mutated Phe87 to Ala87 which 
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resulted in the enzyme being able to hydroxylate various fatty acids exclusively at the 
ω-position.154 In addition to this work it has also been shown that using site-specific 
random mutagenesis at residue 87 of the F87A mutant led to an improved activity 
towards shorter chain fatty acids.155  
Another p450 commonly studied is p450 CAM from Pseudomonas putida, again due to 
the high expression in E. coli. p450 CAM catalyses the hydroxylation of camphor to 5-
exo-hydroxycamphor. Bell et al have used site-directed mutagenesis to create several 
mutants which showed improved activity towards the metabolism of (S)-limonene156 
and (+)-α-pinene 157, both of which are unnatural substrates for the enzyme. 
Due to the large number of reactions p450 is involved in and the much greater number 
of p450 genes present within plants (2401 compared to 55 in humans and 874 in E. 
coli)158, these enzymes represent an untapped resource for use in biotransformation 
applications. In order to apply directed evolution techniques to p450 they must first be 
isolated from the cell. The following section details the work undertaken to isolate p450 
enzymes using reactivity probes based on the BODIPY structure. 
4.2 Probe Design Rationale 
Initial studies directed towards a p450 probe was based on previous work carried out in 
which the metabolic activation of lead drug candidates was analysed using LC-MS.159 
Molecules containing a fluorinated phenyl derivative were incubated with both rat and 
human liver microsomes, with the metabolites identified via ion trap LC-MS. The 
proposed metabolites were conjugates of GSH, which appeared to be the product of the 
reaction between GSH and the ortho-quinone of the parent compound at the phenyl 
ring. The proposed metabolic activation pathway is shown below in Figure 4.2. As the 
electrophilic ortho-quinone intermediate formed by the action of p450 within liver 
microsomes is able to react with nucleophiles such as GSH, it could be expected that 
nucleophilic residues within the enzyme could also react with these intermediates. 
Evidence for this could be seen by a high degree of irreversible binding of radioactivity 
to microsomal proteins when a tritiated analogue of the lead drug candidate was used. 
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Figure 4.2 Proposed metabolic activation mechanisms of halogenated phenyl derivatives 
By making use of the ortho-quinone intermediate mechanism as described above the 
proposed structure of the probe, 113, is shown in Figure 4.3. 113 involved the use of a 
nitrobenzofurazan (NBD) fluorophore derivative. As with the reactivity probes 
described in Chapter 3, the proposed p450 probe also made use of a fluorescent 
quencher group. However, in this case a bromo-substituent was used, which makes use 
of the heavy atom effect. Heavy atoms such as bromine can lead to a decrease in 
fluorescence intensity due to the increase in intersystem crossing induced by the 
interaction between the fluorophore and the heavy atom.160 Following the loss of the 
heavy atom quencher the resulting product would be a covalently bound, fluorescently 
tagged p450. The proposed mechanism of action is shown in Figure 4.4. 
NO2
O
N
O
N
Br
113  
Figure 4.3 Structure of p450 probe containing the NBD fluorophore 
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 Figure 4.4 Proposed mechanism of action of 113 treated with cytochrome p450  
4.2.1 Synthesis 
Work by Crampton et al161 had shown the synthesis of molecules based on 113 could be 
achieved by the reaction of NBD-chloride with an excess of an appropriate phenol. To 
this end the synthesis of 113 was undertaken by treatment of NBD-chloride with 10 eq 
of 3-bromophenol, which afforded the probe molecule 113. Evidence for this was seen 
in the correct integration of signals within the 1H NMR spectroscopy. 
N
O
N
NO2
OBr
113
N
O
N
NO2
Cl
10 eq 3-bromophenol, 0.1 eq NaOH
THF, rt, 2 h, 32%
 
Scheme 4.2 
In order to establish that the loss of the bromo substituent would result in the switching 
on of fluorescence a control, the unsubstituted phenol derivative, 114 was also analysed 
in the current study. This compound was donated by Michael Crampton. Both of these 
compounds were analysed and the resulting fluorescent spectra are shown below 
(Figure 4.5). Disappointingly, 113 was found to exhibit a higher level of fluorescence 
than the control, 114, and therefore this approach was abandoned. 
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Figure 4.5 Comparison of emission of 114 and 115 
4.3 BODIPY-based Probe 
As an alternative, a different p450 probe was designed which was based on the 
BODIPY structure 115. This molecule can be highly substituted without seriously 
affecting its fluorescent profile. 
N
B
N
FF
115  
The rationale design of this p450 probe was similar to the NDB probe in that it involved 
a para-bromo substituted phenyl ring at the 4-position, 116. This would allow the 
isolation of p450 enzymes through the oxidation of the ring and subsequent attack of 
the epoxide intermediate, 117, by a nucleophilic residue within the protein resulting in 
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loss of the bromine atom. The loss of the bromine would result in the switching on of 
the fluorescence due to the loss of the heavy atom. As explained previously (Section 
4.2), following the loss of the heavy atom quencher the resulting product would be a 
covalently bound, fluorescently tagged p450, 118 (Scheme 4.3).  
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Scheme 4.3 
There have been a number of publications involving BODIPY derivatives in use as 
reactivity probes including the targeting of β-amyloid plaques162, the detection of 
hypochlorous acid,163 nitric acid,164 BSA,165 potassium166 and cyanide ions167 and as pH 
sensors.168 In addition to this, BODIPY derivatives have seen use in other areas such as 
light harvesting systems,169 triplet sensitisers170 and laser dyes.171 
4.3.1 Synthesis of probes 
Using literature based methods, efforts were undertaken to synthesise the proposed 
BODIPY probe, 116. This work is detailed in the following section. 
4.3.1.1 From benzaldehyde derivatives 
Initial methods to synthesise the bromo BODIPY derivative was undertaken in three 
steps starting from the commercially available p-bromobenzaldehyde (See Scheme 
4.4).172 
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Scheme 4.4 
The starting material, 119, was dissolved in pyrrole (25 eq), to which was added a drop 
of TFA and this was stirred for 3 h, during which time a deep red colour developed. 
FCC gave the title compound, 120 in a 43% yield. This was evidenced by the signal in 
the 1H NMR spectrum at 5.43 ppm for the proton at the bridging C4 position. 120 was 
treated with the oxidising agent p-chloranil to yield the dipyrromethene derivative 121. 
This could be seen by the loss of the above mentioned signal at 5.43 ppm and the 
molecular ion at m/z = 299.2 seen in the mass spectra (ES+). The final step in producing 
the BODIPY derivative 116 involved complexation with BF3•OEt2 in the presence of 
Et3N. Unfortunately, no product was detected and therefore efforts were made towards 
an alternative method which would enable the isolation of 116. 
Kollmannsberger et al have shown that a one-pot reaction can yield BODIPY 
analogues.173 This again involved the condensation of 119 with pyrrole, however, DDQ 
was used as the oxidant in this synthesis. BF3•OEt2 and Et3N were used to introduce the 
BF2 bridge (See Scheme 4.5).  
CHO
Br
i
N
B
N
FF
Br
i) pyrrole, TFA, rt, 2 h, DDQ, DCM, 15 min, 
BF3OEt2, Et3N, DCM, 16 h, 2%
119
116
 
Scheme 4.5 
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116 was successfully synthesised, albeit in the very poor yield of 2%. Analysis of the 1H 
NMR spectrum revealed the presence of the correct signals and the 19F NMR spectrum 
exhibited the quartet signal for both fluorine atoms (q, -122.2 – 122.4 ppm). The 
photoluminescence properties are shown in Table 4.1 below. 
Excitation (nm) Emission (nm) Quantum yield (φF) Lifetime (τ) 
           504          520               30%       6 ns 
Table 4.1 Photoluminescent properties of 116 
Disappointingly, 116 was shown to be fluorescent, albeit with a slightly longer lifetime 
than the 3 ns exhibited by the corresponding fluorescent molecule, phenyl BODIPY 
122.173 
Unfortunately, when attempting to synthesise compound 122, which was to be used as 
a control probe in future biological experiments, no product could be detected (See 
Scheme 4.6). A complex mixture of products was formed, which were very difficult to 
separate by FCC.  
CHO
N
B
N
FF
i
i) pyrrole, TFA, rt, then DDQ, BF2OEt2
122
 
Scheme 4.6 Attempted synthesis of 122 
A possible reason for this failed reaction and the low yield of 116 has been highlighted 
by Lindsey and co-workers.174 They have shown that several other dipyrromethane 
products, including the so-called N-confused 123 and N-frustrated 124 forms can arise 
during the initial dipyrromethane formation step. 
HNN
H
R
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NH
N
H
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R R
124  
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By altering the ratio of pyrrole to aldehyde they were able to suppress formation of 123 
and 124, however, pure dipyrromethanes were only ever isolated following several 
rounds of purification including distillation and recrystallisation.   
In order to prevent formation of 123 and 124 and in an attempt to improve the yield of 
BODIPY formation, 2,4-dimethylpyrrole was used in all further reactions. The 2,4-
dimethylpyrrole derivative of 122 was synthesised in a one-pot procedure, identical to 
that shown in Scheme 4.6. A small amount of product was detected by 1H NMR 
spectroscopy, however, it could not be isolated pure from the reaction mixture. Given 
the difficulties in the oxidation step, an alternative synthetic strategy was investigated. 
4.3.1.2 From benzoylchloride derivatives 
A search of the literature revealed an alternative starting material, in which an acyl 
chloride was utilised which removed the necessity of DDQ oxidation.175 It was hoped 
that this would increase the yield of the reaction by the removal of this step. The 
synthesis of 122 was successfully achieved in a 17% yield using this method (See 
Scheme 4.7).  
COCl
N
B
N
FF
i
i) 2,4-dimethylpyrrole, reflux, 2 h then BF3OEt2, 
Et3N, rt, 1 h, 17%
122
 
Scheme 4.7 Synthesis of control probe, 122 
As the bromo derivative was shown to be fluorescent, attention now turned to the use 
of other substituents which could affect the quantum yield, and hence fluorescence, of 
BODIPY. It was thought that perhaps iodine could induce the heavy atom effect and its 
synthesis was attempted (See Scheme 4.8).  
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Scheme 4.8 Attempted synthesis of 125 
Unfortunately, no product could be isolated after FCC and this lead to the use of the 
classic fluorescent quencher, the nitro group. Synthesis was achieved using identical 
conditions to those employed in Scheme 4.7 and gave 126 in a modest 30% yield. This 
increase in yield can probably be attributed to the electron withdrawing effect of the 
nitro group, increasing the yield of the dipyrromethene synthesis step. However, the 
ability of the probe to function as hypothesised relies on the leaving group potential of 
the para substituents. The nitro group is a poor leaving group and in addition to this the 
electron density of the phenyl ring will be diminished and may prevent the initial 
oxidation step of the p450 enzyme. In order to overcome this potential downfall, a 
second BODIPY derivative was synthesised. This time the starting material was 2-
methoxy-4-nitrobenzoic acid with the initial step being the conversion of the starting 
carboxylic acid to an acyl chloride by the treatment with oxalyl chloride in the presence 
of a catalytic amount of DMF. IR spectroscopy confirmed the successful conversion by 
the disappearance of the band at 1710 cm-1 and the appearance of a band at 1791 cm-1. 
This intermediate was then redissolved in DCM and used further without additional 
purification. The product 127 was isolated in a 22% yield. These results are summarised 
below in Table 4.2. 
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Table 4.2 Synthesis of BODIPY derivatives starting from benzoyl chlorides 
R
COCl
R1
R
N
B
N
FF
R1
i
 
Compound ID R R1 Yield 
122 H H 17% 
126 NO2 H 30% 
127 NO2 OMe 22% 
125 I H - 
i) 2,4-dimethylpyrrole, reflux, 2 h then BF3•OEt2, Et3N, rt, 1 h 
4.3.2 Photophysical analysis 
Having successfully identified a viable synthetic route, the photoluminescent properties 
of the probes synthesised were then analysed. All were shown to exhibit a very similar 
excitation and emission profile, which is typical of that of BODIPY. In all cases a small 
Stokes shift was seen, typically less than 20 nm, which can be seen in Figure 4.6. Table 
4.3 below summarises the photoluminescent data achieved for the probes synthesised. 
 
Figure 4.6 Comparison of emission of 122 and 126 (CHCl3, 24 °C) 
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Compound 
 
Solvent 
      λex  
(max/nm) 
      λem  
(max/nm) 
 
φf 
 
τ (ns) 
122 acetone 498 508 59 4 
126 acetone 502 n/a 0.3 n/a 
 chloroform 509 n/a n/a n/a 
 MeOH 503 n/a n/a n/a 
 H2O 510 n/a n/a n/a 
 MeCN 502 n/a n/a n/a 
 hexane 507 522 n/a n/a 
 toluene 509 528 n/a n/a 
127 acetone 502 n/a n/a n/a 
Table 4.3 Photoluminescent properties of 122, 126 and 127 
Importantly, 126 exhibits no fluorescence in polar solvents, including H2O, acetone, 
methanol, acetonitrile, chloroform, and dichloromethane. However, when 126 was 
dissolved in either toluene or hexane a strong fluorescence signal was observed. The 
overall results can be seen in Figure 4.7 with an expanded section showing the polar 
solvents in Figure 4.8. 
 
Figure 4.7 Fluorescence spectra of 126 when dissolved in a range of solvents 
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Figure 4.8 Enlarged section of fluorescence spectra of 126 showing polar solvents 
This result suggests that the cause of fluorescent quenching is photoinduced electron 
transfer (PeT). PeT is commonly accepted as a mechanism of fluorescent quenching in 
polar environments at ambient temperatures.176 Electron transfer from a donor system 
to the excited fluorophore causes the quenching of the fluorescence. It is normally the 
case that the two systems are separated by a linker that holds the fluorophore close to, 
but separately from, the electron donor.177 However, recent work by Nagano et al has 
shown that fluorescein derivatives can be thought to exhibit PeT.178 They believe this is 
the case as the fluorescein molecule can be thought of as two separate parts. This is due 
to the orthogonality of the benzoic moiety to the xanthene fluorophore, Figure 4.9. By 
altering the R substituent, changes in the HOMO energy can be brought about resulting 
in an altered quantum yield. They have shown that increasing the HOMO energy 
results in a diminished quantum yield. 
OHO O
COOH
R
xanthene fluorophore
benzoic acid donor
 
Figure 4.9 Fluorescein structure divided into two orthogonal parts. 
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In a similar fashion, the structure of phenyl-substituted BODIPY derivatives, such as 
122, 126 and 127, can also be thought of as exhibiting PeT due to the orthogonality 
between the phenyl ring and BODIPY fluorophore. Reported evidence for this is seen in 
various X-ray crystal structures which have shown a variety of BODIPY derivatives 
which adopt this conformation.179 In addition, work published recently by Sun and co-
workers where a non-fluorescent BODIPY derivative, 128 was designed, which upon 
addition of hypochlorous acid (HOCl) became fluorescent, Figure 4.10.163  
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CONEt2Et2NOC
-8.71 eV
-9.14 eV
-10.9 eV
-9.14 eV
128 129
NON-FLUORESCENT FLUORESCENT  
Figure 4.10 Switching on of fluorescence of 128 upon treatment with HOCl 
It is rationalised that due to the decrease in the energy of the phenyl substituent 
(-8.71 eV to -10.9 eV), the PeT quenching process is prohibited due to the lower energy 
of the phenyl substituent as compared to the BODIPY fluorophore and hence the 
molecule, 129, fluoresces.  
4.3.3 Computational Studies 
Due to the proposed mechanism of quenching being PeT, theoretical calculations could 
be carried out to determine the fluorescent properties of any other BODIPY analogues. 
This is due to the fact that following excitation of an electron from the BODIPY 
chromophore to an excited state, relaxation of that electron falls into the LUMO of the 
nitrophenyl substituent, resulting in a non-fluorescent molecule. This is summarised in 
Figure 4.11.180 
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Figure 4.11 Cartoon representation of proposed PeT mechanism. Reprinted with permission from Journal of 
the American Chemical Society, 2004, 126, 14079-14085. Copyright 2004 American Chemical Society 
Density functional theory (DFT) gives information on electron density within both the 
filled and unfilled molecular orbitals within a molecule. By analysing the electron 
density of both the HOMO and the LUMO of BODIPY derivatives, an indication of the 
PeT quenching mechanism and hence fluorescence of the molecule can be predicted.  
Using Gaussian several DFT calculations were performed to the B3LYP level of theory, 
using the basis sets 6-31G*(d).181 Figure 4.12 shows both the predicted electron density 
within HOMO and LUMO orbitals. 
 
Figure 4.12 DFT analysis of 122 showing the electron density in both a) the HOMO and b) the LUMO 
a) b) 
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It can be seen that the electron density is over the bora-s-indacene part of 122 in both 
the HOMO and the LUMO and therefore this molecule is predicted to be fluorescent, 
which photoluminescent analysis has shown. Performing the same calculation with 126 
and 127, it can be seen that the electron density is now completely different, Figure 4.13. 
 
 
Figure 4.13 DFT analysis of 126 and 127 showing the electron density in both a) the HOMO and b) the 
LUMO 
In both these cases, the electron density in the LUMO is predicted to be in the 
nitrophenyl substituent, which is as predicted by PeT quenching. In this way, DFT 
calculations can now be used to assess the likelihood of a BODIPY derivative 
displaying fluorescence. 
a) b) 
a) b) 
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4.3.4 Cellular/biological Studies 
In order to test the biological viability of compounds 122, 126 and 127, they were tested 
in protoplasts harvested from Arabidopsis thaliana leaves. The probes were tested at a 
final concentration of 5 μM, using acetone as the carrier solvent (less than 1%). The 
incubation time was typically 15 mins, after which time the cells were loaded onto a 
microscope slide and viewed using a fluorescence microscope. Fluorescence was 
observed in all cells as green, punctuate spots. For some examples see Figure 4.14. 
 
Figure 4.14 Two A. thaliana protoplasts incubated with 126. From L-R: White image, Punctuate 
fluorescence can clearly be seen, Red emission from the chloroplasts. Images are at 40x magnification 
It is known that when hydrophobic BODIPY derivatives bind to biomolecules within 
cells, aggregation effects can cause the formation of micellular-like environments182 and 
it was thought that this was the reason for the punctuate fluorescence pattern. 
In order to determine protein binding, SDS-PAGE analysis was carried out. To this end, 
127 was incubated with freshly harvested protoplasts and following cell lysis by 
heating to 90 °C in SDS loading buffer, SDS-PAGE analysis was performed. 
Unfortunately, the only fluorescent bands present on the gel were at a very low 
molecular weight, and this was attributed to free probe. Despite repeated attempts, 
including microsome isolation, no fluorescent bands corresponding to protein 
conjugates were seen.  
4.3.4.1 Inhibition Studies 
In order to show that the observed fluorescence was due to the interaction of the probe 
and p450 oxidative enzymes a variety of inhibition studies were carried out. The aim 
was to show that by inhibiting p450, the green fluorescence would not be seen. The first 
inhibitor tested was 1-aminobenzotriazole (ABT), which causes inhibition of 
cytochrome p450.183  
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ABT is a mechanism-based inhibitor which inactivates p450 by the alkylation of the 
haem group.184 ABT undergoes p450-catalysed oxidation which produces benzyne. It is 
this benzyne that causes the alkylation of the haem group, resulting in the production 
of an abnormal porphyrin and the irreversible loss of activity.185 Protoplasts were first 
incubated with 250 μM ABT for 30 mins, followed by a 5 min incubation with 126. 
When viewed under the fluorescence microscope, green punctuate fluorescence could 
still be seen. Repeating the reaction with 1 mM ABT did not result in prevention of the 
fluorescence. This indicated that the cause of the fluorescence was not due to the action 
of cytochrome p450. As a control reaction, ABT (250 μM) and 126 were mixed and 
incubated at rt for 30 mins and the emission spectrum recorded. No fluorescence was 
seen. 
To confirm this, another p450 inhibitor, piperonyl butoxide (PBO, 131) was tested.  
O
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PBO is able to bind in the active site of p450 therefore preventing enzyme activity from 
occurring.186 Protoplasts were incubated with 250 μM PBO for 30 mins, followed by 
treatment with 126 and incubation for 5 mins. Again, fluorescence was seen in all cells. 
This results confirms that the fluorescence seen is not due to cytochrome p450 action.  
As there are such a large number of cytochrome p450 enzymes, a search through the 
protein crystal databank revealed that allene oxide synthase (AOS) has characteristics 
similar to those of p450s.187 AOS catalyses the conversion of 13-hydroperoxy-linoleic 
acid 132 to allene oxide 133, Scheme 4.9. 
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Scheme 4.9 
132 is a very important lipid intermediate in plants as it is converted to the plant 
signalling molecule jasmonic acid.188 A known inhibitor of AOS is 2-acetoxybenzoic 
acid, 134189. This was synthesised in a 83% yield by the acylation of 2-hydroxybenzoic 
acid followed by recrystallisation from water (See Scheme 4.10).  
COOH
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i) Acetic anhydride, phosphoric acid, 60 oC, 
10 min, 83%
134
 
Scheme 4.10 
The product was confirmed by the appearance of a peak at 2.35 ppm in the 1H NMR 
spectrum due to the methyl ester and a m/z peak of 179.0350 by ES-. Inhibition studies 
were carried out in the same way as with ABT and PBO using 1 mM 126. When the 
protoplasts were viewed under the microscope, green fluorescence could clearly be 
seen. 
It was postulated that the reason for the increase in fluorescence may be the action of 
nitroreductase enzymes, which reduce the nitro group to an amino group. In order to 
show that the amino derivative is fluorescent, DFT calculations were carried out. The 
HOMO and LUMO can be seen in Figure 4.15. It can clearly be seen that the electron 
density in the LUMO is almost completely over the bora-indacene core, which suggests 
that 135 will be fluorescent. 
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Figure 4.15 DFT analysis of 135 showing the electron density within both a) the HOMO and b) the 
LUMO 
In order to verify this theoretical result 135 was synthesised. Li et al have shown that 
amino BODIPY derivatives can be formed from the reduction of the appropriate nitro 
derivative.190 126 was subjected to hydrogenation using a Thales H-Cube®. 
Unfortunately no product was formed, with only starting material being recovered. 
This may have been due to the low solubility of 126 in both MeOH and EtOH, however, 
chlorinated solvents are not useable on the H-Cube®. It was then attempted to 
synthesise 135 starting from 4-aminobenzoic acid in a one-pot procedure, using TFA as 
a catalyst in the dipyrromethene step. Disappointingly no product was formed, with 
only a complex mixture of unknown products observed. 
Due to the failure of the one-pot reaction it was decided to firstly synthesise and isolate 
the 4-aminophenyl substituted dipyrromethene before complexation with BF3•OEt2 (See 
Scheme 4.11).  
NO2
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i) 2,4-dimethylpyrrole, DCM, reflux, 1 h, 15%; ii) SnCl2.2H2O, 35%; iii) BF3OEt2, Et3N, DCM, rt, 2 h, 32%
136 137
135
 
Scheme 4.11 
a) b) 
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To this end, the first step was the formation of the nitro-dipyrromethene 136 by reaction 
of 4-nitrobenzoyl chloride with 2,4-dimethylpyrrole. This successfully gave the product 
in a 15% yield, with formation being confirmed by the m/z peak 322.2 (ES+). 136 was 
reduced using SnCl2•2H2O to give the amino derivative 137. The successful conversion 
could clearly be seen in the 1H NMR spectrum by the large shift in the aromatic 
protons, which shifted upfield from 8.33 – 8.35 ppm to 6.72 – 6.74 ppm and 7.51 – 7.53 
ppm to 7.03 – 7.04 ppm respectively. The final step was the complexation with BF3•OEt2 
in the presence of Et3N to give 135 in a 32% yield (overall yield 2%). The photophysical 
properties of 135 was examined and it was found to be fluorescent, as was predicted by 
DFT calculations. The excitation and emission maxima were 500 and 515 nm, in the 
same range as the other BODIPY derivatives synthesised.  
When incubated with protoplasts 135 shows the same pattern of fluorescence as the 
previously tested probes. In A. thaliana NADPH:thioredoxin reductase (TR) is the 
enzyme responsible for the reduction of nitroaromatic compounds.191 TR and the 
disulfide reducing enzyme thioredoxin (TRX) form a redox system which is able to pass 
electrons from NADPH to FAD, then onto the catalytic disulfide of TR and finally to the 
disulfide of TRX. In this way the nitro group can be reduced to an amino group, Figure 
4.16 
NADPH
NADP+
FAD
FADH2
HS SH
S S
S S
HS SH
ArNO2
ArNH2
TR TRX
 
Figure 4.16 NADPH dependent pathway for the reduction of aromatic nitro compounds to aromatic 
amino compounds 
In order to test whether TR activity was responsible for the biological results seen two 
inhibitors were tested: dicumarol, 138 and 1-chloro-2,4-dinitrobenzene (CDNB). 
Dicumarol has been found to be a competitive inhibitor towards the binding of 
NADPH, thereby preventing the redox system from occurring.192 CDNB is able to 
inhibit reduced TR by the modification of the active site reduced thiol.193  
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20 μM dicumarol was incubated with protoplasts for 30 mins at rt. 2 μL of 126 was 
added and the cells were incubated for a further 10 mins. Green punctuate fluorescence 
was seen in all cells. Dicumarol was tested again at an increased concentration of 
200 μM, but again fluorescence was observed in all cells. CDNB (200 μM) was tested in 
an identical way to that of dicumarol. When viewed under the microscope fluorescence 
was still seen. These results indicated that TR/nitroreductase activity was not the 
system of interest. 
Looking at the protoplast images, it was observed that the fluorescence was often in 
association with the chloroplasts and therefore it was thought that the increase may be 
due to a system associated with photosynthesis. One such system is photosystem II 
(PSII). PSII is one part of a two part system used in photosynthesis, with the other being 
photosystem I (PSI). PSII absorbs light and this is used to promote the electrons  from 
chlorophyll into a higher energy state. These electrons are then passed through the 
cytochrome b6f complex to PSI via an electron transport chain to enable the transport of 
a proton through the membrane to generate ATP. Atrazine is a known inhibitor of 
PSII194 and this was tested with protoplasts in an attempt to ascertain the nature of the 
fluorescence. 200 μM atrazine was incubated with protoplasts for 30 mins, followed by 
a 10 min incubation time with 126. When the cells were viewed under the microscope, 
fluorescence could clearly be seen. 
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The following table (Table 4.4) illustrates the inhibitors that were tested, the system that 
they inhibit and the results obtained. 
Inhibitor Concentration System probing Result 
ABT 
ABT 
PBO 
2-acetoxybenzoic acid 
Dicumarol 
Dicumarol 
CDNB 
250 μM 
1 mM 
250 μM 
1 mM 
20 μM 
200 μM 
200 μM 
Cytochrome p450 
Cytochrome p450 
Cytochrome p450 
Allene Oxide Synthase 
TR/Nitroreductase 
TR/Nitroreductase 
TR/Nitroreductase 
Green, punctuate fluorescence 
Green, punctuate fluorescence 
Green, punctuate fluorescence 
Green, punctuate fluorescence 
Green, punctuate fluorescence 
Green, punctuate fluorescence 
Green, punctuate fluorescence 
Atrazine 250 μM Photosystem II Green, punctuate fluorescence 
Table 4.4 Summary of inhibitors tested on A. thaliana protoplasts followed by incubation with 126 
4.3.4.2 Flow cytometry analysis 
A suspension of protoplasts were analysed by flow cytometry both before and after 
treatment with 126. The resulting histograms can be seen in the figure below (Figure 
4.17). 
 
Figure 4.17 Histograms showing the increase in fluorescence exhibited by protoplasts after incubation 
with 126 
It can be seen that an increase in fluorescence is detected by the flow cytometer. A time 
dependent plot was then taken, from which it was hoped the reaction kinetics could be 
calculated. Blank protoplasts were analysed by the flow cytometer and after 90 secs, the 
   xx 
580/30 nm 580/30 nm 
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analysis was halted, 2 μL of 126 was added and the analysis was restarted. Data was 
collected for 15 mins. The dot plot can be seen in Figure 4.18. 
 
Figure 4.18 Increase in fluorescence seen upon addition of 126 to Arabidopsis thaliana protoplasts. 
The break in the dot plot occurring at around 90 secs is due to the addition of the substrate, during 
which time no data is collected. 
It can clearly be seen that a 10-fold increase in fluorescence occurs at around 2 minutes 
after the addition of 126. This large jump is not typical of enzyme kinetics but of some 
sort of switch, e.g. a change in pH. In order to test this theory, a variety of buffers were 
made up with varying pH and upon addition of 126 the fluorescence was recorded. The 
results can be seen in Figure 4.19. 
 
Figure 4.19 Fluorescence spectra of 123 and 127 at differing pH 
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It can be seen from the graph above that changing the pH has no effect on the 
fluorescence of the probes. This is in agreement with Carriera who has also shown that 
BODIPY derivatives are insensitive to changes in pH.195 
4.3.4.3 Metabolite studies 
As the inhibition studies had failed to determine the cause of fluorescence intensity 
increase attempts to isolate the metabolite of 126 were undertaken. It was hoped that 
this would allow the identification of the system 126 was reacting with.  
Protoplasts were freshly harvested from A. thaliana and incubated with 126. Following 
centrifugation the resulting pellet was resuspended in MeOH:H2O (1:1). This was again 
centrifuged and the resulting supernatant was used in MS studies. Disappointingly, 
both MS and MS/MS analysis did not show any evidence for metabolite formation, 
with only free probe observed. This was repeated using A. thaliana cell cultures, 
however again no metabolite(s) could be detected.  
4.3.4.4 Different cellular types 
A variety of A. thaliana cell types were treated with 126 in order to determine whether 
different cell types gave the same fluorescent result. Protoplasts were isolated from 
both A. thaliana mesophyll cell cultures and root cultures (See Figure 4.20), with green, 
punctuate fluorescence seen in all cases. 
 
Figure 4.20 Protoplast isolated from A. thaliana root culture treated with 126 
Interestingly, when mesophyll cell culture protoplasts were incubated with 126 a much 
higher level of fluorescence was seen, both in terms of intensity and cellular amount. 
Upon further investigation it was discovered that these cell cultures had cooled to 15 °C 
for a period of two days and were therefore stressed cells. It is known in stressed cells 
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that the number of peroxisomes increases and therefore further studies were 
undertaken to show this. This work is detailed in Chapter 5. 
4.4 Summary 
* 113 was successfully synthesised, however, attempts to utilise this a p450 probe were 
abandoned as it had a higher level of fluorescence that the control probe, 114. 
* The synthesis of several BODIPY probes was successfully achieved and the 
introduction of a nitro group resulted in complete quenching of fluorescence. 
* When 126 was dissolved in either toluene or hexane a strong fluorescent signal was 
observed, suggesting that photoinduced electron transfer (PeT) is the quenching 
mechanism. 
* DFT calculations can now be used to assess the likelihood of a BODIPY derivative 
displaying fluorescence. 
* Upon incubation of 126 with A. thaliana protoplasts, fluorescence could be seen. 
However, attempts to isolate a fluorescently labelled protein were unsuccessful. 
* Inhibition studies undertaken with ABT and PBO confirmed that the fluorescence seen 
was not due to cytochrome p450 action. 
* Changing the pH of the solution had no effect on the fluorescent profile of the 
BODIPY probes. 
* A variety of enzyme inhibitors were tested in an attempt to ascertain the cause of 
fluorescence. However, known of the inhibitors tested affected the fluorescence of 126. 
4.5 Conclusions 
Several BODIPY derivatives were synthesised, with 126 and 127 shown to be non-
fluorescent in polar solvents. Theoretical calculations using DFT allowed the 
fluorescent properties of the probes to be predicted accurately, further demonstrating 
the likely mechanism of quenching to be PeT. These calculations can also allow for the 
design of any future profluorescent probes.  
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Cellular studies have shown that these probes are able to cross the cell membrane and 
results in the restored fluorescence of 126 and 127. This was totally reproducible and 
was also seen across a variety of cell types. Identical fluorescence patterns were seen 
with all probes, with incubation times as low as 5 mins. Disappointingly no 
fluorescently tagged proteins could be isolated and inhibition studies and flow 
cytometric analysis showed that the cause of the fluorescence was unlikely to be 
enzymatic in nature. A variety of enzyme inhibitors were tested, with no affect seen on 
the fluorescent profile of the probes. In addition, changes in pH has shown to have no 
affect on the fluorescence intensity of any of the probes tested. Further studies have 
shown that these BODIPY probes localise exclusively within the peroxisome organelle 
within cells and this work and further studies are discussed in Chapter 5. 
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5 BODIPY 
5.1 Introduction  
This chapter describes work undertaken which shows that small fluorescent probes 
based on the BODIPY structure localise exclusively within the peroxisome in both plant 
and mammalian cells. The original aim of these probes were to react with, and isolate, 
oxidative cytochrome p450 enzymes (for a detailed description see Chapter 4).  
5.2 Peroxisomes 
Peroxisomes are small, membrane-bound organelles ubiquitous in eukaryotic cells.196 
These organelles are normally spherical in shape with diameters in the range 0.1 – 
1 μm, however, their shape can alter depending on the cell type. They are highly 
dynamic organelles which are able to move rapidly throughout the cell along 
microtubule and actin filaments.197 Peroxisomes contain coarsely granular or fibrillar 
matrix, dotted with crystalline inclusions containing enzymes, e.g. catalase.  
 
Figure 5.1 Cartoon representation of a peroxisome alongside a scanning electron micrograph of a 
mammalian peroxisome 
They are responsible for fatty acid β-oxidation and the defence against oxidative stress 
through the breakdown of hydrogen peroxide. The proliferation of peroxisomes occurs 
in response to a variety of factors198 including xenobiotics, herbicides, biotic and abiotic 
stress199 and nutrient deprivation. Deficiencies in peroxisome function or biogenesis can 
lead to several disorders including Zellweger syndrome and Infantile Refsum 
disease.200 The ability to visualise the peroxisome directly in living cells would be a 
distinct advantage as this would allow scientists to monitor a variety of processes 
within cells including stress responses.  
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5.2.1 Peroxisome Markers 
In order to study peroxisomes in vivo several techniques have been developed. These 
include the expression analysis of genes which encode for peroxisomal proteins,201 and 
the direct measurement of enzymatic activity, such as catalase.202 However, these 
techniques do not give any direct information on the peroxisome numbers within cells, 
but rather report on the changes in peroxisomal activity. In order to allow the 
visualisation of these organelles, immunolabelling experiments are often performed on 
fixed cells. These experiments involve the treatment of cells with antibodies specific for 
peroxisomal membrane proteins conjugated to a fluorophore, followed by visualisation. 
The most common method for this is electron microscopy coupled with either 3,3’-
diaminobenzidine or cerium staining.203 Recently Colton and co-workers have 
synthesised an antibody-Qdot conjugate.204 Qdots are fluorescent nanocrystals and the 
authors claim that the use of these molecules offer several advantages over 
immunolabelling techniques. These include the large Stokes shift which removes 
autofluorescence problems, increase photostability and increased reliability. Whilst 
these methods allow for accurate peroxisomal imaging, they are very time consuming, 
expensive and labour-intensive. 
In an effort to overcome these problems, new techniques are emerging which involve 
the use of fluorescent molecules which are able to localise within the peroxisome and 
allow the direct visualisation of these organelles. Following the discovery that a 
conserved tripeptide (S/A/C)-(K/R/H)-(L) located at the carboxy terminus of proteins 
targets those proteins to the peroxisome,205 fluorescent compounds utilising this 
peroxisome targeting signal (PTS1) have been synthesised. Nebenführ and co-workers 
have developed a multicolour set of peroxisome markers for A. thaliana by the 
conjugation of PTS1 with four different fluorescent proteins (green, yellow, cyan and 
red). The fluorescent proteins were cloned these into expression vectors and following 
particle bombardment it has been shown that localisation within the peroxisome can be 
seen.206 Dansen et al developed a BODIPY labelled heptapeptide, which contained the 
AKL tripeptide at the carboxy terminus, 139. Following treatment with human 
fibroblasts, punctuate fluorescence was seen in all cells after as little as 10 minutes.207   
159 
 
N
B
N
FF
N
S
O
O
CKGGAKL OHAc
139  
However, to date no fluorescent molecules for peroxisomal targeting exist without a 
peptide recognition unit, specifically PTS1. The results from the present study 
discussed in this chapter will show how small molecules without PTS1 can localise 
exclusively within the peroxisome of plant and mammalian cells. 
5.3 Cell Studies 
5.3.1 Probe synthesis 
A variety of BODIPY-based probes were synthesised and details of this, along with the 
photochemical analysis can be found in Section 4.3.1. The typical method of formation 
involved the acyl chloride condensation with 2,4-dimethylpyrrole, followed by 
complexation with BF3•OEt2 in the presence of Et3N, Scheme 5.1. 
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i) 2,4-dimethylpyrrole, DCM, then BF3OEt2, Et3N
i)
126 R = NO2, R1 = H, 30%
122 R = R1 = H, 17%
127 R = NO2, R1 = OMe, 22%
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Scheme 5.1 
126 exhibits no fluorescence in polar solvents, including H2O, acetone, methanol, 
acetonitrile, chloroform, and dichloromethane. However, when 126 was dissolved in 
either toluene or hexane a strong fluorescence signal was observed. This result 
reinforces the DFT calculations and therefore suggests that photoinduced electron 
transfer (PeT) is the quenching mechanism in operation (See Section 4.3.2).  
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Initial work was carried out in protoplasts isolated from Arabidopsis thaliana leaves. 
Upon incubation with 126, green punctuate fluorescence could be seen in virtually all 
cells, Figure 5.2. Protoplasts were harvested from a variety of sources including root 
and mesophyll Arabidopsis cultures and upon incubation with 126, identical localisation 
was seen. Attention now turned to the possibility of 126 being able to cross the plant 
cell wall. 
 
Figure 5.2 A. thaliana protoplast incubated with 126 
5.3.2 Species/cell types 
In order to test the possibility of 126 crossing the plant cell wall, Bright Yellow (BY-2) 
tobacco cells were incubated with 126. BY-2 cells are tobacco culture cells that are 
commonly used by plant physiologists due to their stability in culture and rapid 
growth. Cells were incubated with the corresponding probe (5 μM final concentration) 
at rt for 5 – 30 minutes prior to being mounted on a glass slide and viewed using 
confocal microscopy. Identical localisation was seen in all cases, with punctuate green 
fluorescence observed (for a typical example see Figure 5.3). 
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Figure 5.3 BY-2 cells incubated with 126 
Localisation was also seen in the root tips of Arabidopsis plants which had been grown 
in media, Figure 5.4 These results clearly illustrate that 126 is able to cross the plant cell 
wall. 
 
Figure 5.4 Arabidopsis thaliana root tips incubated with 126 
After the failed attempts to isolate p450 enzymes using this class of probes, 
investigations were carried out to elucidate the cause of localisation. At this point, other 
work being carried out within the Edwards group on GSH conjugation involved the 
staining of peroxisomes within A. thaliana leaf epidermis cells. Comparing these images 
with those obtained on the confocal microscope (Figure 5.2 – Figure 5.4), led to the 
hypothesis that the cause of the fluorescence was localisation within the peroxisome 
organelle. In addition to this, the GSH conjugation images highlighted the rapid 
movements exhibited by peroxisomes, which could also be seen with cells treated with 
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BODIPY probes. Efforts were now directed towards gaining evidence to show that 
these probes localised within the peroxisome organelle. 
5.3.3 Viability and uptake studies 
To be useful as a marker for stress, the probes should not exhibit cytotoxic effects 
within the cells. To test this BY-2 cells were incubated with 126 (375 nM) for 1 week. 
After this time an aliquot was removed and visualised. Identical fluorescence and 
localisation could be seen when compared to previous images indicating that cells 
remain viable for up to one week with no toxicity observed, Figure 5.5. Pleasingly it 
appeared that the peroxisomes are not affected by treatment with 126 as evidenced by 
their continued rapid movement, which could be visualised in real time. The 
peroxisomes exhibited rapid translational movement, as well as oscillations and 
movement was up to 10 μms-1. 
Photobleaching was a minor effect, however a slight increase in laser power still 
enabled the peroxisomes to be easily visualised. It is interesting to note that no 
significant leaching from the peroxisome was seen with 126. This suggests that the 
import rate is greater than the export rate. This has also been seen in the work of Pap 
when mammalian cells were incubated with 139.208 It was shown that the concentration 
gradient across the peroxisomal membrane is steep, with active import resulting in a 
30-fold concentration increase of 139. Due to the observed internalisation and retention 
of 126 it was also of interest to determine the mechanism of uptake. One such 
mechanism of uptake is endocytosis, which can be tested by both temperature and 
molecular inhibition experiments. 
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Figure 5.5 Confocal microscope image of BY-2 cells after 1 week incubation with 126 
Cells were routinely incubated at room temperature, therefore to test the possibility of 
endocytosis, cells were incubated at 4 °C for 30 minutes prior to treatment with 126. 
After incubation with 5 μM 126 at 4 °C for 20 minutes, fluorescence and therefore 
uptake was still observed. This suggests that endocytosis is not the mechanism of 
uptake. This is in agreement with the work of Pap who also observed this.207,209 
Tyrphostin A23 and A51 are known to inhibit endocytosis and therefore in addition to 
the temperature dependent results, these compounds were also tested. 
The internalisation of many proteins depends upon motifs found within their cytosolic 
domains. One such motif contains a tyrosine residue, which can interact with 
complexes (μ2) involved in the intracellular trafficking pathways through endocytosis 
by clatharin-coated vesicles. A class of compounds known as tyrphostins are able to 
inhibit the interaction between the tyrosine residue of the cytosolic motif and the μ2 
complex, of which tyrphostin A23, 140 is an example.210 Tyrphostin A51, 141 is used as 
a control as it is unable to inhibit the above interaction but is able to inhibit tyrosine 
kinases. Although the majority of work carried out with 140 and 141 has been in 
mammalian cells, 140 has been shown to inhibit the endocytotic pathway in A. thaliana 
protoplasts211 and therefore these compounds were tested. 
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140 was incubated with A. thaliana protoplasts (100 μM) for 30 minutes, followed by 141 
(100 μM) for 10 mins. When the cells were viewed under the confocal microscope, green 
punctuate fluorescence could still be seen, indicating that clathrin-dependent 
endocytosis is not the mechanism of uptake. However, at this time it is not possible to 
ascertain the exact mechanism of uptake of the probes within cells. 
5.3.4 Inhibition Studies 
In order to provide further evidence for the localisation of 126, inhibition studies were 
undertaken with a variety of cellular process inhibitors, which are described in the 
following sections. 
5.3.4.1 Brefeldin A 
Brefeldin A, 142 is a macrocyclic lactone that it synthesised from palmitate by a variety 
of fungi.212 In cells treated with 142 protein secretion is inhibited at an early stage in the 
secretory pathway and it has been shown that the block occurs in a pre-Golgi 
compartment.213 Proteins become retained in the ER and cannot be processed further or 
transported around the cell.214 
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A. thaliana protoplasts were incubated with 100 μM 142 for 30 mins. Following 
treatment with 126, confocal imaging showed that fluorescence was the same as the 
control with movement of peroxisomes still seen. This implies that the protein secretory 
pathway, including the ER and Golgi apparatus are not involved in the localisation of 
126. 
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5.3.4.2 Wortmannin 
Wortmannin, 143 was originally isolated from Penicillium wortmanni and has been 
shown to be a potent inhibitor of important regulatory kinases, such as 
phosphoinositide 3- kinase (PI 3-kinase). 143 binds to the ATP site of  PI 3-kinase by 
covalently modifying the Lys802 residue. PI 3-kinase is the final part of a signalling 
cascade that produces D-3-phosphorylated phosphoinositides which are essential for 
cell growth and differentiation.215 
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A. thaliana protoplasts were incubated with 15 μM 143 for 30 mins. Following treatment 
with 126, confocal imaging showed that fluorescence was the same as the control with 
movement of peroxisomes still seen. This implies that kinase enzyme activity is not 
involved in the localisation of 126. 
143 is also known to inhibit endocytosis within plants,216 therefore these results support 
those demonstrated earlier with 140 and 141 and reinforce the fact that endocytosis is 
not the mechanism of uptake for the BODIPY probes. 
5.3.5 Co-localisation Studies 
In order to conclusively prove that 126 localised exclusively in peroxisomes co-
localisation studies were performed. These studies utilised the peroxisomal targeting 
signal (PTS1) pmP90 linked to the fluorescent protein mCherry. The PTS1-mCherry 
construct was transformed into GV3101 Agrobacterium tumefaciens and infiltrated into 
Nicotiana benthamiana. A section of leaf was removed after 3 days and confocal 
microscopy confirmed successful transformation. A small section of leaf was soaked in 
126 (in H2O, 5 μM final concentration) for 30 minutes. Co-localisation could only be 
seen in stomata cells (See Figure 5.6). In order to observe localisation within leaf 
epidermal cells, a solution of 126 in dH2O was infiltrated into a transformed leaf and 
after 90 minutes a section of the leaf was imaged. Pleasingly, green fluorescence could 
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be seen within leaf epidermal cells and co-localisation was also confirmed (See Figure 
5.7). 
 
Figure 5.6 Co-localisation studies confirm BODIPY is targeted to the peroxisome. Nicotiana 
benthamiana stomata cells were infiltrated with the peroxisome marker GV3101 (pmP90) mCherry and 
subsequently incubated with 126. a) mCherry marker; b) 126; c) images superimposed. White arrows 
indicate peroxisomes. 
 
Figure 5.7 Co-localisation studies confirm BODIPY is targeted to the peroxisome. Nicotiana 
benthamiana epidermal cells were infiltrated with the peroxisome marker GV3101 (pmP90) mCherry 
and subsequently incubated with 126. a) mCherry marker; b) 126; c) images superimposed. White 
arrows indicate peroxisomes. 
Small red dots are mCherry labelled peroxisomes, with green dots being peroxisomes 
labelled with 126. Superimposed dots appear yellow and it can be seen that there are no 
structures that show only 126, which confirms its unique peroxisomal localisation. It 
can also be seen that the peroxisomes are often in close proximity with chloroplasts 
with the preliminary observation being discussed in Section 4.3.4.1. It has been shown 
that in photosynthetically active cells peroxisomes are often associate with chloroplasts 
where they participate in photorespiration.217 This can be seen as further evidence for 
the localisation of the BODIPY probes within the peroxisome. 
a) b) c) 
a) b) c) 
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The studies undertaken so far had shown that the BODIPY probes were able to localise 
exclusively within plant peroxisomes at low concentrations and with a very short 
incubation period. In addition to this, no perceived cytotoxicity was observed and 
indeed cells remain viable for up to one week.  
5.4 Peroxisome Proliferator-activated Receptor (PPAR) Studies 
In order to test the ability of the BODIPY probes to respond to changes in peroxisome 
numbers, peroxisome proliferator-activated receptor (PPAR) studies were undertaken. 
Peroxisome numbers are known to increase to a wide variety of stimuli such as 
increased fatty acids, reactive oxygen species, xenobiotics218 and herbicides.219 The 
mechanism by which proliferation occurs is a result of the induction and transcription 
of a number of biogenesis genes. These genes are in turn induced by the presence of 
receptors known as PPARs. There are three main types of PPARs known as PPARα, 
PPARβ and PPARγ and each of these is distinguishable by the function that they 
undertake.220 Once activated by the above mentioned stimuli, PPARs bind to DNA and 
regulate gene transcription, ultimately resulting in the proliferation of peroxisomes.  
Both natural and synthetic ligands exist for all isoforms of PPARs. PPARα tends to bind 
polyunsaturated fatty acids such as Leukotriene B, whereas PPARγ interacts with 
prostaglandins and oxidised metabolites of linoleic acid. Synthetic ligands often belong 
to one of two classes: thiazolidinediones or fibrates.221 The thiazolidinedione class 
contains compounds such as troglitazone, 144 and pioglitazone, 145 and these activate 
PPARγ. The fibrate class has compounds which include clofibrate, 146 and 
benzafibrate, 147 and these bind mainly to PPARα.222 
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It has been shown that clofibrate can induce peroxisome proliferation in plant cells.223 
Palma et al showed that treatment of Pisum sativum L (pea leaves) with 1 mM clofibrate 
causes a 5-fold increase in the number of peroxisomes.224 In order to show that 126 
could allow an increase in peroxisome numbers to be observed, BY-2 cells were treated 
with clofibrate. 
5.4.1 Clofibrate 
Treatment with the PPARα agonist clofibrate, 146, which is known to increase 
peroxisome numbers, indicated that 126 was able to selectively stain peroxisomes in 
treated cells, with no interference seen. BY-2 cells were treated with 50 μM 146 and 
incubated for 1 hour. Following this, treatment with 126 (final concentration 5 μM) was 
performed and the cells were viewed under the microscope. The peroxisome 
population had increased dramatically in the 146 treated cells (Figure 5.8b) when 
compared to the control (Figure 5.8a) and this could clearly be visualised following 
treatment with 126. 
 
Figure 5.8 BY-2 cells treated with clofibrate, 146,  followed by incubation with 126. a) control; b) 
clofibrate treated cells 
This highlights that 126 is able to respond to changes in peroxisome numbers and 
therefore shows that it has an application towards being a marker for stress within cells. 
5.5 Localisation Causes 
Co-localisation studies have conclusively shown that 126 localises exclusively within 
the peroxisome (See Section 5.3.5). It has also been shown that these probes are able to 
a b 
a) b) 
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localise within the peroxisome of a variety of species and cell types, with only a very 
short incubation time needed. However, the reason for this localisation was unknown. 
Efforts now concentrated on studies to elucidate the cause of this localisation. 
5.5.1 Reactive Oxygen Species 
Peroxisomes are known to be involved in the production and metabolism of reactive 
oxygen species. It was thought that the reason for the localisation of 126 within 
peroxisomes may be due to its reaction with these species and experiments were 
undertaken to prove this. 
Reactive oxygen species (ROS) is a collective term which includes oxygen radicals such 
as •OH, •OOR and O2•- and certain non radicals that are oxidising agents or easily 
converted into radicals, e.g. 1O2, H2O2 and O3. ROS are widely believed to contribute to 
the development of several age related diseases by causing oxidative damage to cells.225 
The ability to measure ROS is crucial for the diagnosis and treatment of these age 
related diseases, and this can be achieved by several methods. One such example is the 
use of molecules to trap the ROS and the subsequent measurement of the trapped 
species. 5,5-dimethyl-1-pyrroline N-oxide (DMPO) is used in this manner, with ESR 
used to measure the decrease in DMPO levels.226  
Another method involves the measurement of levels of oxidative damage to cellular 
components. Examples include the detection of DNA damaged products such as base 
and sugar modifications227 and protein modifications such as methonine sulfoxide228 
which can be achieved using HPLC and GC/LC-MS.  
Finally, fluorescent probes are also used to detect cellular ROS. Dichlorofluorescein 
diacetate (DCFDA), 148 is a non-fluorescent molecule which is taken up by cells and 
through the action of endogenous esterases is converted to dichlorofluorescein (DCF), 
149. 148 is also non-fluorescent and reacts with ROS present within the cell to form the 
radical species 150, which rearranges to give the fluorescent molecule, 151 (See Scheme 
5.2).229 
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Scheme 5.2 Reaction of DCFDA with esterases to form DCF and its subsequent reaction with ROS to 
give the fluorescent molecule 151. 
Another example of a fluorescent ROS probe was recently developed by Scaiano.230 The 
simple reaction of NBD-Cl with 4-aminophenol gives ABFhd, 152. This is a non-
fluorescent molecule which upon reaction with ROS, releases the fluorescent NBD 
group, Scheme 5.3. 
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Scheme 5.3 
It was proposed that the increase in fluorescence seen with 126 in cells may be due to a 
reaction with ROS and experiments were undertaken to investigate this. 
5.5.1.1 ROS Studies 
Several reactive oxygen species were tested with 126 in an attempt to show that one of 
them caused an increase in fluorescence and were therefore responsible for the green 
fluorescence seen within the peroxisome of cells. All spectra were recorded with the 
same slit width and over the same emission wavelength. 
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5.5.1.1.1 Hydrogen peroxide 
H2O2 is able to cross cell and organelle membranes easily and can lead to displacement 
of the inhibitory subunit from the cytoplasmic transcription factor nuclear factor κB, 
allowing the activated factor to migrate to the nucleus.231 H2O2 can also stimulate 
transcription of c-jun and can activate mitogen-activated protein kinases.232 Although 
many ROS can attack DNA, H2O2 does not react with DNA bases at all.233 
1 mM H2O2 was added neat to a solution of 126 in dH2O. The fluorescence 
measurement showed no increase in emission. No change was seen after leaving the 
solution for 1 hr. The reaction was repeated but following H2O2 addition the solution 
was incubated at 40 °C for 30 mins. However, no change in fluorescence was seen. It 
would appear that H2O2 has no affect on the fluorescent intensity of 126 and is therefore 
not responsible for the fluorescence seen in vivo. 
5.5.1.1.2 Hydroperoxyl and peroxyl radical 
Both hydroperoxyl (•OOH) and peroxyl (•OOR) radicals are responsible for the 
peroxidation of lipids within cells. They are also able to oxidise proteins by the attack of 
hydroperoxyl radicals generating amino acid radicals, which may crosslink or react 
with O2 to generate peroxyl radicals. These peroxyl radicals may abstract H•, triggering 
more radical generation and form protein peroxides which can decompose in a variety 
of ways.234 
Two different sources of •OOH were used: tBuOOH and cumenehydroperoxide. Both 
were added to a solution of 126 in dH2O, however no change in fluorescence was seen. 
In order to generate •OOR, 2,2-azobis(2-amidinopropane) (AAPH) was used. 
H2N
N
N
NH2
NH
NH
AAPH  
AAPH is a water-soluble azo compound which is used extensively as a free radical 
generator, often in the study of lipid peroxidation and the characterization of 
antioxidants. Decomposition of AAPH produces molecular nitrogen and two carbon 
radicals. The carbon radicals may combine to produce stable products or react with 
molecular oxygen to give peroxyl radicals. The half-life of AAPH is about 175 hours 
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(37 °C at neutral pH), making the rate of free radical generation essentially constant 
during the first several hours in solution.235 AAPH was added to a solution of 126 in 
dH2O, however despite several attempts and incubation at 40 °C no changes in 
fluorescence were observed. This would indicate that neither •OOH or •OOR are 
responsible for the changes in fluorescence seen with 126. 
5.5.1.1.3 Hydroxyl radical, •OH 
Hydroxyl radicals (•OH) plays many important cellular roles including, messenger 
roles in T-cell activation236 and the mediation of redox alteration of cell-membrane 
Ca2+.237 In addition to this •OH can also damage DNA bases, inducing cells to undergo 
apoptosis.238 
Two reactions were employed in the generation of the hydroxyl radical. The first of 
these was the Fenton reaction. This involves the reaction of FeSO4.7H2O with H2O2 to 
generate •OH, Equation 1. However, when this was attempted no change in 
fluorescence was observed, even with a second addition of FeSO4.7H2O. 
Fe2+ + H2O2               Fe3+ + •OH + -OH            Eqn. 1 
KNO3           ONOO- + H+            ONOOH             NO2• + •OH       Eqn. 2 
The second reaction utilised KNO3, Equation 2.239 A sample of KNO3 was ground using 
a pestle and mortar to a fine powder. This was irradiated with UV light until the 
powder changed from white to yellow. After this time, 5 mg was added to the solution 
containing 126 and the emission spectra was recorded. No change in fluorescence was 
seen. These two results suggest that •OH are not responsible for the change in 
fluorescence seen. 
5.5.1.1.4 Superoxide, O2•- 
The superoxide anion (O2•-), which is characterised by a small lifetime in aqueous 
media, has a prolonged lifetime within cellular membranes and is capable of 
hydrolysing certain lipids, such as phospholipids.240 In this experiment KO2 was used 
as the superoxide source. All fluorescence measurements were carried out at a final 
concentration of 100 μM. After an addition of 5 mg of KO2, measurements were 
recorded at 0 mins, 40 mins and 120 mins. However, no increase in fluorescence was 
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observed despite repeated attempts. This indicates that O2•- is not the cause of the 
fluorescence within cells. 
5.5.1.1.5 Singlet oxygen, 1O2 
In photosynthesis, singlet oxygen (1O2) can be produced and is scavenged by the 
carotenoids by direct quenching to prevent any damaging effects. In mammalian 
systems, 1O2 can cause the oxidation of lipids and result in cardiovascular effects. As 
with H2O2, 1O2 does not react with DNA bases.233 
In order to generate singlet oxygen zinc tetraphenylporphryin (ZnTPP) was used. 
Irradiation of ZnTPP forms an excited state, ZnTPP*, which is able to react with 
molecular oxygen to generate 1O2 and regenerate ZnTPP. ZnTPP has a λex at 420 nm 
(Figure 5.9) and therefore irradiation at this wavelength provides the greatest 
opportunity for 1O2 generation. 
 
Figure 5.9 Absorbance spectrum of ZnTPP 
Probe 126 was added to a solution of ZnTPP in dH2O and the solution was illuminated 
at 420 nm for 30 mins. After this time the fluorescence spectrum was recorded, however 
no change was seen. The solution was illuminated for a further 30 mins but again no 
change in fluorescence was observed. This result indicates that 1O2 is not the species 
responsible for the increase in fluorescence. 
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The following table summarises the ROS tested with 126 and the results obtained. 
ROS SOURCE FLUORESCENCE 
H2O2 H2O2 NO 
•OOH tBuOOH NO 
•OOH Cumenehydroperoxide NO 
•OOR AAPH NO 
•OH Fenton Reaction NO 
•OH KNO3 NO 
O2•- KO2 NO 
1O2 ZnTPP NO 
Table 5.1 Summary of ROS tested with 126 and the results observed 
As the ROS tested had no effect on the fluorescent properties of 126, it was decided to 
systematically alter the structure in the hope of elucidating the part of the molecule 
which was responsible for the localisation within peroxisomes. 
5.5.2 Phenyl substituent substitution 
Initial attempts focused on the phenyl substituent. Compound 153 was synthesised to 
show whether a phenyl substitution was essential for peroxisomal localisation. 153 was 
synthesised according to Scheme 5.4 in less than a 1% yield. Due to the poor yield there 
was not enough product for NMR studies, however, LC-MS indicated successful 
production by the presence of the molecular ion, 249.2 [M+H+]. In addition to this, the 
photoluminescence of 153 exhibited a classic BODIPY excitation and emission profile, 
which again indicated successful synthesis of 153, Figure 5.10. 
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Scheme 5.4 Synthesis of 153 
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Figure 5.10 Excitation and emission profile of 153 
BY-2 cells were treated with 153 and localisation was seen within peroxisomes. This 
result suggests that it is the bora-indacene core which is essential for localisation. 
Furthermore, the original bromo-BODIPY derivative 116 which contained no methyl 
groups on the pyrrole was also tested. This also showed identical localisation and 
fluorescence within cells, indicating that the methyl groups are not needed for 
peroxisomal localisation.  
153 was also purchased from Molecular Probes and when treated with BY-2 cells, 
identical localisation was seen. However, due to the high quantum yield a small 
amount of background fluorescence was seen and therefore it would appear that 126 is 
a better marker for peroxisomes due to the very low background fluorescence, allowing 
for a greater contrast. As the phenyl substituent had not effect on the localisation 
attention now turned to the B-F bonds. 
5.5.3 Fluorine substitution 
In order to ascertain what importance the fluorine groups had and whether the B-F 
bond was the cause of the localisation, each fluorine was substituted starting from 
compound 122 (See Scheme 5.5). This was achieved following recent reports by Ziessel, 
in which the fluorine can be substituted by the reaction with an appropriate Grignard 
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reagent.241 Following FCC both the mono- and disubstituted compounds could be 
isolated. A molecular ion peak at 440.3 in the MADLI MS showed the presence of 154, 
whilst in the spectrum of 155, peaks at 382.2 and 363.2 was seen, with the latter being 
attributed to the loss of HF. In both cases the isotope pattern for boron could clearly be 
seen. In addition to this, both 19F and 11B NMR confirmed the correct number of boron 
and fluorine atoms in the respective compounds. Photoluminescence showed that both 
154 and 155 were fluorescent, with virtually identical excitation and emission maxima 
(154 502 and 523 nm; 155 503 and 523 nm). 
122
i) PhMgBr (2 eq), THF, rt
N
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Scheme 5.5 
Both 154 and 155 were incubated with BY-2 cells (5 μM final concentration), with both 
exhibiting identical subcellular localisation as with all of the previous probes. This 
would suggest that neither the fluorine groups nor the B-F bond are responsible, nor 
required, for the localisation within peroxisomes (See Figure 5.11). 
a b 
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Figure 5.11 Treatment of BY-2 cells with a) 154 and b) 155 
5.5.4 Pyrrole conjugation 
In order to test the possibility of localisation being dependent on the pyrrole group, 
efforts towards modifying this group were undertaken. In addition to this it has also 
been shown that a different fluorescence emission wavelength, and hence colour, can be 
achieved with BODIPY molecules containing an extended conjugated pyrrole system.242 
This probe was based on recent literature by Suzuki, where far-red emitting probes 
were synthesised.243 A slightly modified probe was synthesised based on the synthetic 
route below, Scheme 5.6. 
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i) 4-methoxyphenylboronic acid, Pd(dppf)2Cl2.DCM, toluene, EtOH, Na2CO3, 110 
oC, 13 h, 80%; ii) ethylazidoacetate, 
NaOEt, EtOH, rt, 2 h then reflux, 1 h, 26%; iii) NaOH, EtOH, reflux 1 h, 99%; iv) TFA, reflux, 15 min, benzoyl chloride, 
DCM, then BF3OEt2, Et3N, 30%
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Scheme 5.6 Multi-step synthesis of 160 
a) b) 
178 
 
156 was coupled under standard Suzuki conditions with 4-methoxyphenylboronic acid 
to yield 157 in an 81% yield. This was confirmed by the presence of two multiplets in 
the 1H NMR spectrum corresponding to the protons of the phenyl ring (7.75 – 7.76 and 
6.95 – 6.96 ppm). In addition, a molecular ion in the m/z spectrum was observed which 
is fully consistent with the molecular formula C12H10O3. The next step involved the 
synthesis of the fused furan-pyrrole ring system. The initial stage involves the 
formation of the azide derivative, which undergoes spontaneous cyclisation upon 
heating in toluene. The fused furan-pyrrole molecule 158 was formed in a 26% yield, as 
ascertained by the appearance of peaks corresponding to the pyrrole proton and furan 
proton (6.67 ppm, d 4J 0.5 and 6.49 ppm, d 4J 0.5 respectively) in the 1H NMR spectrum. 
The ethyl ester was hydrolysed by treatment with NaOH in EtOH in a 99% yield to 
afford 159 as a purple solid. IR analysis showed successful hydrolysis by the 
disappearance of the band at 1645 cm-1 and the appearance of 1715 cm-1. The final step 
of the synthesis involved the BODIPY formation, which was achieved in a one-pot 
procedure through the condensation with benzoyl chloride, followed by complexation 
with BF3•OEt2 in the presence of Et3N. MALDI MS showed a peak corresponding to the 
molecular ion at 561.2, with the characteristic boron isotope pattern and a second peak 
corresponding to loss of HF. The overall yield for the synthesis of 160 was 6%. 
Fluorescence analysis showed 160 to emit in the red region, with the maximum at 
687 nm (See Figure 5.12). 
 
Figure 5.12 Fluorescence spectrum of 160 
160 was tested on BY-2 cells (laser emission at 633 nm, 650 nm LP filter), using the same 
methodology as for the other BODIPY probes. Pleasingly, red punctuate fluorescence 
was observed in all cells (See Figure 5.13). Again movement was seen, hence no 
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perceived toxicity could be detected with this probe. This suggests that the pyrrole 
functionality can be adapted to tune the fluorescence without any effect on peroxisome 
localisation. This result leads the way for a multi colour set of peroxisome markers.244 
 
Figure 5.13 BY-2 cells incubated with 160, with red, punctuate fluorescence clearly seen 
5.5.5 Boron substitution 
The final part of the molecule which was highlighted for modification was the boron 
centre. It has been shown that dipyrromethene compounds can be complexed with a 
wide variety of metal salts to form bis(dipyrinnato)-metal(II) or tris(dipyrinnato)-
metal(III) complexes. Examples of metals used include Zn(II),245 Co(II), 246 Ni(II), Cu(II), 
247 Fe(III) and Co(III)248 amongst others. Of those synthesised the only one to exhibit 
fluorescence was the Zn complexes and for this reason the synthesis of this complex 
were attempted.  
Attempts were made to synthesise 161 in a one pot procedure in a similar manner to 
126, with replacement of BF3•OEt2 with Zn(OAc)2, Scheme 5.7. However, no product 
was isolated following FCC, with only 4-nitrodipyrromethene 136 isolated. 
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Scheme 5.7 
Due to the failure of the one pot procedure, synthesis of 161 was attempted by 
treatment of the purified 4-nitrodipyrromethane 162 with Zn(OAc)2, Scheme 5.8. 
Disappointingly, no reaction was seen. Despite repeated attempts, using both Zn(OAc)2 
and Zn(OAc)2.2H2O compound 161 could never be isolated.  
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Scheme 5.8 
It was thought that the reason for the failure may be due to the methyl groups on the 
pyrrole ring causing steric hindrance to the complexation step. For this reason the 
reaction was repeated using pyrrole, Scheme 5.9. Unfortunately no product could be 
detected, even when performing the two step reaction.  
NO2
COCl
O2N
N
N
NO2
N
N
Zn
163
i
i) pyrrole, DCM, then Zn(OAc)2, Et3N, DCM  
Scheme 5.9 
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A final attempt involved the synthesis of 163 using the one-pot procedure, however, no 
product was obtained. Due to time constraints this was not pursued any further. 
5.6 Mammalian Studies 
As the biological studies undertaken so far involved the use of plant systems it was 
therefore of interest to see if the localisation of the BODIPY probes was exclusive to 
plant peroxisomes. To this end, probes 122 and 126 were tested within mammalian 
cells, in particular the mouse fibroblasts NIH 3T3 and human stem cells, MG63 
osteoblasts. NIH 3T3 cells were kindly donated by Elizabeth New and MG63 
osteoblasts were kindly donated by Stefan Przyborski. Details of the methodology and 
results obtained are outlined in the following section. 
5.6.1 NIH 3T3 
NIH3T3 are mouse fibroblast cells that have become a well established cell line. Probe 
126 was tested in NIH3T3 to ascertain the probes use within mammalian cells. Cells 
were grown to confluence on glass slides and treated with 126 (5 μM final 
concentration) with a 1 hour incubation period at 37 °C. Punctuate green fluorescence 
could be seen within all cells showing that these probes also localise with the 
peroxisomes of mammalian cells. Figure 5.14 shows both a white light and fluorescent 
image of an fibroblast cell, where the peroxisomes can clearly be seen. 
 
Figure 5.14 NIH3T3 fibroblasts incubated with 126 
5.6.2 MG63 osteoblasts 
Osteoblasts are bone stem cells that have not undergone complete differentiation. Due 
to the several disorders which can affect humans it was of interest to see if the BODIPY 
probes are also able to localise in the peroxisomes of cells grown from a human cell line. 
To this end, 126 was incubated with MG63 osteoblasts, which had been grown to 
confluence at 37 °C. 126 (~5 μM) was added at rt and incubated for less than 10 
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minutes. When viewed under the confocal microscope, green punctuate fluorescence 
could clearly be seen in all cells, Figure 5.15. As with the NIH3T3 cells, this would 
indicate that 126 is able to localise within the peroxisomes of mammalian cells. 
Conclusive proof of this would only be ascertained following co-localisation studies, 
which due to time constraints were not undertaken. 
 
 
Figure 5.15 MG-63 osteoblasts incubated with 126 
5.7 Summary 
* Treatment of 126 with BY-2 cells indicate it is able to cross the plant cell wall. 
* After incubating cells with 143, followed by 126, fluorescence was still observed, 
suggesting that endocytosis is not the mechanism of uptake. 
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* The infiltration of 126 into Nicotiana benthamiana leaves transformed with the 
peroxisome marker PTS1-mCherry showed co-localisation thus confirming the uptake 
of 126 into the peroxisome. 
* All probes tested were shown to have no perceived toxicity towards BY-2 cells. 
* 126 is able to respond to changes in peroxisome numbers shown by prior treatment of 
cells with the PPARα, clofibrate. 
* When 126 was treated with H2O2, •OH, •OOH, •OOR, 1O2 and O2•- an increase in 
fluorescence was not seen. 
* Results suggest that 126 is a better marker for peroxisomes than 153 due to the very 
low background fluorescence. 
* Neither the fluorine groups, nor the B-F bond are responsible for the localisation 
within the peroxisomes. 
* Pyrrole functionality can be adapted to tune the fluorescence without any effect on 
peroxisome localisation, leading the way for a multi colour set of peroxisome markers. 
* Attempts to substitute the boron for zinc were unsuccessful, despite repeated 
attempts. 
* It appears that 126 is able to localise with the peroxisomes of mammalian cells, but 
further co-localisation studies are required to prove this. 
5.8 Conclusions 
It has been shown that the BODIPY probes 122, 126 and 127 are able to localise 
exclusively within the peroxisomes of plants as established by co-localisation studies 
undertaken with a known peroxisomal marker. Incubation times were typically less 
than 10 minutes, after which time complete uptake and localisation was observed. In 
addition to this no perceived cytotoxic effects could be seen when BY-2 cells were 
incubated with 126, even after one week. Uptake studies have indicated that 
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endocytosis is not the mechanism of uptake, although the exact mechanism is not 
known. 
In an effort to ascertain the cause of localisation, several studies were performed. 126 
was reacted with a wide variety of ROS including H2O2, •OH, 1O2 and O2•-, but no 
change in fluorescence was seen. Several structural modifications were done in an 
attempt to elucidate the part of the molecule which was responsible for the localisation. 
However, removal of the phenyl substituent, substitution of the fluorine atoms, 
extension of the pyrrole conjugation and removal of the pyrrole methyl groups did not 
affect the localisation in any way. Attempts to change the boron centre for zinc were 
unsuccessful. 
Incubation of 126 was performed with the mouse fibroblast cells NIH3T3 and the 
human osteoblast stem cells MG63, with punctuate green fluorescence seen in these 
cells as well. Whilst it would seem that 126 is also localising with the peroxisome of 
mammalian cells, conclusive proof of this can only be given once co-localisation studies 
have been performed.  
Due to the relative ease of synthesis of 126, its photostability within aqueous 
environments, high fluorescence within cells, ease and speed of uptake in both plant 
and mammalian cells and the ability to produce multicoloured derivatives, it easily 
lends itself towards its application as a marker for peroxisomes. 
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6  CONCLUSIONS AND FUTURE WORK 
6.1 Conclusions 
Several conclusions can be drawn from this work. They include: 
* Several ester substrates based on methylumbelliferone were synthesised and screened 
against AtSFGH. Those derivatives which contained an amide bond were poor 
substrates for both AtSFGH and PLE when compared to that of the n-hexyl derivative, 
38. This suggests that some sort of conformational flexibility within the substrate is 
needed. AtSFGH activity towards a selection of these esters more closely resembled the 
activity seen in whole cells than that seen with PLE, which indicated that AtSFGH is a 
better determinant of hydrolysis of these compounds in planta than PLE. However, 
these esters did not appear to be taken up by protoplast cells. In contrast, the 
protoplasts readily hydrolysed FDA with the resulting fluorescence being detected on a 
fluorescence microscope and the MoFlo®. 
* Fluorescein esters 78 – 80 were shown to be hydrolysed by AtCXE12, both in vitro and 
in vivo in the order FDA > 78 > 79 ≈ 80, with 78 and 79 identified as potential probes in 
directed evolution experiments. Tyrosine198 was targeted as a possible residue for 
mutation. This was successfully mutated into alanine by site-directed mutagenesis. 
When 78 – 80 were screened against the AtCXE12 Y198A mutant no activity was seen, 
even with FDA. Western blotting analysis revealed that the lack of activity was not due 
to expression problems and therefore tyrosine198 is critical for enzyme activity. 
* Error-prone PCR techniques were employed in an effort to create a recombinant 
library. Protocol development using the D473G polymerase revealed optimum 
conditions, with the mutational frequency controlled by alteration of the dNTP 
concentration. Efforts toward on-plate screening in E. coli indicated that the background 
activity was too high to allow any meaningful results to be gained. In order to screen 
directly in protoplasts, AtCXE12 was successfully cloned into the Agrobacterium vector 
BIN-STRP3. Nicotiana benthamiana leaves infiltrated with Agrobacterium containing the 
BIN-STRP3-AtCXE12 vector were successfully transformed. The rate of hydrolysis of 
pNPAc by AtCXE12-transformed leaves was 20-fold higher than the background 
activity. However, efforts to introduce random errors into the atcxe12 gene contained 
within the BIN-STRP3 construct were unsuccessful.  
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* The esterase probe 96 was successfully synthesised in a 16% yield. An increase in 
fluorescence was observed following chemical or enzymatic treatment, indicating that 
the proposed 1,6-elimination was occurring. Disappointingly, no evidence was gained 
for binding of 95 to PLE. 105 was synthesised in an overall 13% yield, however attempts 
to chemically remove the methoxy group were unsuccessful. The MOM probe 112 was 
synthesised and shown to breakdown upon treatment with 1 M HCl, resulting in the 
release of the fluorescent quencher group and a concomitant fluorescence increase.  
* The synthesis of several BODIPY probes was successfully achieved and the 
introduction of a nitro group resulted in complete quenching of fluorescence. When 126 
was dissolved in either toluene or hexane a strong fluorescent signal was observed, 
suggesting that PeT is the quenching mechanism. DFT calculations were used to assess 
the likelihood of a BODIPY derivative displaying fluorescence. Upon incubation of 126 
with A. thaliana protoplasts, fluorescence could be seen. However, attempts to isolate a 
fluorescently labelled protein were unsuccessful. A variety of enzyme inhibitors were 
tested in an attempt to ascertain the cause of fluorescence. However, known of the 
inhibitors tested affected the fluorescence of 126. Treatment of 126 with BY-2 cells 
indicate that 126 is able to cross the plant cell wall. However, after incubating cells with 
several compounds including 143, fluorescence was still observed, suggesting that 
endocytosis is not the mechanism of uptake. 
* The infiltration of 126 into Nicotiana benthamiana leaves transformed with the 
peroxisome marker PTS1-mCherry showed co-localisation thus confirming the uptake 
of 126 into the peroxisome. All probes tested were shown to have no perceived toxicity 
towards BY-2 cells. In addition, 126 is able to respond to changes in peroxisome 
numbers shown by prior treatment of cells with the PPARα, clofibrate. Neither the 
fluorine groups, nor the B-F bond are responsible for the localisation within the 
peroxisomes. Pyrrole functionality can be adapted to tune the fluorescence without any 
effect on peroxisome localisation, leading the way for a multi colour set of peroxisome 
markers. 
6.2 Future Work 
Future work on this project should concentrate on developing the directed evolution 
methodology to optimise conditions for introducing mutations. This should involve 
altering the primer to insert ratio, as well as the dNTP concentrations, in an effort to 
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produce a recombinant library within the BIN-STRP3 vector. Following this, the 
method should be transferred to other enzyme systems, such as cytochrome p450. 
Work on the BODIPY peroxisome markers should focus on discovering the mechanism 
of uptake and localisation within both plant and mammalian cells. This should begin by 
investigating the reaction of substituting the boron centre with zinc, which should give 
an indication of the necessity of the BF2 bridge. Further work could concentrate on 
developing a multicoloured set of peroxisome markers. 
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7  EXPERIMENTAL 
7.1 Chemistry 
7.1.1 General Procedures 
All reactions were carried out under an argon atmosphere in glassware dried in an 
oven at 80 C, unless otherwise stated. 
Solvents 
Petrol refers to the fraction of petroleum ether boiling between 40-60 °C and was 
redistilled before use. All solvents were distilled under a nitrogen atmosphere 
according to departmental procedures. In cases where mixtures of solvents were used, 
the ratios refer to the component volumes. 
Reagents 
Reagents were used as supplied unless otherwise stated. 
Chromatography 
Flash column chromatography was carried out using silica gel 40-63u 60A. Analytical 
thin layer chromatography (TLC) was performed using Merck aluminium backed silica 
gel 60 F254 plates and visualised by UV radiation at 254 and/or 333 nm. 
IR Spectroscopy 
Infra-red spectra was recorded via use of a Diamond ATR (attenuated total reflection) 
accessory (Golden Gate) on a Perkin Elmer Paragon 1000 FT-IR spectrometer, or 
recorded as a solution in chloroform via transmission IR cells on a Perkin Elmer Series 
1600 FT-IR spectrometer. 
NMR Spectroscopy 
1H NMR spectra were recorded in CDCl3 on a Varian Mercury 200, Varian Unity-300, 
Bruker Advance 400, Varian Inova-500 or a Varian VNMRS 700 and reported as 
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follows; chemical shift  (ppm) (number of protons, multiplicity, coupling constant J 
(Hz), assignment). Residual protic solvent CHCl3 ( H = 7.26 ppm) was used as the 
internal reference. 13C NMR spectra were recorded at 176 MHz on a Varian VNMRS 
700, 126 MHz on a Varian Inova-500 or at 101 MHz on Bruker Advance 400, using the 
central resonance of CDCl3 ( C = 77.0 ppm) as the internal reference.  19F NMR spectra 
were recorded at 376 MHz on Varian VXR-400 or 188 MHz on Varian Mercury 200 
respectively. 11B NMR spectra were recorded at 128 MHz on a Bruker Advance 400. All 
chemical shifts are quoted in parts per million relative to the internal reference and 
coupling constants given in Hertz (Hz). Assignment of spectra was carried out using 
COSY, HSQC, HMBC and NOESY experiments. 
Mass Spectrometry  
Electrospray mass spectra (ES) were obtained on a Micromass LCT mass spectrometer. 
MALDI mass spectra were obtained on an Applied Biosystems Voyager-DE STR. High 
resolution mass spectra were obtained using a Thermo LTQ mass spectrometer (ES) at 
the University of Durham.  
Photophysical Measurements 
UV-visible absorption spectra were recorded using a Biotech Instruments XS 
spectrometer operating with LabPower software. All samples were recorded in quartz 
cuvettes of 1 cm pathlength, against a reference of pure solvent contained within a 
matched cuvette.  
Steady-state luminescence spectra were recorded using a Jobin Yvon-Spex Instrument 
SA Photomax II spectrometer, equipped with a Hamamatsu R928 photomultiplier tube. 
All samples were studies in quartz fluorescence cuvettes of 1 cm pathlength. Solutions 
were prepared so that the absorbance was ~0.1 to minimise inner filter effects. Emission 
was detected at right angles to the excitation source, with appropriate filters used 
where required to remove second order peaks. All emission spectra were corrected 
after data acquisition for dark count and for the spectral response of the detector. 
Excitation spectra were automatically corrected for lamp output, through the use of a 
beam splitter which directed 8%of the excitation light to a reference photodiode. 
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7.1.2 Experimental detail 
4-methylumbelliferyl acetate, 34 
OO O
O
 
4-MU (3.79 g, 21.5 mmol), Et3N (6.01 ml, 2.0 eq) and DMAP (0.21 g, 0.1 eq) were 
dissolved in anhydrous DCM (55 ml), stirred and cooled to 0 ºC. This was left to stir for 
30 minutes. Acetyl chloride (0.45 ml, 1.8 eq) was added dropwise, upon which a cream 
precipitate formed with the evolution of a white gas. The resulting solution was 
warmed to rt and left to stir overnight. After this time the precipitate became an orange 
colour. The solution was taken up into water (50 ml), organic layer collected. This was 
repeated twice.  Combined organic layers were added to aqueous saturated sodium 
hydrogen carbonate (50 ml) and the resulting organic layer collected. This was added to 
brine (50 ml), organic layer collected, dried using MgSO4 and the solvent removed 
under reduced pressure to afford an off-white solid. Compound triturated using ether 
to yield 34 (0.87 g, 94%) as a white crystalline solid. m.p. 146 – 148 C (Lit. 149 – 150 
°C249); Found: C, 66.24 H, 4.65; Calc. for C12H10O4: C, 66.05 H, 4.62; max (DCM)/nm: 352; 
υmax (ATR)/cm-1: 1742s (C=O), 1698m (lactone), 1140s, 875s; δH (500 MHz, CDCl3): 7.61 
(1H, d, 3J 9, H5), 7.10 (1H, d, 4J 2, H8), 7.07 (1H, dd, 3J 9 and 4J 2, H6), 6.27 (1H, d, 4J 1, 
H3), 2.43 (3H, d, 4J 1, C4-Me), 2.34 (3H, s, H2’); δC (100 MHz, CDCl3): 168.7 (C=O), 160.5 
(C=O), 154.2 (QC), 153.1 (C7), 151.8 (QC), 125.4 (C5), 118.1 (C6), 117.9 (C4), 114.6 (C3), 
110.5 (C8), 21.1 (C4-Me), 18.7 (C2’); m/z (ES+): 219.0 [M+H+]+ 
4-methylumbelliferyl propionate, 35 
OO O
O
 
4-MU (3.79 g, 21.5 mmol), Et3N (6.01 ml, 2.0 eq) and DMAP (0.21 g, 0.1 eq) were 
dissolved in anhydrous DCM (55 ml), stirred and cooled to 0 ºC. This was left to stir for 
30 minutes. Propionyl chloride (2.81 ml, 1.8 eq) was added dropwise, upon which a 
cream precipitate formed with the evolution of a white gas. The resulting solution was 
warmed to rt and left to stir overnight. After this time the precipitate became an orange 
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colour. The solution was taken up into water (50 ml), organic layer collected. This was 
repeated twice. Combined organic layers were added to aqueous saturated sodium 
hydrogen carbonate (50 ml) and the resulting organic layer collected. This was added to 
brine (50 ml), organic layer collected, dried using MgSO4 and the solvent removed 
under reduced pressure to afford an off-white solid. Compound triturated using ether 
to yield 35 (4.05 g, 81%) as a white crystalline solid. m.p. 145 - 146 C; Found: C, 67.13 
H, 5.20; Calc. for C13H12O4: C, 67.23 H, 5.21; max (ATR)/cm-1: 1744s (C=O), 1698m 
(lactone), 1140s; H (500 MHz, CDCl3): 7.60 (1H, d 3J 8, H5), 7.11 (1H, d 4J 2, H8), 7.08 
(1H, dd 3J 8 and 4J 2, H6), 6.27 (1H, d 4J 1, H3), 2.62 (2H, q 3J 8, H2’), 2.43 (3H, d 4J 1, C4-
Me), 1.23 (3H, t 3J 8, H3’); C (125 MHz, CDCl3): 172.5 (C=O), 161.0 (C=O), 154.6 (QC), 
153.7 (C7), 152.2 (QC), 125.6 (C5), 118.2 (C6), 118.0 (C4), 114.9 (C3), 110.8 (C8), 27.9 (C2’), 
19.0 (C4-Me), 9.1 (C3’); m/z (ES+): 233.1 [M+H+]+, 255.1 [M+Na+]+ 
4-methylumbelliferyl hexanoate, 38 
OO O
O
 
4-MU (750 mg, 4.23 mmol), Et3N (1.19 ml, 2.0 eq) and DMAP (41.8 mg, 0.1 eq) were 
dissolved in anhydrous DCM (10 ml), stirred and cooled to 0 ºC. This was left to stir for 
30 minutes. Hexanoyl chloride (1.19 ml, 1.8 eq) was added dropwise, upon which a 
cream precipitate formed with the evolution of a white gas. The resulting solution was 
warmed to rt and left to stir for 150 minutes. The solution was taken up into water 
(20 ml), organic layer collected and repeated. Combined organic layers were added to 
aqueous saturated sodium hydrogen carbonate (20 ml) and the resulting organic layer 
collected. This was added to brine (20 ml), organic layer collected, dried using MgSO4 
and the solvent removed under reduced pressure to afford a yellow solid. Compound 
triturated using ethyl acetate to yield 38 (0.71 g, 61%) as colourless crystals. m.p. 66 – 
68 C; Found: C, 69.80 H, 6.67; Calc. for C16H18O4: C, 70.06 H, 6.61; υmax (ATR)/cm-1: 
3020s, 1760s (lactone), 1733 (C=O); δH (400 MHz, CDCl3):  7.60 (1H, d, 3J 9, H5), 7.10 (1H, 
d, 4J 2, H8), 7.07 (1H, dd, 3J 9, 4J 2, H6), 6.27 (1H, d, 4J 1, H3), 2.59 (2H, t, 3J 7, H2’), 2.43 
(3H, d, 4J 1, C4-Me), 1.70 (2H, q, 3J 7, H3’), 1.40 (4H, m, H4’ and H5’), 0.94 (3H, t, 3J 7, 
H6’); δC (100 MHz, CDCl3): 171.6 (C=O), 160.5 (C=O), 154.2 (QC), 153.2 (C7), 151.9 (QC), 
125.3 (C5), 118.1 (C6), 117.7 (C4), 114.4 (C3), 110.4 (C8), 34.3 (C2’), 31.2 (C3’), 24.5 (C4’), 
22.3 (C4-Me), 18.7 (C5’), 13.9 (C6’); m/z (ES+): 274.9 [M+H+]+ 
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4-methylumbelliferyl-(2’-methyl)hexanoate, 56 
OO O
O
 
To a stirring solution of 2-methylhexanoic acid (0.13 ml, 0.92 mmol) and DMF (1 drop) 
in DCM (20 ml) was added oxalyl chloride (0.1 ml, 1.2 eq) dropwise, upon which a 
colourless gas evolved. The reaction was left stirring at rt until no further effervescence 
was observed. Oxalyl chloride and the solvent were removed under reduced pressure 
to afford a pale yellow solid. 4-MU (90.2 mg, 0.51 mmol), Et3N (0.26 ml, 2.0 eq) and 
DMAP (3.41 mg, 0.1 eq) were dissolved in DCM (20 ml), cooled to 0 ºC and left to stir 
for 30 minutes. 2-methylhexanoyl chloride (1.8 eq) was re-dissolved in DCM (10 ml) 
and the resulting solution was added dropwise to the reaction mixture, upon which the 
solution changed from colourless to red, with the evolution of a white gas. The 
resulting solution was left to stir overnight at rt. The solution was taken up into water 
(20 ml), organic layer collected and repeated. Combined organic layers were added to 
aqueous saturated sodium hydrogen carbonate (20 ml) and the resulting organic layer 
collected. This was added to brine (20 ml), organic layer collected, dried using MgSO4 
and the solvent removed under reduced pressure to afford a yellow solid. Purified by 
flash column chromatography (5:95 MeOH:DCM) to yield 56 (0.23 g, 87%) as a 
colourless oil. υmax (ATR)/cm-1: 3019s, 1757s (lactone), 1729m (C=O); δH (400 MHz, 
CDCl3):  7.59 (1H, d 3J 9, H5), 7.09 (1H, d 4J 2, Η8), 7.06 (1H, dd 3J 9, 4J 2, Η6), 6.25 (1H, d 
4J 1, Η3), 2.71 (2H, m, H2’), 2.43 (3H, d, 4J 1, C4-Me), 1.82 (2H, m, H3’), 1.58 (2H, m, H4’), 
1.39 (2H, m, H5’), 1.30 (3H, d 3J 8, C2’-Me), 0.94 (3H, t 3J 8, H6’); C (100 MHz, CDCl3): 
174.8 (C=O), 160.5 (C=O), 154.4 (QC), 153.5 (C7), 152.0 (QC), 125.4 (C5), 118.2 (C6), 117.8 
(C4), 114.6 (C3), 110.5 (C8), 39.8 (C2’), 33.5 (C3’), 29.5 (C4’), 22.7 (C2’-Me), 18.8 (C4-Me), 
17.0 (C5’), 14.0 (C6’); m/z (ES+): 288.8 [M+H+]+ 
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4-methylumbelliferyl-(4’-methyl)hexanoate, 60 
OO O
O
 
To a stirring solution of 4-methylhexanoic acid (0.13 ml, 0.92 mmol) and DMF (1 drop) 
in DCM (20 ml) was added oxalyl chloride (0.1 ml, 1.2 eq) dropwise, upon which a 
colourless gas evolved. The reaction was left stirring at rt until no further effervescence 
was observed. Oxalyl chloride and the solvent were removed under reduced pressure 
to afford a pale yellow solid. 4-MU (90.2 mg, 0.51 mmol), Et3N (0.26 ml, 2.0 eq) and 
DMAP (3.41 mg, 0.1 eq) were dissolved in DCM (20 ml), cooled to 0 ºC and left to stir 
for 30 minutes. 4-methylhexanoyl chloride (1.8 eq) was re-dissolved in DCM (10 ml) 
and the resulting solution was added dropwise to the reaction mixture, upon which the 
solution changed from colourless to red, with the evolution of a white gas. The 
resulting solution was left to stir overnight at rt. The solution was taken up into water 
(20 ml), organic layer collected and repeated. Combined organic layers were added to 
aqueous saturated sodium hydrogen carbonate (20 ml) and the resulting organic layer 
collected. This was added to brine (20 ml), organic layer collected, dried using MgSO4 
and the solvent removed under reduced pressure to afford a yellow solid. Purified by 
flash column chromatography (5:95 MeOH:DCM) to afford 60 (0.19 g, 72%) as a white 
solid. m.p. 38 – 40 C; υmax (ATR)/cm-1: 3019s, 1759s (lactone), 1730m (C=O); δH (400 
MHz, CDCl3): 7.56 (1H, d 3J 8, H5), 7.05 (1H, d 4J 2, Η8), 7.03 (1H, dd 3J 8, 4J 2, Η6), 6.20 
(1H, d 4J 1, Η3), 2.52 (2H, t 3J 7, H2’), 2.49 – 2.63 (2Η, m, H2’), 2.38 (3H, d, 4J 1, C4-Me), 
1.73 – 1.82 (1H, m, diastereotopic H3’), 1.50 – 1.59 (1H, m, diastereotopic H3’), 1.32 – 
1.45 (2H, m, H5’), 1.15 – 1.23 (1H, m, H4’), 0.85 – 0.91 (6H, m, H6’ and C4’-Me); 
C (100 MHz, CDCl3): 171.8 (C=O), 160.4 (C=O), 154.1 (QC), 153.2 (C7), 151.9 (QC), 125.4 
(C5), 118.1 (C6), 117.7 (C4), 114.4 (C3), 110.3 (C8), 34.0 (C2’), 32.2 (C3’), 31.3 (C4’), 29.1 
(C5’), 18.8 (C4-Me), 18.6 (C4’-Me), 11.3 (C6’); m/z (ES+): 289.2 [M+H+]+ 
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4-methylumbelliferyl –N-Boc glycine, 61 
OO O
O
H
N O
O  
4-MU (2.61 g, 14.8 mmol) and Boc-Gly-OH (3.38 g, 1.3 eq) were dissolved in anhydrous 
DCM (60 ml). DMAP (1.12 g, 1.0 eq) and EDCI (2.84 g, 1.3 eq) were added to the 
reaction mixture and left to stir overnight. The solution was diluted with DCM (50 ml) 
and added to aqueous saturated sodium hydrogen carbonate (50 ml) and the organic 
layer collected. This was repeated twice and the organic layers were combined. These 
were added to brine (50 ml), dried with MgSO4 and the solvent removed under reduced 
pressure to afford a yellow-white solid. Recrystallised from hot EtOAc to afford 61 
(2.55 g, 70%) as a white crystalline solid. m.p. 120 – 124 C; δH (400 MHz, CDCl3): 7.61 
(1H, d 3J 9, H5), 7.13 (1H, d 4J 2, H8), 7.10 (1H, dd 3J 9 and 4J 2, H6), 6.28 (1H, d 4J 1, H3), 
5.08 (1H, br s, NH), 4.20 (2H, d 3J 6, H2’), 2.43 (3H, d 3J 1, C4-Me), 1.48 (9H, s, BocH); C 
(125 MHz, CDCl3): 168.7 (C=O), 160.5 (C=O), 155.8 (C=O), 154.3 (QC), 152.7 (C7), 151.9 
(QC), 125.6 (C5), 118.2 (C6), 117.9 (C4), 114.8 (C3), 110.4 (C8), 42.7 (QC), 31.1 (C2’), 28.4 
(tBu), 18.9 (C4-Me); m/z (ES+): 334.2 [M+H+]+ 
4-methylumbelliferyl –N-Boc-L-Alanine, 62 
OO O
O
H
N O
O  
4-MU (2.61 g, 14.8 mmol) and Boc-Ala-OH (3.64 g, 1.3 eq) were dissolved in anhydrous 
DCM (60 ml). DMAP (1.12 g, 1.0 eq) and EDCI (2.84 g, 1.3 eq) were added to the 
reaction mixture and left to stir overnight. The solution was diluted with DCM (50 ml) 
and added to aqueous saturated sodium hydrogen carbonate (50 ml) and the organic 
layer collected. This was repeated twice and the organic layers were combined. These 
were added to brine (50 ml), dried with MgSO4 and the solvent removed under reduced 
pressure to afford a yellow-white solid. Recrystallised from hot EtOAc to afford 62 
(1.29 g, 25%) a white crystalline solid. m.p. 106 – 109 C; δH (400 MHz, CDCl3): 7.34 (1H, 
d 3J 8, H5), 6.74 (1H, dd 3J 8 and 4J 2, H6), 6.70 (1H, d 4J 2, H8), 6.20 (1H, d 4J 1, H3), 5.08 
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(1H, br s, NH), 4.51 (1H, br s, H2’), 2.36 (3H, d 3J 1, C4-Me), 1.50 (3H, d 3J 7, C2’-Me), 
1.40 (9H, s, BocH); C (100 MHz, CDCl3): 160.5 (C=O), 157.1 (C=O), 154.1 (QC), 153.2 
(C7), 152.0 (QC), 125.6 (C5), 118.2 (C6), 118.0 (C4), 114.8 (C3), 110.4 (C8), 42.4 (QC), 28.5 
(tBu), 23.6 (C2’), 18.8 (C4-Me), 18.3 (C2’-Me); m/z (ES+): 348.6 [M+H+]+ 
4-methylumbelliferyl –N-Boc-D-Alanine, 63 
OO O
O
H
N O
O  
4-MU (2.61 g, 14.8 mmol) and Boc-D-Ala-OH (3.64 g, 1.3 eq) were dissolved in 
anhydrous DCM (60 ml). DMAP (1.12 g, 1.0 eq) and EDCI (2.84 g, 1.3 eq) were added to 
the reaction mixture and left to stir overnight. The solution was diluted with DCM 
(50 ml) and added to aqueous saturated sodium hydrogen carbonate (50 ml) and the 
organic layer collected. This was repeated twice and the organic layers were combined. 
These were added to brine (50 ml), dried with MgSO4 and the solvent removed under 
reduced pressure to afford a yellow-white solid. Purified by flash column 
chromatography (5% MeOH:DCM) to afford 63 (1.31 g, 25%) as a white crystalline 
solid. m.p. 105 – 107 C; δH (400 MHz, CDCl3):  7.34 (1H, d 3J 8, H5), 6.74 (1H, dd 3J 8 
and 4J 2, H6), 6.70 (1H, d 4J 2, H8), 6.20 (1H, d 4J 1, H3), 5.08 (1H, br s, NH), 4.51 (1H, br 
s, H2’), 2.36 (3H, d 3J 1, C4-Me), 1.50 (3H, d 3J 7, C2’-Me), 1.40 (9H, s, BocH); C (100 
MHz, CDCl3): 160.5 (C=O), 157.1 (C=O), 154.1 (QC), 153.2 (C7), 152.0 (QC), 125.6 (C5), 
118.2 (C6), 118.0 (C4), 114.8 (C3), 110.4 (C8), 42.4 (QC), 28.5 (tBu), 18.8 (C4-Me), 18.3 
(C2’-Me); m/z (ES+): 348.5 [M+H+]+ 
4-methylumbelliferyl-N-propionyl glycine, 65 
OO O
O
H
N
O  
4-MU (168 mg, 0.95 mmol), EDCI (201 mg, 1.1 eq) and DMAP (9 mg, 0.1 eq) were 
dissolved in dry DCM (20 ml). This was left to stir for 10 minutes. To this a solution of 
69 in dry DCM (5 ml) was added and the resulting solution left to stir overnight. The 
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solution was taken up into saturated sodium hydrogen carbonate (2 x 30 ml) and the 
organic layer collected. Brine (20 ml) was added and the organic layer collected, dried 
with MgSO4 and the solvent removed under reduced pressure to yield an off-white 
solid. This was washed with EtOAc which gave 65 (231 mg, 84%) as a white solid. m.p. 
164 – 166 ºC; δH (400 MHz, CDCl3): 7.62 (1H, d 3J 9, H5), 7.15 (1H, d 4J 2, H8), 7.10 (1H, 
dd 3J 9 and 4J 2, H6), 6.28 (1H, d 4J 1, H3), 6.01 (1H, br s, NH), 4.34 (2H, d 3J 6, H2’), 
2.44 (3H, d 4J 1, C4-Me), 2.33 (2H, q 3J 8, H5’), 1.21 (3H, t 3J 8, H6’); δC (100 MHz, CDCl3): 
174.6 (C=O), 168.5 (C=O), 160.6 (C=O), 154.3 (QC), 152.8 (C7), 152.2 (QC), 125.8 (C5), 
118.3 (C6), 118.0 (C4), 114.9 (C3), 110.4 (C8), 41.7 (C2’), 29.5 (C4-Me), 18.9 (C5’), 9.8 (C6’); 
m/z (ES+): 312.08416 ([M+Na]+, C15H15NO5Na requires 312.08424); 601.1790 ([2M+Na]+, 
C30H30N2O15Na requires 601.1792) 
N-propionyl glycine, 6699 
N
H
O
COOH
 
Glycine (320 mg, 4.26 mmol) was dissolved in saturated sodium hydrogen carbonate 
(10 ml). Propionic anhydride was added and the resulting solution stirred at reflux for 6 
hours. Solution was acidified to pH 1 with HCl (5 M). The aqueous layer was washed 3 
times with EtOAc (20 ml) and the organic layers collected. The combined organic layers 
were dried with MgSO4 and the solvent removed under reduced pressure to yield 66 
(334 mg, 60%) as a white solid, which was used without further purification. m.p. 
126 ºC (lit. 128 °C); υmax (ATR)/cm-1: 1715 (s); δH (500 MHz, CDCl3): 6.43 (1H, br s, NH), 
3.92 (2H, d 3J 5, Hα), 2.20 (2H, q 3J 8, H2’), 1.09 (3H, t 3J 8, H3’); δC (125 MHz, CDCl3): 
174.0 (C=O), 171.8 (C=O), 41.2 (Cα), 29.2 (C2’), 9.6 (C3’); m/z (ES-): 130.0509 ([M-H]-, 
C5H8O3 requires 130.0510) 
N-propionyl-O-methoxy glycine, 68 
N
H
OMe
O
O
 
Glycine methyl ester (200 mg, 1.59 mmol), was dissolved in dry DMF (15 ml). Et3N (0.23 
ml, 2.0 eq) and DMAP (16 mg, 0.1 eq) were added and the reaction allowed to stir for 20 
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minutes. The reaction was cooled to 0 °C and propionyl chloride (0.21 ml, 1.5 eq) was 
added dropwise. The resulting solution was warmed to rt and left stirring overnight. 
The solution was diluted with EtOAc (30 ml) and added to aqueous saturated sodium 
hydrogen carbonate (30 ml) and the organic layer collected. This was repeated twice 
and the organic layers were combined. These were added to brine (30 ml), dried with 
MgSO4 and the solvent removed under reduced pressure to afford 68 (55 mg, 13%) as a 
white solid, which was used without further purification. m.p. 37 – 38 °C; υmax 
(ATR)/cm-1: 1736 (s); δH (400 MHz, CDCl3):  6.19 (1H, br s, NH), 4.05 (2H, d 3J 5, Hα), 
3.76 (3H, s, OMe), 2.29 (2H, q 3J 8, H2’), 1.18 (3H, t 3J 8, H3’); δC (125 MHz, CDCl3): 174.9 
(C=O), 170.0 (C=O), 39.9 (Cα), 29.3 (C2’), 21.3 (Me), 9.63 (C3’); m/z (ES+): 146.1 [M+] 
4-methylumbelliferyl-N-propionyl alanine, 69 
OO O
O
H
N
O  
62 (150 mg, 0.45 mmol) was dissolved in dry DCM (2 ml) and TFA (2 ml) was added. 
This was left to stir for 30 minutes and after this time the solvents were removed under 
reduced pressure to yield a colourless oil. This was redissolved in dry DCM (2 ml) and 
DIPEA (0.09 ml, 1.0 eq) was added. The resulting solution was left to stir for 30 minutes. 
DIC (0.08 ml, 1.1 eq), DMAP (4 mg, 0.1 eq) and propionic acid (0.03 ml, 1.0 eq) were 
added and the solution was left to stir overnight. The solution was taken up into water 
(2 x 20 ml) and the organic layer was collected. The combined organic layers were 
washed with saturated sodium hydrogen carbonate (20 ml), brine (20 ml) and dried 
using MgSO4. The solvent was removed under reduced pressure to yield a white solid. 
Purified by flash column chromatography (45% EtOAc:petroleum ether) to yield 69 
(40 mg, 29%) as a white solid. m.p. 123 – 125 ºC; δH (400 MHz, CDCl3): 7.61 (1H, d 3J 8, 
H5), 7.13 (1H, d 4J 2, H8), 7.09 (1H, dd 3J 8 and 4J 2, H6), 6.28 (1H, d 4J 1, H3), 5.94 (1H, br 
s, NH), 4.84 (1H, quint 3J 8 H2’), 2.44 (3H, d 4J 1, C4-Me), 2.29 (2H, q 3J 8, H5’), 1.60 (3H, 
d 3J 8, C2’-Me), 1.20 (3H, t 3J 8, H6’); δC (100 MHz, CDCl3): 174.8 (C=O), 168.9 (C=O), 
160.7 (C=O), 154.3 (QC), 152.7 (C7), 152.2 (QC), 125.9 (C5), 118.3 (C6), 118.0 (C4), 114.9 
(C3), 110.2 (C8), 40.8 (C2’), 29.7 (C4-Me), 18.9 (C5’), 18.4 (C2’-Me), 9.9 (C6’); m/z (ES+): 
303.6 [M+] 
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1-naphthyl acetate, 73 
O
O  
1-naphthol (300 mg, 2.08 mmol), Et3N (0.58 ml, 2.0 eq) and DMAP (20 mg, 0.1 eq) were 
dissolved in dry DCM (5 ml) and cooled to 0 C. The solution was left to stir for 20 
minutes. Acetyl chloride (0.27 ml, 1.8 eq) was added dropwise upon which an orange 
precipitate formed. This was warmed to rt and left to stir for 3 hours, after which time 
the reaction mixture had become a dark orange colour. The solution was added to 
saturated sodium hydrogen carbonate (2 x 30 ml) and the organic layers were collected 
and combined. To these were added brine (30 ml) and the organic layer dried using 
MgSO4. The solvent was removed under reduced pressure to yield 73 (248 mg, 64%) as 
a dark orange oil. max (ATR)/cm-1: 1754 (s) C=O; λmax (DCM)/nm: λex 277, λem 345; δH 
(500 MHz, CDCl3): 7.86 – 7.88 (2H, m, H7 and H8), 7.74 (1H, d 3J 8, H2), 7.44 – 7.53 (3H, 
m, H3, H4 and H6), 7.25 (1H, d 3J 8, H5), 2.45 (3H, s, CH3); δC (125 MHz, CDCl3): 169.6 
(C=O), 146.8 (C1), 134.8 (QC), 128.2 (C7), 127.0 (C4), 126.6 (C6), 126.2 (C2), 125.5 (C3), 
121.3 (C8), 118.2 (C5), 21.1 (Me); m/z (ES+): 187.1 [M+H]+ 
2-naphthyl acetate, 74 
O
O
 
2-naphthol (300 mg, 2.08 mmol), Et3N (0.58 ml, 2.0 eq) and DMAP (20.4 mg, 0.1 eq) 
were dissolved in dry DCM (5 ml) and cooled to 0 C. The solution was left to stir for 20 
minutes. Acetyl chloride (0.27 ml, 1.8 eq) was added dropwise upon which an orange 
precipitate formed. This was warmed to rt and left to stir for 3 hours, after which time 
the reaction mixture had become a dark orange colour. The solution was added to 
saturated sodium hydrogen carbonate (2 x 30 ml) and the organic layers were collected 
and combined. To these were added brine (30 ml) and the organic layer dried using 
MgSO4. The solvent was removed under reduced pressure to yield a dark orange oil. 
The oil was triturated using EtOAc/Petroleum ether (60:40) to yield 74 (337 mg, 87%) as 
an off white solid. m.p. 64 – 66 °C; max (ATR)/cm-1: 1752 (s) C=O; λmax (DCM)/nm: λex 
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275, λem 340; H (500 MHz, CDCl3): 7.80 – 7.87 (3H, m, H4, H7 and H8), 7.56 (1H, d 4J 2, 
H1), 7.44 – 7.52 (2H, m, H5 and H6), 7.24 (1H, dd 3J 8 and 4J 2, H3), 2.36 (3H, s, Me); 
C (126 MHz, CDCl3): 169.8 (C=O), 148.5 (C2), 133.9 (QC), 131.6 (QC), 129.5 (C4), 127.9 
and 127.8 (C7 and C8), 126.7 (C5), 125.8 (C6), 121.3 (C3), 118.7 (C1), 21.3 (Me); m/z (ES+): 
186.2 [M+] 
2-(2-hydroxyphenyl)benzoxazole acetate, 75250 
O
N
O
O
 
2-(2-hydroxyphenyl)benzoxazole (300 mg, 1.42 mmol), Et3N (0.28 ml, 2.0 eq) and 
DMAP (14 mg, 0.1 eq) were dissolved in dry DCM (5 ml) and cooled to 0 C. The 
solution was left to stir for 20 minutes. Acetyl chloride (0.18 ml, 1.8 eq) was added 
dropwise upon which an orange precipitate formed. This was warmed to rt and left to 
stir for 3 hours, after which time the reaction mixture had become a dark orange colour. 
The solution was added to saturated sodium hydrogen carbonate (2 x 30 ml) and the 
organic layers were collected and combined. To these were added brine (30 ml) and the 
organic layer dried using MgSO4. The solvent was removed under reduced pressure to 
yield a dark orange oil. The oil was triturated using EtOAc/Petroleum ether (60:40) to 
yield 75 (359 mg, 99%) as an off white solid. m.p. 70 – 72 °C (Lit. value 72 °C); max 
(ATR)/cm-1: 1752 (s) C=O, 1640 C=N; max (DCM)/nm: 320; δH (500 MHz, CDCl3): 8.30 
(1H, dd 3J 8 and 4J 1, H3’), 7.73 – 7.78 (1H, m, H4), 7.54 – 7.59 (2H, m, H6 and H5’), 7.43 
(1H, td 3J 8 and 4J 1, H4’), 7.33 – 7.40 (2H, m, H5 and H7), 7.25 (1H, dd 3J 8 and 4J 1, H6’), 
2.49 (3H, s, CH3); δC (125 MHz, CDCl3): 170.0 (C=O), 159.9 (C2’), 150.3 (C2), 149.4 (C1’), 
142.1 (QC), 132.5 (C5’), 130.4 (C3’), 126.6 (C4’), 125.5 and 124.7 (C5 and C7), 124.2 (C6’), 
120.6 (QC), 120.5 (C4), 110.6 (C6), 21.4 (Me); m/z (ES+): 254.1 [M+H]+ 
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Fluorescein dihexanoate, 78 
O OO
O O
O
O  
To a solution of fluorescein (300 mg, 0.90 mmol) in pyridine (5 ml) was added hexanoyl 
chloride (0.63 ml, 5.0 eq). A red-orange precipitate formed and this was stirred for 4 
hours. The suspension was poured onto ice and the resulting orange precipitate was 
taken up into chloroform. The solvent was removed under reduced pressure to yield a 
deep orange oil. Flash column chromatography (25% EtOAc:Petroleum ether) gave 78 
(320 mg, 67%) as a pale yellow oil. λmax (DCM)/cm-1: λex 490, λem 520; max (ATR)/cm-1: 
1611 (s), 1767 (s), 2959 (m); δH (400 MHz, CDCl3): 8.03 (1H, d 3J 7, H9), 7.61 – 7.70 (2H, 
m, H10 and H11), 7.18 (1H, d 3J 7, H12), 7.08 (2H, d 4J 2, H4 and H5), 6.78 – 6.83 (4H, m, 
H1, H2, H7 and H8), 2.56 (4H, t 3J 8, H2’), 1.72 – 1.79 (4H, m, H3’), 1.37 – 1.41 (8H, m, 
H4’ and H5’), 0.91 – 0.95 (6H, t 3J 8, H6’); δC (126 MHz, CDCl3): 171.9 (C=O), 169.3 
(C=O), 153.1 (C9a), 152.3 (C3 and C6), 151.7 (C4a and C5a), 135.4 (C11), 130.2 (C10), 
129.1 (C1 and C8), 126.2 (C12a), 125.3 (C9), 124.2 (C12), 117.9 (C2 and C7), 116.4 (C1a 
and C8a), 110.5 (C4 and C5), 81.9 (spiroC), 34.5 (C2’), 29.5 (sp3C), 29.4 (sp3C), 29.2 
(sp3C), 25.0 (C3’); m/z (ES+): 529.2 [M+H]+ 
Fluorescein didecanoate, 79 
O OO
O O
O
O  
To a solution of fluorescein (300 mg, 0.90 mmol) in pyridine (5 ml) was added decanoyl 
chloride (0.94 ml, 5.0 eq). An orange precipitate formed and this was stirred for 4 hours. 
The suspension was poured onto ice and the resulting orange precipitate was taken up 
into chloroform. The solvent was removed under reduced pressure to yield an orange 
oil. Flash column chromatography, gradient elution (25% EtOAc/petroleum ether to 
100% EtOAc) gave 79 (431 mg, 75%) as a pale yellow oil. max (ATR)/cm-1: 1611 (s), 1767 
(s), 2959 (m); δH (500 MHz, CDCl3): 8.03 (1H, d 3J 8, H9), 7.62 – 7.70 (2H, m, H10 and 
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H11), 7.18 (1H, d 3J 8, H12), 7.08 (2H, d 4J 2, H4 and H5), 6.78 – 6.84 (4H, m, H1, H2, H7 
and H8), 2.56 (4H, t 3J 8, H2’), 1.74 (4H, quin 3J 8, H3’), 1.27 – 1.42 (28H, m, H4’ – H9’), 
0.88 (6H, t 3J 8, H10’); δC (126 MHz, CDCl3): 171.9 (C1’), 169.3 (C=O), 153.1 (C9a), 152.3 
(C3 and C6), 151.7 (C4a and C5a), 135.4 (C11), 130.2 (C10), 129.1 (C1 and C8), 126.2 
(C12a), 125.3 (C9), 124.2 (C12), 117.9 (C2 and C7), 116.4 (C1a and C8a), 110.5 (C4 and 
C5), 81.9 (spiroC), 34.5 (C2’), 32.0 (C8’), 29.5 (sp3C), 29.4 (sp3C), 29.4 (sp3C), 29.2 (sp3C), 
25.0 (C3’), 22.8 (C9’), 14.2 (C10’); m/z (ES+): 641.3 [M+H]+ 
Fluorescein di(3,3-dimethyl)butanoate, 80 
O OO
O O
O
O  
To a solution of fluorescein (300 mg, 0.90 mmol) in pyridine (5 ml) was added 3,3-
dimethylbutanoyl chloride (0.63 ml, 5.0 eq). An orange precipitate formed and this was 
stirred for 4 hours. The suspension was poured onto ice and the resulting orange 
precipitate was taken up into chloroform. The solvent was removed under reduced 
pressure to yield an orange oil. Flash column chromatography, gradient elution (25% 
EtOAc/petroleum ether to 100% EtOAc) gave 80 (370 mg, 78%) as a yellow oil. max 
(ATR)/cm-1: 1611 (s), 1767 (s), 2959 (m); δH (500 MHz, CDCl3): 8.03 (1H, d 3J 8, H9), 7.61 
– 7.69 (2H, m, H10 and H11), 7.17 (1H, d 3J 8, H12), 7.07 (2H, d 4J 2, H4 and H5), 6.78 – 
6.84 (4H, m, H1, H2, H7 and H8), 2.44 (4H, s, H2’), 1.12 (18H, s, tBu); δC (126 MHz, 
CDCl3): 170.3 (C1’), 169.3 (C=O), 153.1 (C9a), 152.1 (C3 and C6), 151.6 (C4a and C5a), 
135.4 (C11), 130.1 (C10), 129.0 (C1 and C8), 126.2 (C12a), 125.3 (C9), 124.2 (C12), 118.0 
(C2 and C7), 116.4 (C1a and C8a), 110.5 (C4 and C5), 81.8 (spiroC), 47.8 (C2’), 31.3 (C3’), 
29.7 (tBu); m/z (ES+): 529.3 (94%) [M+H]+, 551.3 (100) [M+Na]+ 
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4-(tert-butyldimethylsilyloxy)benzaldehyde, 89 
O
CHO
Si
 
To a solution of 4-hydroxybenzaldehyde (500 mg, 4.10 mmol) in DCM (10 ml) at 0 °C 
was added DMAP (50 mg, 0.1 eq), Et3N (0.68 ml, 1.2 eq) and TBDMSCl (649 mg, 
1.05 eq). The resulting solution was allowed to warm to rt and stirred for 2 hours. 
Saturated aqueous sodium hydrogen carbonate (20 ml) was added, followed by brine 
(20 ml). The aqueous layer was separated and extracted with DCM (3 x 20 ml). The 
combined organic extracts were dried over MgSO4, filtered and concentrated under 
reduced pressure to yield a yellow oil. Flash column chromatography (30% 
EtOAc:Petroleum ether) gave 89 (600 mg, 65%) as a very pale yellow oil. max 
(ATR)/cm-1: 1722 (s) C=O, 1252 (s) Si-C; δH (500 MHz, CDCl3): 9.86 (1H, s, CHO), 7.76 
(2H, m, AA’ part of the AA’XX’ system, H2 and H6), 6.92 (2H, m, XX’ part of the 
AA’XX’ system, H3 and H5), 0.97 (9H, s, tBu), 0.22 (6H, s, 2 x Me); δC (126 MHz, CDCl3): 
190.9 (C=O), 161.6 (C1), 132.0 (C2 and C6), 130.5 (C4), 120.5 (C3 and C5), 25.6 (tBu), 18.3 
(QC), -4.3 (Me); m/z (ES+): 237.1304 ([M+H]+, C13H21O2Si requires 237.1305). 
1-(4-(tert-butyldimethylsilyloxy)phenyl)-3-phenylprop-2-yn-1-ol, 90 
O
Si
OH  
n-Butyllithium (1.6 M solution in hexane, 0.79 ml, 1.27 mmol) was added to a stirred 
solution of phenylacetylene (0.13 ml, 1.17 mmol) in THF (5 ml) at -78 °C. The resulting 
solution was left to stir for 15 minutes. 89 (250 mg, 1.06 mmol) was added and was 
allowed to warm to rt. This was left to stir for 1 hour. Saturated ammonium chloride 
solution (20 ml) was added. The aqueous layer was separated and extracted with ether 
(2 x 20 ml). The combined organic extracts were dried over MgSO4, filtered and 
concentrated under reduced pressure to yield a yellow oil. Flash column 
chromatography, gradient elution (100% petroleum ether to 100% EtOAc) gave 90 
(57 mg, 16%) as a pale yellow oil. max (ATR)/cm-1: 3310 (alkyne C-H), 2194 (C C), 1250 
(s) Si-C; δH (500 MHz, CDCl3): 7.47 - 7.49 (4H, m, H2, H6 and ArH), 7.32 – 7.33 (3H, m, 
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ArH), 6.86 (2H, m, AA’ part of the AA’XX’ system, H3 and H5), 5.62 (1H, d 3J 7, H1’), 
2.24 (1H, d 3J 7, OH), 0.99 (9H, s, tBu), 0.21 (6H, s, 2 x Me); δC (126 MHz, CDCl3): 156.1 
(C1), 133.6 (ArC), 131.8 (C2 and C6), 128.7 (ArC), 128.4 (C4), 128.3 (ArC), 122.6 (C4’), 
120.3 (C3 and C5), 89.0 (C2’), 86.6 (C3’), 64.9 (C1’), 25.8 (tBu), 18.4 (QC), -4.3 (Me); m/z 
(ES+): 321.1669 ([M-OH2]+, C21H25OSi requires 321.1669). 
1-(4-(tert-butyldimethylsilyloxy)phenyl)-3-phenylprop-2-ynyl 4-nitrophenylcarbamate, 91 
O
Si
O
O
H
N
NO2  
To a solution of 89 (50 mg, 0.15 mmol) in DCM (1 ml) was added Et3N (2 μL, 0.1 eq) and 
the mixture was allowed to stir for 15 mins. p-Nitrophenylisocyanate (26 mg, 1.1 eq) 
was added and the reaction was allowed to stir for 1 hour. Saturated ammonium 
chloride solution (10 ml) was added. The aqueous layer was separated and extracted 
with DCM (2 x 20 ml). The combined organic extracts were dried over MgSO4, filtered 
and concentrated under reduced pressure to yield a yellow oil. Flash column 
chromatography (3:1 DCM: Petroleum ether) gave 91 (26 mg, 35%) as a dark yellow oil. 
λmax (DCM)/nm: 371; δH (500 MHz, CDCl3): 8.12 – 8.15 (2H, m, A1A1’ part of the 
A1A1’X1X1’ system, H3” and H5”),  7.48 - 7.50 (2H, m, AA’ part of the AA’XX’ system, 
H2 and H6), 7.40 – 7.44 (2H, m, ArH), 7.38 – 7.44 (3H, m, ArH), 6.88 – 6.90 (2H, m, XX’ 
part of the AA’XX’ system, H3 and H5), 6.73 – 6.75 (2H, m, X1X1’ part of the A1A1’X1X1’ 
system, H2” and H6”), 5.52 (1H, d 5J 0.5, H1’), 4.83 (1H, br s, NH), 0.99 (9H, s, tBu), 0.22 
(6H, s, 2 x Me); δC (126 MHz, CDCl3): 156.3 (C1), 151.6 (C1”), 139.1 (C4”), 131.9 (ArC), 
130.7 (C4), 128.9 (C4’), 128.7 (ArC), 128.5 (C2 and C6), 126.3 (C3’’ and C5’’), 120.7 (C3 
and C5), 112.5 (C2’’ and C6’’), 86.8 (C2’), 85.8 (C3’), 49.7 (C1’), 25.8 (tBu), 18.4 (QC), -4.2 
(Me); m/z (ES+): 502.1918 ([M+], C28H30N2O5Si requires 502.1924). 
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4-(1-hydroxy-3-phenylprop-2-ynyl)phenol, 94 
HO
OH  
nBuLi (1.6 M in hexane, 2.3 ml, 3.69 mmol) was added to a solution of 4-
hydroxybenzaldehdye (500 mg, 4.1 mmol) in THF (10 ml) at -78 °C and left to stir for 5 
minutes. A solution of phenylacetylene (0.54 ml, 4.92 mmol) and nBuLi (1.6 M in 
hexane, 3.1 ml, 4.92 mmol) was added and the reaction was warmed to rt and left to stir 
for 90 minutes. Saturated ammonium chloride solution (20 ml) was added. The aqueous 
layer was separated and extracted with diethyl ether (2 x 10 ml). The combined organic 
extracts were dried over MgSO4, filtered and concentrated under reduced pressure to 
yield an orange oil. Flash column chromatography, (30% EtOAc/petroleum ether) gave 
94 (320 mg, 35%) as an off-white solid. max (ATR)/cm-1: 3341 (alkyne C-H), 3149 (OH), 
2231 (C C); δH (500 MHz, CDCl3): 8.57 (1H, s, ArOH), 7.39 – 7.41 (5H, m, H2, H6 and 
ArH), 7.25 – 7.27 (2H, m, ArH), 6.80 – 6.82 (2H, m XX’ part of AA’XX’ system, H3 and 
H5), 5.53 (1H, d 3J 7, H1’), 3.99 – 4.00 (1H, d 3J 7, OH); δC (126 MHz, CDCl3): 157.1 (C1), 
132.3 (C4), 131.6 (ArC), 128.3 (C2 and C6), 128.2 (ArC), 122.8 (ArC), 115.5 (C3 and C5), 
89.9 (C2’), 85.6 (C3’), 64.4 (C1’); m/z (ES+): 207.1 [M-(H2O)+H]+ 
4-Acetoxybenzaldehyde, 97 
O
CHO
O
 
4-Hydroxybenzaldehyde (500 mg, 4.1 mmol), Et3N (0.75 ml, 8.2 mmol) and DMAP (50 
mg, 0.41 mmol) were dissolved in DCM (10 ml) and stirred at rt for 20 minutes. The 
reaction was cooled to 0 °C and acetyl chloride (0.52 ml, 7.4 mmol) was added 
dropwise. A yellow-orange precipitate formed and this mixture was warmed to rt and 
left to stir for 45 minutes. Saturated aqueous sodium hydrogen carbonate (20 ml) was 
added, followed by brine (10 ml). The aqueous layer was separated and extracted with 
DCM (3 x 20 ml). The combined organic extracts were dried over MgSO4, filtered and 
concentrated under reduced pressure to yield 97 (670 mg, 99%) as a dark orange oil. 
This was used without further purification. δH (500 MHz, CDCl3): 9.99 (1H, s, CHO), 
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7.91 - 7.93 (2H, m, AA’ part of the AA’XX’ system, H2 and H6), 7.27 – 7.28 (2H, m, XX’ 
part of the AA’XX’ system, H3 and H5), 2.33 (3H, s, Me); δC (126 MHz, CDCl3): 191.1 
(aldehyde C=O), 168.9 (ester C=O), 155.5 (C4), 134.1 (C1), 131.3 (C2 and C6), 122.5 (C3 
and C5), 21.3 (Me); m/z (ES+): 180.2 [M+H]+ 
4-(1-hydroxy-3-phenylprop-2-ynyl)phenyl acetate, 98 
O
OH
O
 
95 (250 mg, mmol) and Et3N ( ml, mmol) were dissolved in DCM (5 ml) and stirred at 0 °C for 
10 minutes. Acetyl chloride ( ml, mmol) was added dropwise. A pale yellow precipitate formed 
and this mixture was left to stir at 0 °C for 15 minutes. Saturated aqueous sodium hydrogen 
carbonate (10 ml) was added, followed by brine (5 ml). The aqueous layer was 
separated and extracted with DCM (3 x 10 ml). The combined organic extracts were 
dried over MgSO4, filtered and concentrated under reduced pressure to yield a yellow 
oil. Flash column chromatography (20% EtOAc:Petroleum ether) gave 98 (212 mg, 71%) 
as a yellow oil. max (ATR)/cm-1: 3337 (alkyne C-H), 3150 (OH), 2230 (C C), 1744 (C=O); 
δH (500 MHz, CDCl3): 7.60 – 7.62 (2H, m AA’ part of AA’XX’ system, H2 and H6), 7.46 – 
7.48 (2H, m, ArH), 7.27 – 7.33 (3H, m, ArH), 7.11 – 7.13 (2H, m XX’ part of AA’XX’ 
system, H3 and H5), 6.69 (1H, s, H1’), 2.30 (3H, s, Me); δC (126 MHz, CDCl3): 169.9 
(C=O), 151.0 (C4), 138.7 (C1), 132.1 (ArC), 129.1 (ArC), 128.7 (ArC), 128.3 (C2 and C6), 
122.7 (ArC), 122.1 (C3 and C5), 88.9 (C2’), 87.2 (C3’), 64.9 (C1’), 21.5 (Me); m/z (ES+): 
249.1 [(M-H2O)+Na]+ 
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4-(1-(4-nitrophenylcarbamoyloxy)-3-phenylprop-2-ynyl)phenyl acetate, 96 
O
O
O
O
H
N
NO2  
To a solution of 99 (170 mg,  0.62 mmol) in DCM (5 ml) was added Et3N (0.1 ml, 0.1 eq) 
and the mixture was allowed to stir for 15 mins. p-Nitrophenylisocyanate (111 mg, 1.1 
eq) was added and the reaction was allowed to stir for 1 hour. Saturated ammonium 
chloride solution (10 ml) was added. The aqueous layer was separated and extracted 
with DCM (2 x 20 ml). The combined organic extracts were dried over MgSO4, filtered 
and concentrated under reduced pressure to yield a yellow oil. Flash column 
chromatography (20% EtOAc: Petroleum ether) gave 96 (173 mg, 65%) as a yellow solid. 
λmax (DCM)/nm: 331; δH (500 MHz, CDCl3): 8.13 – 8.15 (2H, m A1A1’ part of the 
A1A1’X1X1’ system, H3’’ and H5’’),  7.62 - 7.64 (3H, m, H2, H6 and NH), 7.53 – 7.55 (2H, 
m XX’ part of the AA’XX’ system, H3 and H5), 7.45 – 7.47 (2H, m, ArH), 7.29 – 7.36 (3H, 
m, ArH), 7.12 – 7.14 (2H, m X1X1’ part of the A1A1’X1X1’ system, H2’’ and H6’’), 6.71 
(1H, s, H1’), 2.31 (3H, s, Me); δC (126 MHz, CDCl3): 151.9 (C=O), 151.3 (C=O), 143.9 
(C1’’), 143.1 (C4’’), 134.3 (C1), 132.0 (ArC), 129.3 (C2 and C6), 129.2 (ArC), 128.5 (ArC), 
125.2 (C3’’ and C5’’), 122.1 (C3 and C5), 121.7 (ArC), 118.0 (C2” and C6”), 88.2 (C3’), 84.7 
(C2’), 67.2 (C1’), 21.2 (Me); m/z (ES+): 431.2 [M+H]+  
1-(4-methoxyphenyl)-3-phenylprop-2-yn-1-ol, 106 
MeO
OH  
n-Butyllithium (1.6 M solution in hexane, 2.76 ml, 4.41 mmol) was added to a stirred 
solution of phenylacetylene (0.48 ml, 4.41 mmol) in THF (10 ml) at -78 °C. The resulting 
solution was left to stir for 15 minutes. p-anisaldehyde (0.45 ml, 3.68 mmol) was added 
and allowed to warm to rt. This was left to stir for 1 hour. Saturated ammonium 
chloride solution (20 ml) was added. The aqueous layer was separated and extracted 
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with ether (2 x 20 ml). The combined organic extracts were dried over MgSO4, filtered 
and concentrated under reduced pressure to yield a yellow oil. Flash column 
chromatography (25% EtOAc/petroleum ether) gave 106 (429 mg, 49%) as a cream 
solid. max (ATR)/cm-1: 3334 (alkyne C-H), 2254 (C C); δH (500 MHz, CDCl3): 7.54 - 7.56 
(2H, m, AA’ part of the AA’XX’ system, H2 and H6), 7.47 – 7.49 (2H, m, ArH), 7.32 – 
7.33 (3H, m, ArH), 6.92 – 6.94 (2H, m, XX’ part of the AA’XX’ system, H3 and H5), 5.64 
(1H, d 3J 7, H1’), 3.82 (3H, s, Me), 2.30 (1H, d 3J 7, OH); δC (126 MHz, CDCl3): 159.8 (C4), 
133.1 (C1), 131.9 (ArC), 128.7 (ArC), 128.4 (C2 and C6), 128.3 (ArC), 122.6 (C4’), 114.1 
(C3 and C5), 89.0 (C2’), 86.6 (C3’), 64.9 (C1’), 55.5 (Me); m/z (ES+): 221.1 [M-H2O]+ 
1-(4-methoxyphenyl)-3-phenylprop-2-ynyl 4-nitrophenylcarbamate, 105 
MeO
O
O
H
N
NO2  
Et3N (0.01 ml, 0.1 mmol) was added to a stirring solution of 106 (250 mg, 1.04 mmol) in 
DCM (2 ml) and the resulting reaction was stirred for 10 minutes. p-
Nitrophenylisocyanate (189 mg, 1.15 mmol) was added and stirring was continued for 1 
hour. Saturated ammonium chloride solution (20 ml) was added. The aqueous layer 
was separated and extracted with DCM (2 x 10 ml). The combined organic extracts were 
dried over MgSO4, filtered and concentrated under reduced pressure to yield a yellow 
solid. Flash column chromatography, (3:1 DCM:hexane) gave 105 (195 mg, 47%) as a 
yellow solid. λmax (DCM)/nm: 369; δH (500 MHz, CDCl3): 8.12 – 8.14 (2H, m A1A1’ part 
of the A1A1’X1X1’ system, H3” and H5”), 7.54 – 7.56 (2H, m AA’ part of the AA’XX’ 
system, H2 and H6), 7.41 – 7.43 (2H, m, ArH), 7.30 – 7.33 (3H, m, ArH), 6.95 – 6.97 (2H, 
m XX’ part of the AA’XX’ system, H3 and H5), 6.73 – 6.74 (2H, m X1X1’ part of the 
A1A1’X1X1’ system, H2” and H6”), 5.54 (1H, d 5J 6, H1’), 4.86 (1H, d 5J 6, NH), 3.84 (3H, 
s, Me); δC (126 MHz, CDCl3): 160.0 (C4), 151.6 (C1”), 139.2 (C4”), 131.9 (ArC), 130.2 (C1), 
128.9 (ArC), 128.7 (ArC), 128.5 (C2 and C6), 126.3 (C3” and C5”), 122.3 (C4’), 114.6 (C3 
and C5), 112.5 (C2” and C6”), 86.8 (C2’), 85.9 (C3’), 55.5 (Me), 49.7 (C1’); m/z (ES+): 403.1 
[M+H]+ 
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1-(4-methoxyphenyl)-3-phenyl-3-(phenylthio)propan-1-one, 107 
MeO
O S
 
105 (150 mg, 0.37 mmol), thiophenol (0.03 ml, 0.37 mmol), KF (2 mg, 0.04 mmol) and 
NMP (0.5 ml) were heated to 100 °C for 1 hour, during which time the solution became 
a deep orange colour. The reaction was allowed to cool to rt and adjusted to pH 14 with 
5% aqueous NaOH (5 ml). The aqueous layer was separated and extracted with diethyl 
ether (3 x 5 ml). The combined aqueous extracts were acidified in an ice bath with 6 M 
HCl (2 ml) and extracted with diethyl ether (3 x 5 ml). The combined organic extracts 
were washed with brine (5 ml), dried over MgSO4, filtered and concentrated under 
reduced pressure to yield a yellow oil. Flash column chromatography (25% 
EtOAc/Petroleum ether) gave 107 (14 mg, 49%) as a yellow solid. max (ATR)/cm-1: 
2972w, 1668s (C=O), 1599s; λmax (CDCl3)/nm: λex 371, λem 440; δH (500 MHz, CDCl3): 
7.86 – 7.88 (2H, m, AA’ part of the AA’XX’ system, H2 and H6), 7.31 – 7.34 (4H, m, 
ArH), 7.21 – 7.25 (6H, m, ArH), 6.89 – 6.91 (2H, m, XX’ part of the AA’XX’ system, H3 
and H5), 4.94 (1H, dd 3J 9 and 3J 6, H3’), 3.85 (3H, s, OMe), 3.50 (1H, dd 3J 9 and 3J 6, H2’), 
3.59 (1H, dd 3J 9 and 3J 6, H2’); δC (126 MHz, CDCl3): 195.6 (C=O), 163.7 (C4), 141.4 
(ArC), 134.5 (ArC), 132.8 (ArC), 130.5 (C2 and C6), 130.0 (C1), 129.0 (ArC), 128.6 (ArC), 
127.9 (ArC), 127.6 (ArC), 127.5 (ArC), 113.9 (C3 and C5), 55.6 (OMe), 48.5 (C3’), 44.4 
(C2’); m/z (ES+): 349.1257 ([M+H]+, C22H21O2S requires 349.1257) 
(1-(4-methoxyphenyl)-3-phenylprop-2-ynyl)phenylsulfane, 108 
MeO
S
 
105 (39 mg, 0.1 mmol), thiophenol (0.01 ml, 0.1 mmol), KF (1 mg, 0.01 mmol) and NMP 
(0.5 ml) were stirred at rt for 1 hour. The reaction was adjusted to pH 14 with 5% 
aqueous NaOH (5 ml). The aqueous layer was separated and extracted with diethyl 
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ether (3 x 5 ml). The combined aqueous extracts were acidified in an ice bath with 6 M 
HCl (2 ml) and extracted with diethyl ether (3 x 5 ml). The combined organic extracts 
were washed with brine (5 ml), dried over MgSO4, filtered and concentrated under 
reduced pressure to yield a yellow oil. Flash column chromatography (20% 
EtOAc/petroleum ether) gave 108 (17 mg, 52%) as a yellow oil. max (ATR)/cm-1: 2233 
(C C); δH (500 MHz, CDCl3): 7.49 – 7.51 (4H, m, ArH), 7.37 – 7.39 (4H, m, ArH and AA’ 
part of the AA’XX’ system, H2 and H6), 7.30 – 7.32 (4H, m, ArH), 6.85 – 6.87 (2H, m, XX’ 
part of the AA’XX’ system, H3 and H5), 5.21 (1H, s, H1’), 3.81 (3H, s, OMe); δC (126 
MHz, CDCl3): 159.4 (C4), 137.2 (ArC), 134.5 (ArC), 130.2 (C1), 129.4 (C2 and C6), 128.8 
(ArC), 128.4 (ArC), 127.6 (ArC), 127.3 (ArC), 114.0 (C3 and C5), 87.8 (C2’), 86.8 (C3’), 
55.5 (OMe), 43.9 (C1’); m/z (ES+): 331.1153 ([M+H]+, C22H19OS requires 331.1151) 
(E)-1-(4-methoxyphenyl)-3-phenylprop-2-en-1-one, 109 
MeO
O  
BBr3 (0.02 ml, 0.12 mmol) in DCM (0.5 ml) was added to a solution of 105 (50 mg, 0.12 
mmol) in DCM (1 ml) at -78 °C. The solution was allowed to slowly warm up to rt and 
left to stir for 16 hours. Water (5 ml) was added. The aqueous layer was separated and 
extracted with diethyl ether (2 x 20 ml). The combined organic extracts were dried over 
MgSO4, filtered and concentrated under reduced pressure to yield a yellow oil. Flash 
column chromatography (20% EtOAc: Petroleum ether) gave 109 (14mg, 49%) as a 
yellow oil. δH (500 MHz, CDCl3): 7.89 – 7.90 (2H, m, ArH), 7.72 (1H, d 3J 15, H2’), 7.53 – 
7.55 (2H, m, AA’ part of the AA’XX’ system, H2 and H6), 7.42 – 7.45 (3H, m, ArH), 7.35 
(1H, d 3J 15, H3’), 6.86 – 6.89 (2H, m, XX’ part of the AA’XX’ system, H3 and H5), 3.79 
(3H, s, OMe); δC (126 MHz, CDCl3): 190.8 (C=O), 161.8 (C4), 144.9 (ArC), 138.7 (ArC), 
132.1 (ArC), 130.4 (C2 and C6), 128.7 (C1), 128.6 (ArC), 114.6 (C3 and C5), 55.6 (OMe), 
41.5 (C2’), 38.9 (C3’); m/z (ES+): 239.2 [M+H]+  
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4-(methoxymethyl)benzaldehyde, 110 
O
CHO
O
 
To a solution of 4-hydroxybenzaldehyde (1 g, 8.20 mmol) in DCM (10 ml) was added 
diisopropylamine (1.57 ml, 9.84 mmol) and the resulting solution was stirred for 10 
minutes at 0 °C. MOMCl was added dropwise over a period of 5 minutes and stirred 
for a further 2 hours. Saturated aqueous sodium hydrogen carbonate (20 ml) was 
added, followed by brine (20 ml). The aqueous layer was separated and extracted with 
DCM (3 x 20 ml). The combined organic extracts were dried over MgSO4, filtered and 
concentrated under reduced pressure to yield 110 (1.34 g, 99%) as a very pale yellow oil. 
This was used without further purification. δH (500 MHz, CDCl3): 9.89 (1H, s, CHO), 
7.82 – 7.83 (2H, m, AA’ part of the AA’XX’ system, H2 and H6), 7.12 – 7.14 (2H, m, XX’ 
part of the AA’XX’ system, H3 and H5), 5.24 (2H, s, CH2), 3.48 (3H, s, CH3); δC (126 
MHz, CDCl3): 191.0 (C=O), 162.0 (C4), 132.0 (C2 and C6), 130.8 (C1), 116.4 (C3 and C5), 
94.2 (CH2), 56.5 (CH3); m/z (ES+): 167.0703 ([M+H]+, C9H11O3 requires 167.0703) 
1-(4-methoxymethyl)phenyl)-3-phenylprop-2-yn-1-ol, 111 
OO
OH  
Phenylacetylene (0.78 ml, 6.63 mmol) and nBuLi (2.5 M in hexane, 2.89 ml, 7.23 mmol) 
were stirred in THF (10 ml) at -78 °C for 15 minutes. 110 (1 g, 6.02 mmol) was added as 
a solution in THF (5 ml) and this was left to stir for 1 hour. Saturated ammonium 
chloride solution (20 ml) was added. The aqueous layer was separated and extracted 
with diethyl ether (3 x 20 ml). The combined organic extracts were dried over MgSO4, 
filtered and concentrated under reduced pressure to yield 111 (1.55 g, 96%) as a yellow 
oil. This was used without further purification. δH (500 MHz, CDCl3): 7.53 – 7.55 (2H, 
m, AA’ part of the AA’XX’ system, H2 and H6), 7.46 – 7.54 (2H, m, ArH), 7.31 – 7.33 
(3H, m, ArH), 7.06 – 7.08 (2H, m, XX’ part of the AA’XX’ system, H3 and H5), 5.64 (1H, 
s, H1’), 5.24 (2H, s, CH2), 3.48 (3H, s, CH3), 2.60 (1H, br s, OH); δC (126 MHz, CDCl3): 
157.4 (C4), 134.3 (C1), 131.8 (ArC), 128.7 (ArC), 128.4 (ArC), 128.3 (C2 and C6), 122.6 
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(ArC), 116.4 (C3 and C5), 94.6 (CH2), 89.0 (C3’), 86.6 (C2’), 64.7 (C1’), 56.5 (CH3); m/z 
(ES+): 251.1068 ([(M-H2O)+H]+, C17H15O2 requires 251.1067) 
1-(4-(methoxymethyl)phenyl)-3-phenylprop-2-ynyl 4-nitrophenylcarbamate, 112 
OO
O
O
H
N
NO2  
111 (1 g, 3.73 mmol) and Et3N (0.05 ml, 0.37 ml) was stirred in DCM (4 ml) for 10 
minutes. p-Nitrophenylisocyanate (673 mg, 4.10 mmol) was added and the reaction was 
stirred for 1 hour. Saturated ammonium chloride solution (5 ml) was added. The 
aqueous layer was separated and extracted with DCM (3 x 10 ml). The combined 
organic extracts were dried over MgSO4, filtered and concentrated under reduced 
pressure to yield an orange oil. Flash column chromatography (20% EtOAc: Petroleum 
ether) gave 112 (558 mg, 35%) as a yellow oil. λmax (CHCl3)/nm: 364; δH (400 MHz, 
CDCl3): 8.11 – 8.13 (2H, m, AA’ part of the AA’XX’ system, H3’’ and H5’’), 7.54 – 7.56 
(2H, m, AA’ part of the AA’XX’ system, H2 and H6), 7.41 – 7.43 (2H, m, ArH), 7.30 – 
7.33 (3H, m, ArH), 7.09 – 7.11 (2H, m, XX’ part of the AA’XX’ system, H3 and H5), 6.71 – 
6.74 (2H, m, XX’ part of the AA’XX’ system, H2’’ and H6’’), 5.54 (1H, d 5J 8, H1’), 5.20 
(2H, s, CH2), 4.95 (1H, d 5J 8, NH), 3.49 (3H, s, CH3); δC (126 MHz, CDCl3): 157.9 (C4), 
151.8 (C1”), 139.1 (C4”), 132.0 (ArC), 131.2 (C1), 128.7 (ArC), 128.4 (ArC), 128.3 (C2 and 
C6), 126.6 (C3” and C5”), 122.4 (C4’), 116.9 (C3 and C5), 112.9 (C2” and C6”), 94.5 (CH2), 
86.1 (C3’), 87.3 (C2’), 56.4 (Me), 49.5 (C1’); m/z (ES+): 433.3 [M+H+]+ 
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4-Nitro-7-(3'-bromophenoxy) benzofurazan, 113 
N
O
N
O
NO2
Br
 
To a solution of NaOH (30 mg, 0.75 mmol) in THF:H2O (5 ml) at 0 °C was added 
3-bromophenol (1.3 g, 15.0 eq). The resulting solution was stirred for 10 mins, during 
which time a white colour developed. NBD-Cl (150 mg, 1.0 eq) was added, upon which 
the solution became orange, and this was stirred for 2 hours. Saturated aqueous sodium 
hydrogen carbonate (20 ml) was added. The aqueous layer was separated and extracted 
with ether (2 x 20 ml). The combined organic extracts were dried over MgSO4, filtered 
and concentrated under reduced pressure to yield an orange oil. Flash column 
chromatography (75% DCM:Petroleum ether) gave 113 (159 mg, 32%) as a yellow solid. 
m.p. 110 – 113 °C; δH (500 MHz, CDCl3): 8.45 (1H, d 3J 8, H5), 7.54 – 7.55 (2H, m, ArH), 
7.41 – 7.45 (1H, m, ArH), 7.22 – 7.24 (1H, m, ArH), 6.60 (1H, d 3J 8, H6); δC (126 MHz, 
CDCl3): 152.7 (QC), 153.4 (QC), 145.2 (QC), 144.3 (QC), 133.2 (QC), 132.0 (C5), 131.3 
(ArC), 130.7 (ArC), 124.5 (ArC), 123.8 (ArC), 119.8 (ArC), 108.3 (C6). 
8-(4’-bromophenyl)-dipyrromethane, 120174 
HNNH
Br
 
TFA (0.02 ml, 0.27 mmol) was added to a stirred solution of 4-bromobenzaldehyde 
(500 mg, 2.70 mmol) in pyrrole (4.72 ml, 67.6 mmol) with the evolution of a white gas. 
The resulting solution was stirred for 10 minutes. 0.1 M NaOH (30 ml) was added and 
the aqueous layer separated and extracted with EtOAc (2 x 30 ml). The combined 
organic extracts were dried over MgSO4, filtered and concentrated under reduced 
pressure to yield a brown oil. Flash column chromatography, gradient elution (100% 
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Petrol 40/60 to 50% EtOAc/petrol 40/60) gave 120 (465 mg, 58%) as a pale brown solid. 
m.p. 138 – 141 °C; δH (500 MHz, CDCl3): 7.90 (2H, br s, NH), 7.43 – 7.45 (2H, m AA’ part 
of AA’XX’ system, H3’ and H5’), 7.08 – 7.10 (2H, m XX’ part of AA’XX’ system, H2’ and 
H6’), 6.70 – 6.71 (2H, m, pyH), 6.16 – 6.18 (2H, m, pyH), 5.89 – 5.90 (2H, m, pyH), 5.43 
(1H, s, H8); δC (126 MHz, CDCl3): 141.3 (C1’), 132.0 (pyC), 131.8 (C3’ and C5’), 130.3 (C2’ 
and C6’), 121.0 (pyC), 117.6 (pyC), 108.7 (pyC), 107.8 (pyC), 43.6 (C8); m/z (ES+): 300.8 
[M+H+]+ 
8-(4-bromophenyl)-dipyrromethene, 121172 
NNH
Br
 
A suspension of p-chloranil (1.50 mmol, 369 mg) in DCM was added to a solution of 120 
(1.50 mmol, 455 mg) in DCM (6 ml) and left to stir for 1 hour. The solvent was removed 
under reduced pressure to yield a brown solid. Flash column chromatography, gradient 
elution (100% Petrol 40/60 to 100% EtOAc) gave 121 (54 mg, 12%) as a brown oil. δH 
(500 MHz, CDCl3): 7.66 – 7.66 (2H, m, pyH), 7.58 – 7.60 (2H, m AA’ part of AA’XX’ 
system, H3’ and H5’), 7.35 – 7.38 (2H, m XX’ part of AA’XX’ system, H2’ and H6’), 6.56 
– 6.58 (2H, dd 3J 4 and 4J 1, pyH), 6.40 – 6.42 (2H, dd 3J 4 and 4J 2, pyH); m/z (ES+): 299.5 
[M+H]+ 
4,4-difluoro-8-(4-bromophenyl)-4-bora-3a,4a-diaza-s-indacene, 116 
N
B
N
FF
Br
 
4-bromobenzaldehyde (500 mg, 2.70 mmol) and pyrrole (362 mg, 5.40 mmol) were 
dissolved in DCM (15 ml). One drop of TFA was added and the reaction stirred for 2 
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hours. A suspension of DDQ (610 mg, 2.70 mmol) in DCM was added and the stirring 
was continued for 15 minutes. DIPEA (0.71 ml, 4.05 mmol) and BF3•OEt2 (0.86 ml, 5.40 
mmol) was added and the reaction was stirred for 30 minutes. The reaction mixture 
was washed with water (20 ml), dried over MgSO4, filtered and concentrated under 
reduced pressure to yield a black solid. Flash column chromatography (50% 
DCM/hexane) gave 116 (9 mg, 2%) as a brown solid. m.p. 194 – 197 °C; λmax 
(CHCl3)/nm: λex 504, λem 520; δH (500 MHz, CDCl3): 7.96 (2H, s, H3 and H5), 7.68 – 7.69 
(2H, m AA’ part of AA’XX’ system, H3’ and H5’), 7.44 – 7.46 (2H, m XX’ part of AA’XX’ 
system, H2’ and H6’), 6.91 (2H, d 3J 4, H2 and H6), 6.56 (2H, d 3J 4, H1 and H7); δF (376 
MHz, CDCl3): -145.3 - -145.6 (m); m/z (ES+): 347.4 [M+H]+ 
4,4-difluoro-1,3,5,7-tetramethyl-8-phenyl-4-bora-3a,4a-diaza-s-indacene, 122 
N
B
N
FF  
Benzoyl chloride (200 mg, 1.42 mmol) and 2,4-dimethylpyrrole (0.29 ml, 2.84 mmol) 
were dissolved in DCM (10 ml) and refluxed for 3 hours, after which time the solution 
became deep red. After cooling to rt Et3N (0.36 ml, 2.56 mmol) and BF3•OEt2 (0.49 ml, 
3.84 mmol) were added and the reaction stirred for 3 hours. Water (20 ml) was added 
and the aqueous layer was separated and extracted with DCM (2 x 20 ml). The 
combined organic extracts were dried over MgSO4, filtered and concentrated under 
reduced pressure to yield an orange solid. Flash column chromatography (50% 
DCM/hexane) followed by recrystallisation (CHCl3/hexane) gave 122 (78 mg, 17%) as a 
crystalline orange solid. m.p. 150 – 152 °C; max (ATR)/cm-1: 1465m (B-F); λmax 
(acetone)/nm: λex 498, λem 508; δH (500 MHz, CDCl3): 7.46 – 7.48 (3H, m, ArH), 7.27 – 
7.28 (2H, m, ArH), 5.97 (2H, s, H2 and H6), 2.55 (6H, s, C3Me and C5Me), 1.36 (6H, s, 
C1Me and C7Me); δC (126 MHz, CDCl3): 155.5 (C3 and C5), 143.3 (C1 and C7), 141.8 
(C8), 135.1 (C1’), 131.5 (C1a and C7a), 129.2 (ArC), 129.0 (ArC), 128.4 (ArC), 128.2 (ArC), 
128.0 (ArC), 121.3 (C2 and C6), 14.7 (C1Me and C7Me), 14.4 (C3Me and C5Me); δF (376 
MHz, CDCl3): -146.8 - -146.4 (m); δB (128 MHz, CDCl3): 0.78 (t, JB-F 31); m/z (ES+): 
325.16787 (20%) ([M+H]+, C19H20N2BF2 requires 325.16821), 347.1497 (100) ([M+Na]+, 
C19H19N2BF2Na requires 347.1501). 
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4,4-difluoro-1,3,5,7-tetramethyl-8-(4-nitrophenyl)-4-bora-3a,4a-diaza-s-indacene, 126 
NO2
N
B
N
FF  
4-Nitrobenzoyl chloride (300 mg, 1.62 mmol) and 2,4-dimethylpyrrole (0.38 ml, 3.23 
mmol) were dissolved in DCM (10 ml) and refluxed for 4 hours, after which time the 
solution became deep red. After cooling to rt Et3N (0.36 ml, 2.56 mmol) and BF3•OEt2 
(0.49 ml, 3.84 mmol) were added and the reaction stirred for 16 hours. Water (20 ml) 
was added and the aqueous layer was separated and extracted with DCM (2 x 20 ml). 
The combined organic extracts were dried over MgSO4, filtered and concentrated under 
reduced pressure to yield an orange solid. Flash column chromatography (50% 
DCM/hexane) followed by recrystallisation (CHCl3/hexane) gave 126 (179 mg, 30%) as 
a crystalline red solid. m.p. 169 – 170 °C; λmax (acetone)/nm: 502; max (ATR)/cm-1: 1516s 
and 1343s (NO2), 1468m (B-F); Found: C, 55.82 H, 4.52 N, 10.19; Calc. for 
C19H18BF2N3O2.0.4CHCl3: C, 55.82 H, 4.44 N, 10.06; δH (500 MHz, CDCl3): 8.38 – 8.40 
(2H, m, AA’ part of the AA’XX’ system, H3’ and H5’),  7.53 - 7.55 (2H, m, XX’ part of the 
AA’XX’ system, H2’ and H6’), 6.02 (2H, s, H2 and H6), 2.56 (6H, s, C3Me and C5Me), 
1.34 (6H, s, C1Me and C7Me); δC (126 MHz, CDCl3): 156.8 (C5 and C3), 148.5 (C4’), 142.7 
(C7 and C1), 142.1 (C8), 138.5 (C1’), 130.8 (C1a and C7a), 129.8 (C2’ and C6’), 124.5 (C3’ 
and C5’), 122.0 (C2 and C6), 14.9 (C3Me and C5Me), 14.8 (C1Me and C7); δF (376 MHz, 
CDCl3): -146.8 - -146.5 (m); δB (128 MHz, CDCl3): 0.70 (t, JB-F 31); m/z (ES+): 370.1529 
(M+H+, requires 370.15329) (M+, C22H21O2S requires 349.1257) 
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4,4-difluoro-1,3,5,7-tetramethyl-8-(2-methoxy-4-nitrophenyl)-4-bora-3a,4a-diaza-s-
indacene, 127 
NO2
N
B
N
FF
OMe
 
To a stirring solution of 2-methoxy-4-nitrobenzoic acid (300 mg, 1.52 mmol) in DCM 
(10 ml) was added oxalyl chloride (0.52 ml, 6.09 mmol) and 2 drops of DMF. This was 
left to stir until no more effervescence was seen. Oxalyl chloride and the solvent were 
removed under reduced pressure to afford a pale yellow solid. This was redissolved in 
DCM (10 ml) and 2,4-dimethylpyrrole (0.31 ml, 3.04 mmol) was added and the resulting 
solution refluxed for 3 hours, after which time the solution became deep red. After 
cooling to rt Et3N (0.38 ml, 2.74 mmol) and BF3•OEt2 (0.52 ml, 4.11 mmol) were added 
and the reaction stirred for 3 hours. Water (20 ml) was added and the aqueous layer 
was separated and extracted with DCM (2 x 20 ml). The combined organic extracts were 
dried over MgSO4, filtered and concentrated under reduced pressure to yield an orange 
solid. Flash column chromatography (50% DCM/hexane) followed by recrystallisation 
(CHCl3/hexane) gave 127 (133 mg, 22%) as a crystalline orange solid. λmax 
(acetone)/nm: 502; max (ATR)/cm-1: 1518s and 1346s (NO2), 1468m (B-F); δH (500 MHz, 
CDCl3): 8.00 (1H, dd 3J 8 and 4J 2, H5’), 7.86 (1H, d 4J 2, H3’), 7.38 (1H, d, 3J 8, H6’), 5.99 
(2H, s, H2 and H6), 3.90 (3H, s, OMe), 2.56 (6H, s, C3Me and C5Me), 1.42 (6H, s, C1Me 
and C7Me); δC (126 MHz, CDCl3): 157.9 (C2’), 156.5 (C3 and C5), 150.1 (C4’), 142.4 (C1 
and C7), 136.0 (C8), 131.3 (C6’), 131.1 (C1a and C7a), 131.0 (C1’), 121.8 (C2 and C6), 
117.0 (C5’), 106.6 (C3’), 56.8 (OMe), 15.1 (C3Me and C5Me), 14.5 (C1Me and C7Me); δB 
(128 MHz, CDCl3): 0.74 (t, JB-F 31); δF (376 MHz, CDCl3): -146.8 - -147.1 (m); m/z (ES+): 
400.1633 ([M+H]+, C20H21N3O3 BF2 requires 400.1639). 
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2-acetoxybenzoic acid, 134 
COOH
O
O  
Salicylic acid (200 mg, 1.45 mmol) was dissolved in acetic anhydride (2 ml). 3 drops of 
phosphoric acid was added and the resulting solution was stirred for 10 minutes at 
60 °C. Water (8 ml) was slowly added. The reaction was cooled in an ice bath which 
yielded 134 (217 mg, 83%) as white crystals. m.p. 134 – 135 °C; max (ATR)/cm-1: 2950(s) 
OH, 1750(s) ester C=O, 1700(s) acid C=O; Found: C, 59.73 H, 4.47; Calc. for C9H8O4: C, 
60.00 H, 4.48; δH (500 MHz, CDCl3): 8.12 (1H, dd 3J 8 and 4J 2, H6), 7.62 (1H, td 3J 8 and 
4J 1, H4), 7.36 (1H, td 3J 8 and 4J 1, H5), 7.14 (1H, dd 3J 8 and 4J 2, H3), 2.35 (3H, s, Me); δC 
(126 MHz, CDCl3): 170.1 (C=O), 169.9 (C=O), 151.4 (C2), 135.1 (C4), 132.7 (C6), 126.3 
(C5), 124.2 (C3), 122.3 (C1), 21.2 (Me); HRMS (ES-): 179.0350 (95%) ([M-H]-, C9H7O4 
requires 179.0350), 137.0244 (5) ([M-Ac]-, C7H5O3 requires 137.0244) 
1,3,5,7-tetramethyl-8-(4-nitrophenyl)-dipyrromethene, 136 
NO2
NNH
 
4-Nitrobenzoyl chloride (500 mg, 2.69 mmol) and 2,4-dimethylpyrrole (0.55 ml, 5.39 
mmol) were dissolved in DCM (10 ml) and refluxed for 4 hours, after which time the 
solution became deep red. Water (20 ml) was added and the aqueous layer was 
separated and extracted with DCM (3 x 20 ml). The combined organic extracts were 
dried over MgSO4, filtered and concentrated under reduced pressure to yield a brown 
solid. Flash column chromatography (DCM, alumina) followed by recrystallisation 
(CHCl3/hexane) gave 136 (125 mg, 15%) as a brown solid. Found: C, 70.44 H, 6.19 N, 
12.39; Calc. for C19H19N3O2.0.03 CHCl3: C, 70.45 H, 5.91 N, 12.95; max (ATR)/cm-1: 
1512(s) and 1350(s) NO2; δH (500 MHz, CDCl3): 8.33 – 8.35 (2H, m, AA’ part of the 
AA’XX’ system, H3’ and H5’), 7.51 – 7.53 (2H, m, XX’ part of the AA’XX’ system, H2’ 
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and H6’), 5.90 (2H, s, H2 and H6), 2.35 (6H, s, C3Me and C5Me), 1.27 (6H, s, C1Me and 
C7Me); δC (126 MHz, CDCl3): 152.6 (C5 and C3), 148.0 (C4’), 145.3 (C7 and C1), 139.7 
(C8), 135.7 (C1’), 135.5 (C1a and C7a), 130.8 (C2’ and C6’), 123.9 (C3’ and C5’), 120.4 (C2 
and C6), 16.2 (C3Me and C5Me), 15.0 (C1Me and C7Me); m/z (ES+): 322.1551 ([M+H]+, 
C19H19N3O2BF2 requires 322.1550). 
1,3,5,7-tetramethyl-8-(4-aminophenyl)-dipyrromethene, 137 
NH N
NH2
 
136 (100 mg, 0.31 mmol) was dissolved in DCM which had been saturated with 
concentrated HCl and stirred for 30 minutes at 0 °C. SnCl2.2H2O (1.4 g, 6.23 mmol) was 
added and the reaction was warmed to rt and left to stir for 16 hours. 2M NaOH (10 ml) 
was added and the aqueous layer separated and extracted with DCM (2 x 20 ml). The 
combined organic extracts were dried over MgSO4, filtered and concentrated under 
reduced pressure to yield a dark orange oil. Flash column chromatography (DCM) gave 
137 (32 mg, 35%) as an orange oil. δH (400 MHz, CDCl3): 7.03 – 7.05 (2H, m, AA’ part of 
the AA’XX’ system, H2’ and H6’),  6.72 – 6.74 (2H, m, XX’ part of the AA’XX’ system, 
H3’ and H5’), 5.91 (2H, s, H2 and H6), 3.82 (2H, br s, NH2), 2.36 (6H, s, C3Me and 
C5Me), 1.42 (6H, s, C1Me and C7Me); δC (126 MHz, CDCl3): 154.9 (C5 and C3), 147.1 
(C4’), 143.3 (C7 and C1), 129.1 (C8), 124.9 (C1’), 121.1 (C1a and C7a), 115.9 (C2’ and C6’), 
124.2 (C3’ and C5’), 120.6 (C2 and C6), 14.9 (C3Me and C5Me), 14.7 (C1Me and C7Me);  
m/z (ES+): 292.1809 ([M+H]+, C19H22N3 requires 292.1808). 
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4,4-difluoro-1,3,5,7-tetramethyl-8-(4-aminophenyl)-4-bora-3a,4a-diaza-s-indacene, 135 
NH2
N
B
N
FF  
DIPEA (0.5 ml) was added to a solution of 137 (32 mg, 0.11 mmol) in DCM (10 ml) and this was 
stirred for 10 minutes. BF3•OEt2 (0.5 ml) was added and the reaction was left to stir for 45 
minutes. A mixture of water and 2M NaOH (30 ml 1:1) was added and the aqueous layer 
separated and extracted with DCM (2 x 20 ml). The combined organic extracts were 
dried over MgSO4, filtered and concentrated under reduced pressure to yield a dark 
orange oil. Flash column chromatography (DCM, alumina) gave 135 (12 mg, 32%) as an 
orange solid. λmax (acetone)/nm: λex 502, λem 512; δH (500 MHz, CDCl3): 7.00 – 7.02 (2H, 
m, AA’ part of the AA’XX’ system, H2’ and H6’),  6.77 – 6.79 (2H, m, XX’ part of the 
AA’XX’ system, H3’ and H5’), 5.98 (2H, s, H2 and H6), 2.54 (6H, s, C3Me and C5Me), 
1.49 (6H, s, C1Me and C7Me); δC (126 MHz, CDCl3): 155.1 (C5 and C3), 147.1 (C4’), 143.3 
(C7 and C1), 129.1 (C8), 124.9 (C1’), 121.1 (C1a and C7a), 115.6 (C2’ and C6’), 123.9 (C3’ 
and C5’), 120.4 (C2 and C6), 14.8 (C3Me and C5Me), 14.7 (C1Me and C7Me); δF (376 
MHz, CDCl3): -146.9 – -146.7 (m); δB (128 MHz, CDCl3): 0.79 (t, JB-F 31); m/z (ES+): 
340.1787 ([M+H]+ C19H21N3BF2 requires 340.1791). 
4,4-difluoro-1,3,5,7-tetramethyl-4-bora-3a,4a-diaza-s-indacene, 153 
N
B
N
FF  
2,4-Dimtheylpyrrole (0.21 ml, 2.10 mmol) and formic acid (0.04 ml, 1.05 mmol) were 
dissolved in DCM (2 ml). To this was added a drop of TFA and the resulting solution 
was stirred for 2 hours. Et3N (0.27 ml, 2.84 mmol) and BF3•OEt2 (0.36 ml, 2.84 mmol) 
were added and stirring was continued for 1 hour. Water (10 ml) was added and the 
aqueous layer separated and extracted with DCM (2 x 10 ml). The combined organic 
extracts were dried over MgSO4, filtered and concentrated under reduced pressure to 
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yield a dark orange oil. Flash column chromatography (DCM, silica) gave 153 (2 mg, 
0.01%) as an orange solid. λmax (acetone)/nm: λex 503, λem 508; m/z (ES+): 248.2 [M+H]+  
4,4-diphenyl-1,3,5,7-tetramethyl-8-(4-phenyl)-4-bora-3a,4a-diaza-s-indacene, 154 and 
4-fluoro-4-phenyl-1,3,5,7-tetramethyl-8-(4-phenyl)-4-bora-3a,4a-diaza-s-indacene, 155 
N
B
N
F
N
B
N
 
To a stirring solution of 122 (150 mg, 0.46 mmol) in THF (5 ml) was added PhMgBr (2 
eq) and the resulting solution was left to stir for 1 hour. Water (10 ml) was added and 
the aqueous layer separated and extracted with diethyl ether (2 x 20 ml). The combined 
organic extracts were dried over MgSO4, filtered and concentrated under reduced 
pressure to yield a brown solid. Flash column chromatography (CHCl3) gave 154 
(35 mg, 8%) as an orange oil and 155 (29 mg, 8%) as an orange oil. Data for 154: λmax 
(acetone)/nm: λex 502, λem 523; δH (500 MHz, CDCl3): 7.59 – 7.61 (3H, m, ArH), 7.43 – 
7.48 (4H, m, ArH), 7.32 – 7.34 (5H, m, ArH), 7.19 – 7.24 (3H, m, ArH), 5.92 (2H, s, H2 
and H6), 1.78 (6H, s, C3Me and C5Me), 1.39 (6H, s, C1Me and C7Me); δC (126 MHz, 
CDCl3): 154.7 (C3 and C5), 142.5 (C1 and C7), 141.4 (C8), 140.4 (ArC), 136.2 (ArC), 134.0 
(ArC), 131.6 (C1a and C7a), 129.0 (ArC), 128.9 (ArC), 128.9 (ArC), 128.7 (ArC), 128.6 
(ArC), 127.4 (ArC), 127.3 (ArC), 127.2 (ArC), 125.8 (ArC), 122.1 (C2 and C6), 17.1 (C1Me 
and C7Me), 14.9 (C3Me and C5Me); δB (128 MHz, CDCl3): -0.01 (s); m/z (ES+): 440.3 
[M+H]+ (5%), 363.3 [M-Ph]+ (100). 
Data for 155: λmax (acetone)/nm: λex 503, λem 523; δH (700 MHz, CDCl3): 7.35 – 7.55 (8H, 
m, ArH), 7.16 – 7.23 (2H, m, ArH), 5.88 (2H, s, H2 and H6), 2.20 (6H, s, C3Me and 
C5Me), 1.40 (6H, s, C1Me and C7Me); δC (176 MHz, CDCl3): 155.6 (C3 and C5), 142.1 
(C1a and C7a), 141.9 (C1 and C7), 133.2 (ArC), 132.0 (ArC), 131.1 (C8), 129.24 (ArC), 
129.18 (ArC), 129.0 (ArC), 128.4 (ArC), 128.3 (ArC), 127.4 (ArC), 127.1 (ArC), 126.3 
(ArC), 121.5 (C2 and C6), 15.4 (C1Me and C7Me), 14.6 (C3Me and C5Me); δF (376 MHz, 
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CDCl3): -147.4 (br s); δB (128 MHz, CDCl3): 2.96 (br s); m/z (ES+): 382.2 [M+H]+ (100%), 
363.2 [M-HF]+ (30) 
5-(4-Methoxyphenyl)-furan-2-carbaldehyde, 157 
MeO
O
CHO
 
5-Bromo-2-furaldehyde (0.53 g, 3.03 mmol) and 4-methoxyphenylboronic acid (0.46 g, 
3.03 mmol) was dissolved in toluene (18 ml), ethanol (4.5 ml) and 2M sodium carbonate 
(3 ml) and the resulting solution was degassed using the freeze-pump-thaw method. 
Pd(dppf)2Cl2.DCM (14 mg, 3% by mass of boronic acid) was added and the reaction 
mixture heated to 110 °C for 13 hours. This was left to cool to rt, water (30 ml) was 
added and the aqueous layer separated and extracted with toluene (2 x 30 ml). The 
combined organic extracts were dried over MgSO4, filtered and concentrated under 
reduced pressure to yield an orange oil. Flash column chromatography, gradient 
elution (95% hexane/EtOAc to 70% hexane/EtOAc) gave 157 (0.48 g, 80%) as an orange 
oil. δH (700 MHz, CDCl3): 9.59 (1H, s, CHO), 7.75 – 7.76 (2H, m, AA’ part of the AA’XX’ 
system, H2’ and H6’), 7.29 (1H, d 3J 4, furan H), 6.95 – 6.96 (2H, m, XX’ part of the 
AA’XX’ system, H3’ and H5’), 6.70 (1H, d 3J 4, furan H), 3.85 (3H, s, OMe); δC (175 MHz, 
CDCl3); 177.0 (CHO), 161.0 (C4’), 159.9 (C5), 151.8 (C2), 127.1 (C2’ and C6’), 121.9 (C1’), 
114.6 (C3’ and C5’), 106.4 (furan C), 55.5 (OMe); m/z (ES+): 203.0703 ([M+H]+, C12H11O3 
requires 203.0703) 
Ethyl 2-(4-Methoxyphenyl)-4H-furo[3,2-b]pyrrole-5-carboxylate, 158 
MeO
O
N
H
COOEt
 
157 (920 mg, 4.56 mmol) and ethyl azidoacetate (2.4 g, 18.2 mmol) were dissolved in 
anhydrous EtOH (30 ml) and stirred at 0 °C. A solution of sodium ethoxide (20% 
weight in EtOH, 1.24 g, 18.2 mmol) was added dropwise and the resulting solution was 
stirred for 2 hours. Saturated ammonium chloride solution (50 ml) was added and the 
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yellow precipitate that formed was collected by centrifugation. This was washed with 
water and dried. The yellow solid was redissolved in toluene (15 ml) and heated to 
reflux for 90 minutes. The reaction was cooled to rt and the solvent was removed under 
reduced pressure to yield an orange oil. Flash column chromatography (25% 
EtOAc/petroleum ether) gave 158 (342 mg, 26%) as an orange solid. Found: C, 67.80 H, 
5.19 N, 4.60; Calc. for C16H15NO4: C, 67.36 H, 5.26 N, 4.91; δH (500 MHz, CDCl3): 9.86 
(1H, br s, NH), 7.54 – 7.56 (2H, m, AA’ part of the AA’XX’ system, H2’ and H6’), 6.82 – 
6.84 (2H, m, XX’ part of the AA’XX’ system, H3’and H5’), 6.67 (1H, d 4J 0.5, H6), 6.49 
(1H, s, H3), 4.25 (2H, q 3J 7, CH2), 3.74 (3H, s, OMe), 1.29 (3H, t 3J 7, CH3); δC (125 MHz, 
CDCl3): 162.0 (C=O), 159.7 (C2), 159.4 (C4’), 147.1 (QC), 130.9 (QC), 125.3 (C2’ and C6’), 
124.1 (C1’), 123.3 (C5), 114.1 (C3’ and C5’), 96.3 (C6), 92.3 (C3), 60.1 (CH2), 55.2 (OMe), 
14.4 (CH3); m/z (ES-): 284.0926 (M-H-, C16H14NO4 requires 284.0928) 
2-(4-Methoxyphenyl)-4H-furo[3,2-b]pyrrole-5-carboxylic acid, 159 
 
MeO
O
N
H
COOH
 
158 (150 mg, 0.53 mmol) was dissolved in EtOH (5 ml). NaOH (316 mg, 7.89 mmol) in 
water (5 ml) was added and the reaction stirred at reflux for 1.5 hours. The solution was 
cooled to rt and acidified to pH 1 with HCl. The resulting purple precipitate was 
collected by centrifugation, washed with water (5 ml), dried and gave 159 (135 mg, 
99%) as a grey-purple solid. δH (500 MHz, d6-DMSO): 12.3 (1H, br s, OH), 11.6 (1H, br s, 
NH), 7.72 – 7.74 (2H, m, AA’ part of the AA’XX’ system, H2’ and H6’), 6.97 – 7.01 (2H, 
m, XX’ part of the AA’XX’ system, H3’and H5’), 6.96 (1H, d 4J 1, H3), 6.70 (1H, dd 4J 1 
and 5J 0.5, H6), 3.79 (3H, s, OMe); δC (125 MHz, CDCl3): 163.2 (C=O), 159.8 (C4’), 159.4 
(C2), 147.1 (QC), 131.3 (QC), 125.9 (C2’ and C6’), 124.6 (C5), 124.4 (C1’), 115.1 (C3’ and 
C5’), 96.4 (C6), 94.0 (C3), 55.9 (OMe); m/z (ES-): 257.1 [M-H]- 
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4,4-difluoro-di(4-methoxyphenyl)-difuro[2,3-b]-[3,2-g]-8-(4-phenyl)-4-bora-3a,4a-
diaza-s-indacene, 160 
N
B
N
FF
OO
OMeMeO
 
159 (200 mg, 0.94 mmol) and benzoyl chloride (88 mg, 0.47 mmol) were stirred in DCM 
(10 ml) for 2 hours. Et3N (0.24 ml, 1.69 mmol) and BF3•OEt2 (0.32 ml, 2.54 mmol) were 
added and the reaction stirred for 1 hour. Water (20 ml) was added and the aqueous 
layer was separated and extracted with DCM (2 x 20 ml). The combined organic 
extracts were dried over MgSO4, filtered and concentrated under reduced pressure to 
yield a green oil. Flash column chromatography (50% DCM/hexane) gave 160 (179 mg, 
30%) as a green oil. λmax (CHCl3)/nm: λex 678, λem 687; δH (500 MHz, CDCl3): 7.75 – 7.77 
(4H, m AA’ part of AA’XX’ system, H2’ and H6’), 7.56– 7.59 (2H, m, ArH), 7.51 – 7.55 
(3H, m, ArH), 6.97 – 6.99 (4H, m XX’ part of AA’XX’ system, H3’ and H5’), 6.87 (2H, s, 
H6), 6.25 (2H, s, H3), 3.88 (6H, s, OMe); δC (126 MHz, CDCl3): 168.0 (C4’), 161.5 (QC), 
149.8 (QC), 145.3 (QC), 131.1 (QC), 130.8 (QC), 129.8 (ArC), 129.3 (ArC), 129.0 (ArC), 
128.4 (ArC), 127.3 (C2’ and C6’), 126.7 (ArC), 122.8 (C1’), 118.6 (QC), 114.7 (C3’ and C5’), 
103.1 (C6), 94.2 (C3), 55.6 (OMe); δF (376 MHz, CDCl3): -146.9 - -146.7 (m); m/z (ES+): 
561.3 [M+H]+ 
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1,3,5,7-tetramethyl-8-(4-nitrophenyl)-dipyrromethane, 162 
NO2
HNNH
 
TFA (0.27 mmol, 0.02 ml) was added to a stirred solution of 4-nitrobenzaldehyde 
(300 mg, 1.99 mmol) and 2,4-dimethylpyrrole (0.42 ml, 4.17 mmol) in DCM (10 ml). The 
resulting solution was stirred for 10 minutes. Water (20 ml) was added and the aqueous 
layer separated and extracted with DCM (2 x 20 ml). The combined organic extracts 
were dried over MgSO4, filtered and concentrated under reduced pressure to yield a 
brown oil. Flash column chromatography (DCM) gave 162 (410 mg, 64%) as a brown 
solid. δH (500 MHz, CDCl3): 8.13 – 8.15 (2H, m, AA’ part of the AA’XX’ system, H3’ and 
H5’), 7.32 – 7.34 (2H, m, XX’ part of the AA’XX’ system, H2’ and H6’), 5.75 (2H, s, H2 
and H6), 5.55 (2H, s, NH), 2.19 (6H, s, Me), 1.83 (6H, s, Me); δC (126 MHz, CDCl3): 152.6 
(C5 and C3), 148.0 (C4’), 145.3 (C7 and C1), 139.7 (C8), 135.7 (C1’), 135.5 (C1a and C7a), 
130.8 (C2’ and C6’), 123.9 (C3’ and C5’), 120.4 (C2 and C6), 16.2 (C3Me and C5Me), 15.0 
(C1Me and C7Me); m/z (ES+): 324.4 [M+H]+ 
7.2 Biology 
7.2.1 General Procedures 
Flow Cytometry 
Flow cytometric analysis and sorting was conducted using a Beckman Coulter MoFlo 
multi-laser flow cytometer operating at 60 psi and a 70 μm nozzle. Samples were 
interrogated with a 100 mW, 488 nm solid state laser. Fluorescence signals were 
detected and collected through the FL1 (530/40) and FL2 (580/30) interference filter in 
logarithmic mode. The data were analysed using Summit v4.3 (Beckman Coulter) 
software. 
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Confocal Microscopy 
The samples were observed using a Zeiss 510 inverted confocal microscope, with an 
Argon/Krypton laser, equipped with a Plan-Neofluor 40x 1.3 oil immersion objective. 
127 fluorescence was imaged using excitation with a 488 nm laser, coupled with a 505–
530 nm band pass filter and mCherry fusions were imaged using a 543 nm laser with a 
650-nm-long pass filter. For each fluorophore combination, controls lacking each 
fluorophore in turn confirmed negligible channel crosstalk and autofluorescence 
(except from chloroplasts). Images were edited with Zeiss LSM Image Browser.  
FlashScan Kinetic Analysis 
Enzymatic kinetic analysis was performed using a FlashScan 550 (Analytik Jena AG).  
The data were analysed using WinFLASH (Analytik Jena AG) software. 
Site-Directed Mutagenesis and Error-prone Polymerase Chain Reaction 
All PCR reactions were undertaken in a ThermoHybaid PCR Sprint thermocycler 
(Thermo Scientific) or an Eppendorf Mastercycler Gradient using standard PCR tubes. 
Primer Design and DNA Sequencing 
Primers were supplied by MWG Biotech, Ebersberg, Germany and sequencing was 
performed by DBS Genomics, Durham, UK or GATC Biotech AG, Konstanz, Germany. 
Protein analysis via SDS-PAGE 
SDS-PAGE gels were ran using a Mini-PROTEAN® 3 cell system (BioRad) and analysed 
using fluorescent imaging on a Gel Doc™ EQ system (BioRad), using Quantity One® 
1-D Analysis software. 
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7.2.2 Experimental detail 
Isolation of protoplasts from Arabidopsis thaliana leaves 
Driselase from Basidiomycetes sp. (100 mg), cellulase from Aspergillus niger (30 mg), 
pectinase from Rhizopus sp. (20 mg), CaCl2.2H2O (7.5 mg) and sucrose (1.75 g) were 
dissolved in dH2O (10 ml). Small leaves were removed from an At plant, using a 
scalpel, approximately 2 months after seeding. Plant material (~200 mg) was placed 
into above enzyme solution (2.5 ml) and left at rt for 24 hours. The enzyme solution was 
removed and placed into an eppendorf tube. The contents were allowed to settle for 30 
minutes during which time the protoplasts floated to the top. These were drawn off and 
placed into an eppendorf tube containing 10 mM sucrose. This was repeated and the 
concentration of protoplasts determined using a haemocytometer. Concentrations were 
typically in the range of 3 x 105 protoplasts/ml 
Isolation of protoplasts from Arabidopsis thaliana cell cultures 
Driselase from Basidiomycetes sp. (100 mg), cellulase from Aspergillus niger (30 mg), 
pectinase from Rhizopus sp. (20 mg), CaCl2.2H2O (7.5 mg) and sucrose (1.75 g) were 
dissolved in dH2O (10 ml). Protoplasts were harvested from At 5 days after being 
subcultured. The cell culture suspension was filtered through nylon mesh, washed with 
distilled water and dried to form a yellow powder. This was placed in the above 
enzyme solution (2.5 ml) and left at rt for 24 hours. The enzyme solution was removed 
and placed into an eppendorf tube. The contents were allowed to settle for 30 minutes 
during which time the protoplasts floated to the top. These were drawn off and placed 
into an eppendorf tube containing 10 mM sucrose. This was repeated and the 
concentration of protoplasts determined using a haemocytometer. Concentrations were 
typically in the range of 3 x 105 protoplasts/ml 
Protein extraction from Arabidopsis thaliana 
5 g of At leaves were ground to a fine powder in a pestle and mortar containing liquid 
N2 and sand. A cold solution fo Tris buffer (20 ml, 0.1 M, pH 7.4), EDTA (200 μL, 
5 mM), DTT (40 μL, 2mM) and PVPP (1 g) was added and the leaves were further 
ground up. The suspension was sieved through fabric filter paper to remove large 
debris and the resulting suspension was centrifuged (10 minutes, 10,000 RCF). The 
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supernatant was poured off and collected. (NH4)2SO4 (7.56 g) was added to the 
supernatant as 5 portions over 10 minutes. The tube containing the suspension was 
placed on ice and gently shaken for 30 minutes. The solution was placed into eppendorf 
tubes and centrifuged (10 minutes, 12,000 RCF). The supernatant was poured off with 
the protein pellet remaining at the bottom, which were stored at -80 °C. 
A gel filtration column was placed in a centrifuge tube and centrifuged (2 minutes, 1000 
RCF). Tris buffer (0.1 M, pH 7.4) was added to the column, which was centrifuged 
again (2 minutes, 1000 RCF). 2 protein pellets were taken up into 0.1 M Tris buffer 
(1 ml, 0.1 M, pH 7.4), placed on the top of the column and centrifuged (2 minutes, 1000 
RCF). The protein was suspended in solution and used immediately. 
Bradford protein concentration assay 
0, 20, 40, 60 and 80 μL of γ1A standard protein was placed into separate cuvettes and 
made up to 1 ml with Bradford’s reagent. 0, 5 and 10 μL of At protein extract were 
placed into separate cuvettes and made up to 1 ml with Bradford’s reagent. After 5 
minutes absorbance readings at 595 nm were taken using a spectrophotometer. 
Error-prone PCR of atcxe12 
The atcxe12 gene contained in the pET24d vector was isolated from E. coli XL10 
(Stratagene) cells using the QIAprep Spin Miniprep kit (Qiagen) and used as a template 
for error-prone PCR with the D473G Pfu (exo-) DNA polymerase. All reactions were 
carried out with the primer pair NcoIF (5’-TTAAGAAGGAGATATACCATGGATG-3’) 
and XhoIR (5’-TGGTGGTGGTGGTGGTGCTCGAG-3’). The cycling parameters were 
98 °C for 2 mins, 30 cycles of 95 °C for 30 sec, 55 °C for 35 sec and 70 °C for 2 mins 
10 secs and a final cycle of 95 °C for 30 sec, 55 °C for 35 sec and 70 °C for 10 mins. The 
Pfu D473G PCR mixture contained 0.25 μM each dNTP, 150 ng AtCXE12 template, 5 μL 
Pfu buffer, 100 ng of each primer, sterile dH2O up to a final volume of 50 μL and 1 μL of 
Pfu D473G. Amplified megaprimers (1 Kb) obtained by PCR were purified from a 1% 
agarose gel using the Perfectprep® Gel Cleanup kit (Eppendorf). Their concentrations 
were determined by a ND-1000 spectrophotometer (NanoDrop) with excitation at 
230 nm. 
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The remainder of the construct was synthesised using the high-fidelity DNA 
polyermase Phusion (Finnzymes). The PCR mixture consisted of 250 ng megaprimer, 
500 ng AtCXE12 template, 0.25 μM each dNTP, 5 μL Pfu buffer, sterile dH2O up to a 
final volume of 50 μL and 1 μL Phusion. The cycling parameters were 95 °C for 2 mins, 
26 cycles of 95 °C for 35 sec, 55 °C for 40 sec and 69 °C for 6 mins. Mutants obtained by 
PCR were purified with a QIAquick PCR purification kit (Qiagen). DpnI digestion was 
undertaken on 20 μL of the purified PCR mixture, with the addition of 1 μL DpnI, 3 μL 
Tango buffer and 6 μL sterile dH2O. This mixture was incubated at 37 °C for 4 hours. 
The resulting mutated plasmid library was isolated from E. coli XL10 (Stratagene) cells. 
Bacterial transformation 
Amplification of plasmid DNA was achieved by transforming competent E. coli XL-10 
ultracompetent cells (Stratagene). 1 μL of the appropriate plasmid was added to 20 μL 
of competent cells and incubated on ice for 5 mins. The cells were then heat shocked for 
30 secs at 42 °C and placed back on ice for 2 mins. 80 μL LB media was added and cells 
were incubated at 37 °C with shaking at 270 rpm, for 1 hour. Competent cells were 
plated onto agar plates containing the appropriate antibiotic and incubated overnight at 
37 °C.  
Protein expression 
Following transformation of E. coli tuner(DE3)pRARE cells (Novagen) cultures were 
grown to an OD (measured at 600 nm) of 0.6 at 37 °C, then cooled to 10 °C prior to 
induction with IPTG (100 μL, 1 mM). Following growth at 37 °C for 2 hours, bacteria 
were pelleted and resuspended in a solution of 20 mM Tris/0.5 M NaCl/20 mM 
imidazole (5 ml) and sonicated for 30 secs. Recombinant His-tagged proteins were then 
purified by nickel-chelate affinity chromatography.92 
Site-directed mutagenesis 
The atcxe12 gene contained in the pET24d vector was isolated from E. coli XL10 
(Stratagene) ultracompetent cells using the QIAprep Spin Miniprep kit (Qiagen) and 
used as a template for site-directed mutagenesis with the Pfu ultra DNA polymerase 
(Stratagene). All reactions were carried out with the primer pair Y198AF 
(5’-GGAATCATCTTGCTTCATCCTGCCTTCTGGTCGAAAACA-3’) and Y198AR (5’-
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GGTGTTTTCGACCAGAAGGCAGGATGAAGCAAGATGATTCC-3’). The cycling 
parameters were 95 °C for 1 mins, 17 cycles of 95 °C for 50 sec, 60 °C for 50 sec and 
68 °C for 6 mins 10 secs and a final cycle of 95 °C for 50 sec, 60 °C for 50 sec and 68 °C 
for 7 mins. The Pfu ultra PCR mixture contained 0.25 μM each dNTP, 50 ng atcxe12 
template, 5 μL 10x reaction buffer, 100 ng of each primer, sterile dH2O up to a final 
volume of 50 μL and 1 μL of Pfu ultra. DpnI digestion was undertaken on 20 μL of the 
PCR mixture, with the addition of 0.5 μL DpnI. This mixture was incubated at 37 °C for 
1 hour. The resulting mutated plasmid was isolated from Top 10 (Invitrogen) 
competent cells. 
DNA Cloning – Digestion and Ligation 
DNA fragments to be ligated were prepared by digestion with the appropriate 
restriction enzyme (1 μL) at 37 °C for 2.5 hours. Fragments were separated by 
electrophoresis and following excision from the gel were purified using the QIAquick 
Gel Extraction kit (QIAgen). 
Agrobacterium tumefaciens transformation and infiltration 
Amplification of plasmid DNA was achieved by transforming Agrobacterium cells. 1 μL 
of the appropriate plasmid was added to 20 μL of Agrobacterium cells. The cells were 
electroporated (2400 V, Gene Pulser Xcell, Bio-Rad) and 250 μL prechilled LB media 
was immediately added. Cells were incubated at 28 °C for 2 hours. 100 μL was plated 
onto agar plates containing kanamycin, rifampicin and gentamycin and incubated at 
28 °C for 2 days.  
A single colony was incubated overnight in LB media at 28 °C. Cultures were mixed 1:1 
with similarly prepared cultures containing the construct 35S:p19, to provide co-
expression of the tomato bushy stunt virus p19 protein The resulting suspension was 
centrifuged (3 minutes, 10,000 RCF) and the pellet resuspended in dH2O. Underside of 
Nicotiana benthamiana leaves were infiltrated using a 1 mL syringe filled with solution. 
Transformed leaf tissue were harvested 4 days later and used immediately for imaging. 
For co-localization studies, similar A. tumefaciens cultures containing the constructs px-
rk for labelling of peroxisomes206, were co-infiltrated with 127. This construct expressed 
the red fluorescent protein mCherry, with a C-terminal SKL motif added for 
peroxisomal targeting. 1 hour prior to imaging, transformed leaves were infiltrated 
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with a solution of 127 (5 μM in dH2O) and subsequently analysed by confocal 
microscopy. 
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